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 The eastern oyster, Crassostrea virginica, is an ecologically and economically 
important bivalve mollusk in the state of Louisiana.  There has been a decline in oyster 
populations during the past century due to overharvesting, habitat destruction, and 
disease.   Although overharvesting and habitat destruction have been major problems, 
along the Atlantic coast and Gulf of Mexico, diseases have plagued oyster populations 
since the 1950’s (Burreson and Calvo 1996; Ford 1996; Kennedy 1996).  These 
devastating diseases have lead to an increase in scientific research to restore eastern 
oyster populations. 
 The development of an oyster cell line would aid research into understanding of 
the physiology of oysters and the effects of viruses and pathogens.  The overall goal of 
these studies was to evaluate the effect of differential growth temperatures on in vivo cell 
proliferation of oyster somatic tissues.  The results of this study can be used for 
advancing the development of an oyster cell line. 
 This research was a collaborative effort between the Aquaculture Research 
Station (ARS), of the Louisiana State University (LSU) Agricultural Center, and the LSU 
Department of Biological and Agricultural Engineering (BAE). Portions of this project 
were presented at conferences and meetings (Table 1).  This thesis was organized into 
seven chapters.  Chapter one provides background on cell culture, oyster biology, and 
current methods for detection of cell proliferation.  At the beginning of this project, an 
assay was developed for detecting proliferating cells from in vivo somatic tissues of the 
eastern oyster (Chapter 2).   Next, an assay was developed for detecting nuclear RNA 
from in vivo somatic tissues of the eastern oyster (Chapter 3).  This assay allowed for 
 v
estimating cell proliferation by measuring cellular metabolism and conditions of in vivo 
cells in relation to environmental changes.  Finally, the effects of constant and fluctuating 
temperatures on cell proliferation and cellular metabolism were examined, by using the 
two assays, on in vivo somatic tissues of the eastern oyster (Chapters 4 and 5).  
Conclusions are covered in Chapter six. 
 Chapters 2 and 3 will be submitted for publication in Marine Biology, and 
Chapters 4 and 5 will be submitted for publication in Journal of Aquaculture 
Engineering, all chapters are written in the format of the respective journals.  A compact 
disc, which contains the text of this thesis and the unanalyzed data from this study, is 
enclosed inside the back cover. 
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The goal of this thesis was to evaluate temperature effects on cell proliferation of 
eastern oyster somatic tissues for the development of an oyster cell line.  Understanding 
the in vivo cell proliferation of an organism is essential for the development of cell 
culture.  Cell proliferation can be measured by identifying nuclear cellular proteins 
involved in growth regulation and cellular transformation.  The primary objectives of this 
study were to: 1) to develop an assay to evaluate cell proliferation, 2) develop an assay to 
analyze nuclear RNA content, and 3) to evaluate temperature effects on cell proliferation 
in somatic tissues.  
Proliferating cell nuclear antigen was detected in all the phases of the cell cycle of 
the eastern oyster.  The concentrations of PCNA increased from G0/G1-phase into the S 
phase, where it peaked in mid-S-phase, and decreased in G2/M-phase.  The 
immunohistochemically stained slides were analyzed using image analysis and compared 
to the flow cytometric detection of PCNA.   Overall, flow cytometry was superior to 
immunohistochemistry in time and cost efficiency, and in sensitivity to the detection of 
PCNA in oyster somatic tissues.  A flow cytometric assay was developed to detect 
nuclear RNA in oyster somatic tissues.  Nuclear RNA was detected in all the phases of 
the cell cycle of the eastern oyster.  The amount of nuclear RNA increased from G0/G1-
phase into the S-phase, where they peaked in mid-S-phase, and decreased in G2/M-phase.  
Temperature effects on cell cycle, proliferation, and cell metabolism of oyster somatic 
tissues were evaluated.  The cell cycle analysis of the heart and labial palps cells showed 
that the G0/G1-phase cells decreased as the S-phase and G2/M-phase cells increased.  The 
cell cycle analysis of both tissues also showed the opposite effect, as G0/G1-phase cells 
 xvii
increased the S-phase and G2/M-phase cells decreased.  Heart and labial palps cells for 
oysters held between 10°C and 25°C increased in cell proliferation after one week of 
temperature fluctuation.  The nuclear RNA/DNA ratio at all phases of the cell cycle for 
heart and labial palps cells for oysters between 15°C and 20°C was higher than at all 
other temperature regimes.  Temperature fluctuations affected the cell cycle, 
proliferation, and the metabolic condition of oyster somatic cells.These results support 
the use of flow cytometry for the analysis of cell cycle, cell proliferation, and cell 
metabolism.  The results also suggested that temperature fluctuation has an effect on cell 
cycle, cell proliferation, and cell metabolism.  Future research needs to focus on 
improving the current in vivo study and adapt the assays for cultured cells.
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CHAPTER 1 – INTRODUCTION 
In the state of Louisiana, culture of the eastern oyster, Crassostrea virginica, as 
reported in 2004 by the Louisiana Department of Wildlife and Fisheries, is a $30 million 
dockside industry.  The state’s coastal waters produce 13 million pounds or 2 to 2.5 
million sacks of oysters annually.  Louisiana exports 60% of the product to other states 
and countries.  Louisiana is the largest producer of oysters in the nation.  Oysters are a 
valuable commodity for Louisiana and must be closely regulated because of 
overharvesting and habitat destruction.  Although these are major concerns, along the 
Atlantic and the Gulf coasts, diseases have plagued oyster populations since the 1950’s 
(Burreson and Calvo 1996; Ford 1996; Kennedy 1996). 
 Infectious oyster diseases (Table 1.1), such as, “MSX” and “Dermo” have had 
significant and chronic effects on oyster populations.  The combined impact of both 
diseases has caused hundreds of millions of dollars in losses over the last 35 to 45 years 
and seriously threatens natural and cultured oyster populations (Ewart and Ford 1993).  
To control these diseases, researchers must first understand how affected organisms 
respond to the disease-causing agent, as well as knowledge of the agent itself.   
The development of oyster cell culture would be a crucial step in understanding 
oyster tissue physiology, effects of viruses and pathogens on these tissues, and would 
assist scientists in developing beneficial genetic traits such as disease resistance or 
increase growth rates.  These advantages would provide a better cultured oyster product 
and result in higher yields. 
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Table 1.1. Diseases and parasites of the eastern oyster reported for the northeastern, southern and Gulf coast region of the United 
States. 
Disease/Parasite Description Reference 
Dermo disease  
Perkinsus marinus (protozoan) 
Causes high mortalities 
Proliferates rapidly at temperature between 25°C and 30°C and 
salinity greater than 15 ppt 
Transmitted directly from oyster to oyster 
Craig et al. 1989 
Ford 1992 
La Peyre et al. 1993 




Causes high mortalities 
Active at temperatures above 10°C and intolerant of salinities 
below 10 ppt 
Mode of transmission unknown 
Ford 1988 
Burreson 1991 
Chintala and Fisher 1991 
Cardiac edema associated with 
Vibrio anguillarum 
(bacteria) 
Enlargement of pericardial chamber and heart Elston et al. 1982 
Shell disease caused by 
Ostracoblabe implexa 
(fungus) 
Penetrates and proliferates in shell, causes wart-like 
depositions at adductor muscle attachment Li et al. 1983 
Juvenile Oyster Disease 
Causes high mortalities in the northeastern U.S. 
Affects cultured oysters <25mm shell height 
Mode of transmission unknown 
Bricelj et al. 1992 
Davis et al. 1995 
Farley et al. 1995 
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This chapter is intended to provide the reader with a brief background and 
overview of the steps required to improve the development of oyster cell cultures.  
Specifically, this chapter explains the history and development of cell culture, the biology 
of the eastern oyster, and provides brief explanations of various techniques used for 
detecting proliferating cells. 
CELL CULTURE 
In 1907 Ross Harrison, an embryologist from Yale University in Connecticut, 
first grew a fragment of embryonic frog tissue in a drop of lymph fluid. The fluid hung 
from a cover slip over a hollow slide, and the tissue was enclosed in glass (in vitro) and 
could be observed using a microscope.  Harrison proved, after watching the isolated 
process over time that nerve fibers originated from a single cell.  He showed that cells 
kept in aseptic conditions at the correct temperature could live outside the body (Harrison 
1907; Landecker 2002).  Alexis Carrel, in 1912 at the Rockefeller Institute for Medical 
Research in New York, introduced the idea of continuous cultures of cells.  Not only did 
he maintain a living fragment of tissue for weeks, but used pieces of the tissue to start 
new cultures.  Carrel concluded that scientists would never need to go back to the animal 
body, if only the method could be improved to keep cells alive forever. He introduced the 
idea of “permanent life” – or immortality – to cell culture (Carrel 1912; Landecker 2002). 
Cell culture allows individual cells to act as semi-independent units, with the cells 
dividing by mitosis and the cell population growing until limited by nutrient depletion or 
by the presence of potentially toxic metabolites (Mothersill and Austin 2001).  Cultured 
cells have several advantages: cells in culture are homogeneous in their morphological 
properties; experimental conditions can be controlled more rigorously than in whole 
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organisms (Freshney 1987); standardization of in vitro systems is possible; growth of 
obligate pathogens is possible; cellular biochemistry studies are possible (Lodish et al. 
2001); studies of interactions between prokaryotic and eukaryotic cells are possible, 
allowing for the study of pathogenic mechanisms more naturally than the standard 
microbial culturing techniques; and the need for whole organism studies is reduced 
(Mothersill and Austin 2001).   
There are three types of cell cultures: primary cultures, secondary cultures, and 
immortalized or transformed cultures.  Primary cultures are explanted directly from a 
donor organism.  These cells may be able to divide once or twice and survive for some 
time in culture, but they will not continue to grow and eventually senesce and die.   These 
cells are cultured because they are thought to represent acceptable experimental models 
for in vivo situations, and because they may express characteristics not seen in long-term 
cultured cells that are more realistic to animal cells in vivo.  Secondary cultures are 
explanted from a donor organism and are able to divide and grow for some time in vitro 
(50 – 100 generations).  However, these cells do not continue to divide indefinitely and 
eventually also senesce and die.  Immortalized or transformed cells continue to grow and 
divide indefinitely in vitro as long as the culture conditions are maintained (e.g., HeLa 
cells) (Lodish et al. 2001; Cann 1999). 
There are three general concepts that are important to the development of cell 
cultures: basic methods and media, tissue choice, and characterization (Mothersill et al. 
2001).  The understanding of basic methods and media allows for flexibility in approach 
and a rapid response to observed changes in the cell culture.  This understanding is also 
valuable for the optimization of each step.  The choice of tissue for in vitro culture is 
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important because it will influence the developmental status, methodological factors, and 
eventual application of the cell culture (Freshney 1994; Evenden 2001).  Cell 
characterization in vitro is essential to be able to determine differentiated cellular 
functions and to relate to cell behavior in vivo (occurring within the living body of an 
organism) (Freshney 1994; Doyle et. al. 1993; Lyons-Alcantara 2001). 
Since Harrison and Carrel, cell culture technologies have been adapted into 
routine applications in medicine and industry and scientists are currently using cultured 
cells for research of cell membrane proteins, stem cells, and tissue engineering.  Although 
the majority of cell cultures are still developed using higher vertebrate organisms, 
scientists are shifting to developing cell cultures for lower vertebrates and invertebrate 
organisms.  The reasons for the development of these cell cultures are: the unique 
biological development of lower vertebrate and invertebrate organisms (e.g. tissue 
regeneration in amphibians and metamorphosis in insects); the need to improve pest 
control in agriculture (e.g. toxicity and virological studies in insects); interest in 
pharmaceutical compounds from the sea, and the understanding of normal biological 
development and pathogenesis to improve aquaculture (Freshney 1987).   
BIOLOGY 
A first step in the development of oyster cell cultures is to gain an understanding 
of the biology of the organism.  The eastern oyster (Phylum Mollusca and Class Bivalvia) 
is ectothermic, and thus temperature affects virtually every aspect of their biology 
including survival, feeding and growth, gonadal development and spawning, sex 
determination, larval settlement, heart rate and respiration, disease outbreaks (Shumway 
1996) and somatic tissue cell proliferation.   Eastern oysters live in shallow and semi-
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enclosed water bodies, where water temperatures can vary greatly (Fig. 1.1), along the 
east coast of North America from the Gulf of St. Lawrence to Key Biscayne, Florida and 
south through the Caribbean to the Yucatan Peninsula of Mexico and Venezuela 
(Osborne 1999).  Adult eastern oysters are commonly found in waters where the annual 
temperatures range from -2°C to 36°C (Butler 1954; Galtsoff 1964).  Survival of oysters 
is more affected by the rate in change of temperature, than actual temperatures 
(Fingerman and Fairbanks 1957). Growth rates of larval and adult eastern oysters are 
more rapid in warmer waters (Butler 1953).  In the Gulf of Mexico, an oyster can grow to 
marketable size (90 mm) in 2 years, while in cooler waters such as Long Island Sound, it 
can require 4 to 5 years to attain the same size (Shumway 1996). 
 
Figure 1.1. Daily average water temperatures in Terrebone Bay, Louisiana ranged from 
8°C, in December and January, to about 31°C from June to August in 2003. 
 
Eastern oysters have a tolerance for wide salinity ranges.  They are found in areas 
were the annual salinity variations ranges from 5 to 40 parts per thousand (ppt) (Galtsoff 
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1964; Wallace 1966).  Commercial production areas have annual salinity variations that 
range from 0 to 42.5 ppt (Ingle and Dawson 1950). 
Eastern oysters are active suspension feeders.  From the planktotrophic larval 
stage to the benthic life stages, they feed by removing suspended particles from the water 
column.  The particulate food is composed of mixtures of living organisms, detritus, and 
inorganic particles (Berg and Newell 1986; Baldwin and Newell 1991).  The suspended 
particles are pumped through the gills were they are trapped and sorted by size before 
transfer from the gills to the mouth and gut were they are ingested and digested (Beninger 
et al. 1991). 
Eastern oysters are gonochoric or dioecious alternate hermaphrodite organisms 
with an annual reproductive cycle (Mackie 1984).  That is, eastern oysters initially 
function as males and may change to females depending on environmental conditions 
such as water quality and temperature.  Eastern oysters, in an unsuitable environment 
may not develop as females (Kennedy and Battle 1964). Gonad development in females 
demands more energy and persisting unfavorable environments would limit energy for 
gametogenesis (Giese and Pearse 1974).  Gametogenesis is synchronized in eastern 
oysters, whereby eggs and sperm are released concurrently to ensure fertilization and to 
maximize the number of zygotes.  Gamete maturation was found to begin at 15°C at a 
slow rate while at higher temperatures the rate of maturation increased (Sastry 1968).  
Manipulation of water temperature, in a hatchery environment, is a means of stimulation 
to ripen eastern oysters (Loosanoff and Davis 1963).  Spawning occurs generally when 
water temperatures increase above 20°C (Hayes and Menzel 1981), it is stimulated by 
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environmental cues in the surrounding water and the presence of gametes from adjacent 
oysters (Thompson et al. 1996).  
Although a number of factors have been suggested to affect larval settlement, 
such as food supply, oxygen supply, light, type of cultch, and waterborne chemicals, 
temperature has been determined to be a major factor.  The most favorable temperatures 
for larvae to settle are between 19°C and 24°C (Ryder 1885). 
The heart rate increased in the eastern oyster as temperature increased from a 
range of 5°C to 30°C (Menzel 1956).  There is a linear relationship between the number 
of leucocytes in suspension in the hemolymph and the water temperature.  The number of 
leucocytes in suspension was influenced by heart rate (Feng 1965).  Similarly to heart 
rate, respiration decreases as temperature decreases (Shumway and Koehn 1982). 
   High temperatures promote disease outbreaks in eastern oysters (Ford and Tripp 
1996). Temperatures above 20°C favored the development of Perkinsus marinus (an 
oyster disease caused by the protistan parasite of the same name) in the Gulf of Mexico.  
Eastern oysters that were infected with P. marinus experienced 100% mortality when 
held for 4 weeks at 28°C, but when the infected oysters were held at 15°C for the same 
amount of time, the infection ceased and mortalities were negligible (Hewatt and 
Andrews 1956).  The incidence of oysters infected with Multinucleated Spore Unknown 
(MSX) disease was found to be lower at low temperatures (Hofmann et al. 2001). 
Cell proliferation in somatic tissues of the eastern oyster is known to be highly 
variable and dependent on seasonality (Nguyen et al. Department of Veterinary 
Sciences).  High proliferation is found in somatic tissues in the late fall to early spring, 
when animals are not spawning.  Cell proliferation ceases in these tissues in late spring 
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and throughout the summer while the gonads develop (Nguyen et al. Department of 
Veterinary Sciences).   
DETECTION OF CELL PROLIFERATION 
The second step in the development of the oyster cell culture is to understand the 
in vivo cell proliferation of the organism.  Understanding the cell cycle and its controls is 
the basis for various methods used in evaluating rates of proliferation in tissues (Yu et al. 
1992).  The eukaryotic cell cycle is an ordered series of events during which 
chromosomes are duplicated and one copy of each duplicated chromosome segregates to 
each of two daughter cells.  The cell cycle is controlled by a number of enzymes that 
regulate the activities of multiple proteins involved in DNA replication and mitosis.  In 
the adult organism, cell proliferation is essential in the repair processes and in normal cell 
replacement for certain tissues (Klug and Cummings 1997). 
In the late 1980’s, it was determined that chromosome replication and cell 
division processes were fundamentally similar in all eukaryotic cells.  Although mitosis is 
the shortest component of the cell cycle, it is a period of vigorous and continual activity.  
It is subdivided into four discrete phases: prophase, metaphase, anaphase, and telophase.  
After the cell has undergone mitosis, it begins a new cycle of nuclear DNA replication 
during interphase, which typically accounts for about 90% of the time that elapses during 
each cell cycle.  Interphase consists of three periods of growth: G1-phase, S-phase, and 
G2-phase.  All cells follow one of two paths.  The cell might enter a resting phase, (G0), 














Figure 1.2.  The eukaryotic cell cycle comprises four phases that proceed successively.  
Interphase comprise three phases: G1, S, and G2.  DNA is synthesized in S 
phase, and other cellular macromolecules are synthesized throughout 
interphase, so the cell doubles in its size.  The genetic material is evenly 
partitioned and the cell divides during mitosis (M).  Non-dividing cells exit 
the normal cycle and enter a quiescent state (G0). 
 
The rate of cell proliferation is different among organisms and among tissues 
within an organism (Table 1.2)(Lodish et al. 2000). 
Table 1.2.  Different eukaryotic cell cycle times. 
 
Cell type Cell cycle times 
Early frog embryo cells 30 min 
Yeast cells 1.5 – 3 hours 
Intestinal epithelial cells ~12 hours 
Mammalian fibroblasts in culture ~20 hours 
Human liver cells 1 year 
 
Cell proliferation can be measured quantitatively by direct and indirect methods.  
With direct methods, proliferation is measured by the time it takes for cell populations to 
double in number (or rate of doubling) in culture (Scott et al. 2003).  This measurement 
can also be used to determine the average doubling time of cell populations either in vitro 










division is also considered a measurement of proliferation.  Although DNA synthesis can 
occur without cell division, use of an assay to measure the quantity of cellular DNA 
being synthesized enables evaluation of the rate of proliferation.  In indirect methods, 
proliferation can be measured by calculating the number of cells undergoing mitotic 
progression minus the number of cells that are undergoing cell death.  Cell proliferation 
can also be measured by determining the length of time that it takes for cells to traverse 
between phases of the cell cycle and the effects of the interactions between each phase.  
Such assays are dependent on several factors: experimental conditions, cell cycle 
parameters under investigation, and the source and condition of cells or tissue being 
assayed. 
Assessment of cell proliferation can be done by counting mitosis, silver-staining 
of the nucleolar organizer region (AgNOR), In situ hybridization, of 5-bromo-
deoxyuridine (BrdU) uptake, tritiated-thymidine labeling, immunohistochemical 
detection of cell cycle protein, and flow cytometry. 
Mitotic index is a simple method of counting the number of cells visible in 
mitosis, but it suffers from a lack of standardization and reproducibility.  Silver staining 
of the nucleolar organizer region is relatively easy to carry out and does not require fresh 
tissue; but it recognize proteins found only in early G1 phase, and its significance and the 
practical applications of the AgNOR technique require further evaluation (Yu et al. 
1992).  In situ hybridization, a technique used to locate the chromosomal location of a 
specific DNA (or RNA) probe, for localization of histone H3 mRNA proteins is able to 
detect levels of these proteins only at the S-phase of the cell cycle (Crocker 1994).  
Staining with BrdU is an accurate method for measuring cell proliferation (Ortego et al. 
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1994).  5-bromo-deoxyuridine is an analogue of thymidine, and can be introduced to 
proliferating cells that in turn incorporate BrdU into the DNA during the S phase, prior to 
cell division (Lyons-Alcantara 2001).  Precise timing and dosage of BrdU enables tissue-
kinetic studies.  Administration of BrdU may be used for labeling tissues with low 
proliferative activity.  Incorporation of BrdU into the nucleus gives a strong and reliable 
signal regardless of the method of fixation and tissue processing (Mokroy and Nemecek 
1995).  This method measures only S phase of the cell cycle and it uses a radioactive 
thymidine analog that must be administered into living organisms (Ortego et al. 1995). 
The main principle for evaluating cell proliferation by immunohistochemical 
methods is that there are cell-cycle-associated alterations in the amount or distribution of 
cellular proteins or other molecules that can be recognized as antigens (Hall and Woods 
1990).  Immunohistochemistry is one of the most effective methods to detect cell cycle 
proteins.  Although the technology is advanced in higher vertebrates it is not well 
established for marine invertebrates.  Most commercial antibodies are produced against 
human proteins only (Lyons-Alcantara et al. 1999).  Antibodies that recognize a 
particular site on human antigens called an antigenic determinant (or epitope) have been 
applied to crustaceans and cross-reactivity has been demonstrated (Lyons-Alcantara et al. 
2002).  The assessment of cell proliferation can be done by several immunohistochemical 
methods, but each has inherent advantages and disadvantages.  The best-known 
endogenous proliferating markers are Ki-67 and proliferating cell nuclear antigen 
(PCNA) that may be detected with specific commercially available antibodies.  Ki-67 is a 
non-histone nuclear antigen tightly associated with the cell cycle.  In cells from 
mammals, the Ki-67 antigen expression is found in mid-to-late G1 phase, rises through S 
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phase and G2 phase to reach a maximum in mitosis, but is not found in the resting phase 
(G0) (Gerdes et al. 1984).  An immunohistochemical assay for the endogenous marker, 
proliferating cell nuclear antigen, avoids most of these disadvantages.  Proliferating cell 
nuclear antigen, a stable and highly conserved nuclear protein found in higher vertebrate 
tissues, is directly involved in DNA synthesis, and is synthesized during all phases of the 
cell cycle except the resting phase (G0) (Kurki et al. 1986).  Nuclear PCNA 
concentrations vary during the cell cycle.  In mammalian cells, the PCNA concentration 
begins to increase from the G1 phase, peaks at the G1 phase/S phase interface, decreases 
through the G2 phase, and reaches undetectable levels in quiescent cells (Morris and 
Matthews 1989).  The increasing concentrations of PCNA protein can be detected by 
monoclonal antibodies (Erlanson et al. 1997).  The development of monoclonal 
antibodies against PCNA has facilitated the estimation of growth activities of human 
malignant tumors and has allowed retrospective analysis of formalin fixed-paraffin-
embedded tissues (Garcia et al. 1989; Waseem et al. 1990; Wilkins et al. 1992). 
To detect immunoreactivity of antibody binding to PCNA, several factors must be 
considered: the type of antibody (e.g., monoclonal or polyclonal) and fixative, the 
fixation conditions and the staining procedure (Sasaki et al. 1993).  By using antigen-
retrieving procedures, PCNA can be localized in routinely fixed paraffin-embedded 
specimens, which allows retrospective studies (Hall et al. 1990).  Although PCNA 
methodology was developed and applied mostly for mammalian tissues, PCNA has been 
identified in routinely processed, paraffin-embedded specimens of three fish species 
(medaka, Oryzias latipes; guppy, Poecilia reticulata; and western mosquitofish, 
Gambusia affinis)(Ortego et al. 1994).  The optimum staining conditions were dependent 
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on fixative, primary antibody selection, antigen retrieval processing, and protein blocking 
reagent (Ortego et al. 1994).  Proliferating cell nuclear antigen has been detected in 
proliferating cells of bivalves by use of an immunohistochemical procedure (Marigomez 
et al. 1999; Winstead 1995).  Studies, conducted at the Louisiana State University 
Department of Veterinary Science (Nguyen et al. Department of Veterinary Sciences, 
Jenkins et al. unpublished), used a modified version of a commercially available PCNA 
staining kit (Zymed Laboratories Inc., San Francisco) to examine cell proliferation in the 
eastern oyster.  The studies found that cell proliferation depended on tissue type (Jenkins 
et al. unpublished) and seasonality (Nguyen et al. Department of Veterinary Sciences).  
To determine the rate of cell proliferation the study used a labeling index expressed as the 
number of labeled cells per total cells counted for each tissue (Iatropoulos and Williams 
1996; Foley et al. 1991).  Although the PCNA immunohistochemical assay was reliable, 
it was slow and laborious, whereas flow cytometry instrumentation can quickly assess 
cell proliferation in individual cells. 
Flow cytometry was first used in medical sciences such as oncology and 
hematology.  Currently, flow cytometry has become a valuable tool in biology, 
pharmacology, toxicology, bacteriology, virology, environmental sciences, and 
bioprocess monitoring (Rieseberg et al. 2001).  Current major applications of flow 
cytometry include phenotypic analysis of cells, cell sorting, and DNA content analysis.  It 
can be used with suspensions of fresh cells, fixed cells, or cells extracted from paraffin-
embedded tissues (Martinez et al. 1990).  In flow cytometry, single cells or nuclei pass 
through a laser beam in a directed fluid stream.  As they pass through the beam a variety 
of measurements (e.g. absorption, scattering, or fluorescence) can be simultaneously 
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collected for each cell.  The forward-scattered light can be used to gather information on 
the size of the cells.  The sideways-scattered light can be used to obtain information on 
cell granularity, size, and morphology.  Intracellular components that fluoresce [e.g., 
nicotinamide adenosine dinucleotide phosphate (NADP)], or those stained with specific 
fluorescent dyes, allow for certain cell components to be selectively assayed.  The 
fluorescent emissions are processed through photomultiplier tubes in the data-processing 
system, and software analyzes the resulting data.  These measurements can be correlated 
with different cell characteristics and cell components, thus obtaining distributions of cell 
populations (i.e. segregated data) (Rieseberg et al. 2001).   
The advantages of flow cytometry over immunohistochemistry are the ability to 
objectively and rapidly analyze cellular properties (DNA content, cell cycle position, or 
ploidy).  In cell cycle analysis, flow cytometry can be used to determine the kinetics of 
progression through the phases of the cycle or to visualize the distribution of cells in a 
particular phase (Darzynkiewicz et al. 2001).  Cells in the resting phase (G0) and the G1 
phase have a DNA content that can be set equal to a relative unit typically (1.0) or 
expressed as a 2C or diploid (“C” refers to DNA mass; “N” would refer to chromosome 
number).  Cells in the S-phase are synthesizing DNA that result in an increase of DNA 
content proportional to the progression through synthesis.  In the G2 phase, and later, 
mitosis, the cell has twice the amount of DNA content (or 4C) as in the resting phase (G0) 
and the G1 phase (Martinez et al. 1990).  To determine the distribution of cells in a 
particular phase, or to quantify relative cellular DNA content, cells must be fixed or 
permeabilized with a detergent, and stained with a fluorescent dye.  Dyes are classified 
into two groups: (1) those that intercalate between base pairs of DNA and RNA (e.g., 
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ethidium bromide, propidium iodide, and acridine orange), and (2) those that are base-
specific, binding to guanine-cytosine (e.g., mithramycine and chromomycin) or adenine-
thymidine moieties (e.g., 4’-6-diamidio-2-phenylindole (DAPI) and Hoechst dyes).  
These dyes bind stoichiometrically to the DNA of each cell.  Use of dyes from either 
group requires that samples be incubated with ribonuclease (RNAse) during staining to 
remove fluorescence caused by RNA-dye complexes so that the amount of fluorescence 
is proportional to the amount of DNA in each cell (Martinez et al. 1990).  Thus, as the 
DNA content in the cells increases, so does the quantity of the dye bound, thereby 
increasing the fluorescent signal.  The fluorescence from cells in suspension can be 
rapidly integrated and displayed as a DNA frequency histogram.  These histograms show 
the proportions of cells in the respective phases of the cycle based on differences in 










Figure 1.3.  Cell cycle distribution of oyster labial palp nuclei that were labeled with 
propidium iodide as determined by flow cytometry.  The Y-axis represents 
the cell or nuclei numbers and the X-axis represents the fluorescence 
intensity that translates to the quantity of DNA per cell.  The leftmost peak 
represents cells at the G1 phase and G0 phase with 2C amounts of DNA, the 
rightmost peak represents cells in G2 phase and M-phase with 4C amount of 
DNA, and the cells in between are in the S phase undergoing DNA synthesis 
with amounts of DNA between 2C and 4C. 
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In cell proliferation analysis, flow cytometry has been used to detect the fraction 
of cells that are proliferating in vitro (Kurki et al. 1986; Sasaki et al. 1993; Lohr et al. 
1995).  Proliferating cell nuclear antigen in human cells has been successfully detected by 
flow cytometry (Kurki et. al 1986; Kurki et al. 1988; Landberg and Roos 1991; Casasco 
et al. 1993; Beppu et al. 1994; Erlanson et al. 1997).  The anti-PCNA monoclonal 
antibody (PC10) has been used as an S-phase probe in human cell lines and was 
determined to be an S-phase marker (Landberg and Roos 1991).  The percent of PC10-
positive cells was significantly correlated with cells that were in the S-phase of the cell 
cycle, as determined by DNA histograms (Erlanson et al. 1997).  The analysis of PCNA 
expression and cellular DNA content showed that S-phase expression and the fraction of 
PC10-positive cells could be determined (Landberg and Roos 1991).  A study of HeLa 
cells found that if cells were treated with a detergent (e.g. Triton X-100) to release nuclei 
and stained with anti-PCNA monoclonal antibody (PC10) it was possible to rapidly 
analyze the cell cycle without the need to label the cells with DNA precursors such as 
BrdU and 3H-thymidine (Sasaki et al. 1993). 
Thus with the technology available, development of an oyster cell-culture system 
could be possible.  This would be an essential step in addressing questions and problems 
related to oyster physiology and pathology.  There are several reports of successful short-
term oyster and molluscan cell cultures, but there are fewer reports of secondary cell 
cultures, and there has been little standardization between laboratories (Mulcahy 2001) 
(Table 1.3).  
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Table 1.3.  Primary cell cultures and cell lines of oysters and other mollusca species.   
 * The Bge cell line. 
 
Molluscan species Common name Type of cultured cells Survival time Reference 
Crassostrea virginica eastern oyster Mantel cells 42 days Perkins and Menzel 1964 
Crassostrea virginica eastern oyster Ventricles cells 10.5 months Rosenfield 1965 
Crassostrea virginica eastern oyster Cardiac cells 2-14 days Li et al. 1966 
Crassostrea virginica eastern oyster Amoebocytes 70 days Tripp et al. 1966 
Spisula solidissima surf clams Heart cells 2-120 days Cecil 1969 
Biomphalaria glabrata* freshwater snail Trochophore larvae >50 days Hansen 1976 
Crassostrea virginica eastern oyster Amoebocytes 180 days Brewster and Nicholson 1979 
Crassostrea virginica eastern oyster Heart, mantle, and gonad cells 7-21 days Hetrick et al. 1981 
Ruditapes decussatus butterfish clam Gill cells 45 days Auzoux et al. 1993 
Crassostrea gigas Pacific oyster Heart cells 10 days Le Deuff et al. 1994 
Mya arenaria soft-shell clam Heart cells 42 days Kleinschuster et al. 1996, 1997
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CHAPTER 2 – DEVELOPMENT OF A FLOW CYTOMETRIC ASSAY TO DETECT 
PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IN OYSTER SOMATIC TISSUES 
 
INTRODUCTION 
 An established cell line derived from the eastern oyster (Crassostrea virginica) 
would provide a valuable tool for pathology, molecular biology, endocrinology, cell 
kinetics, and cell physiology studies.  Successful short-term bivalve cell cultures have 
been reported, including primary cultures of gill cells of the hard clam (Meretrix lusoria), 
heart cells from the Pacific oyster (Crassostrea gigas), and embryoic cells of the 
Japanese scallop (Mizuchopecten yessoensis) (Chen et al. 1989; Odintsova and 
Khomenko 1991; Le Deuff et al. 1994).  In vitro studies of primary cell cultures from 
bivalve mollusks are limited by the low number of proliferating cells (Lowe and Pipe 
1994; Giard et al. 1998).  Effective efforts to stimulate cell division in oysters and other 
bivalve primary cultures have used vertebrate growth-promoting factors, but continuous 
mitotic activity has not been reported (Giard et al. 1998). 
A crucial aspect in the establishiment of any cell line is monitoring the 
proliferation rate of the cells in culture (Doyle et al. 1993).  Cell proliferation is an 
essential biological process for normal tissue growth and for the repair of damaged 
tissues due to pathogenic agents (Hillman 1963; Nelson and Morton 1979; Mix 1971; 
Awaji and Suzuki 1995; Ortego et al. 1995).  Cell proliferation and mitotic activity is 
most commonly measured by DNA synthesis.  Evidence of cell proliferation in the great 
scallop (Pecten maximus) (Le Marrec-Croq et al. 1999) and Pacific oyster (Cornet 2000) 
has been shown by using a combination of colchicine with Giemsa staining, and [3H]-
thymidine and 5-bromo-deoxyuridine (BrdU) for dynamic staining.  Although this latter 
technique was successful, it was technically demanding and required live tissues. 
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 Identification of nuclear proteins involved in cell proliferation helps to understand 
growth regulation and cellular transformation.  Proliferating cell nuclear antigen (PCNA), 
also known as cyclin (Bravo and Celis 1980; Bravo et al. 1984; Takasaki et al. 1984), is a 
nuclear auxiliary protein of DNA polymerase δ (Tan et al. 1986; Bravo et al. 1987), and 
essential for DNA synthesis and repair, and is found at different concentrations during the 
cell cycle (Leonardi et al. 1992; Bravo 1986).  A study of mammalian tissues found two 
different PCNA populations in different cellular locations (Landberg and Roos 1991).  
One was found in the nucleus tightly bound to intracellular structures and is closely 
associated with DNA replication, while the other was found in the nucleus and 
cytoplasm, where it is loosely bound to nuclear structures and is believed to assist in 
DNA repair (Landberg and Roos 1991; Erlanson 1997; Beppu 1994).   
Monoclonal antibodies against PCNA have been developed for mammalian 
applications and used in immunohistochemical and flow cytometric assays (Kurki et. al. 
1988; Robbins et. al 1987; Garcia et. al. 1989).  Immunohistochemical assays have been 
adapted to identify proliferating cells in vertebrate aquatic organisms such as winter 
flounder (Pleuronectes americanus), English sole (Pleuronectes vetulus), mummichog 
(Fundulus heteroclitus) medaka (Oryzias latipes), guppy (Poecilia reticulata), and 
western mosquitofish (Gambusia affinis) (Ortego et al. 1994; Ortego et al. 1995).  The 
immunohistochemical assay has also been adapted for invertebrate marine organisms 
such as the eastern oyster (Crassostrea virginica) (Nguyen et al. Department of 
Veterinary Sciences) and common marine mussel (Mytilus galloprovincialis) 
(Marigomez et al. 1999).  Although this technique is effective for paraffin-embedded 
tissues, it is time consuming and expensive.  A flow cytometric assay to detect the 
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monoclonal antibody anti-PCNA has not been developed for vertebrate or invertebrate 
aquatic organisms.  This assay would provide a detailed, rapid, and accurate analysis of 
growth kinetics of cycling cells; it could be adapted to analyze cells from paraffin-
embedded tissues. 
Intracellular antigen detection by flow cytometry is dependent on optimal 
membrane permeabilization and fixation methods due to variable antigen characterization 
(Landberg and Roos 1992; Beppu et al. 1994).  In this report, we discuss the development 
of a flow cytometric assay to detect PCNA in oyster somatic tissues.  The objectives of 
this study were to: (1) optimize cell fixation, (2) optimize cell permeabilization, and (3) 
compare between flow cytometric analysis and immunochistochemical staining for the 
detection of PCNA.  We were able to detect PCNA and found that the fluorescence was 
13-times higher in S phase than in G0/G1 or in G2/M phase of the cell cycle in heart cells.  
We determined that a paraformaldehyde fixation method could be used for fresh heart 
and labial palp tissues, and that flow cytometry was more sensitive in detecting PCNA 
than the immunohistochemical method. 
MATERIALS AND METHODS 
Oyster Collection 
Eastern oysters were collected in August 2003 from the Louisiana Sea Grant 
Oyster Hatchery at Grand Isle, Louisiana, (90° 2’ 13.3” W, 29° 12’ 26” N) and were 
maintained for 10 weeks in an indoor temperature-controlled recirculating system until 
use.  The oysters were kept at a water temperature of 27°C with a salinity of 18 parts per 
thousand.  Cross sections (4-5mm) of the labial palps and the junction posterior to the 
labial palps and gills were collected and placed in embedding cassettes, and fixed in     
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4% formalin [36% concentrated formaldehyde diluted in sterilized artificial seawater 
(HW marine mix, Wiegandt GmbH Co., Krefeld, Germany)] for 24 hr.  The salinity 
sterile artificial seawater was adjusted according to the water salinity of the indoor                    
temperature-controlled recirculating system. 
Cell Preparation 
Oysters were opened and the heart and labial palps were surgically removed.   For 
the analysis by flow cytometry, the hearts and labial palps were crushed using a 
homogenizer with a glass pestle.  The cells were suspended in 0.01M-phosphate buffered 
saline (PBS) (1.37 M NaCl, 0.03 M KCl, 0.009 M KH2PO4, 0.06 M Na2HPO4, pH 7.4) 
and filtered through a 35-µm mesh to remove connective tissue. Samples were placed 
into 1.5-mL microcentrifuge tubes at a concentration of 2 X 106 cell/mL and placed on 
ice.  These samples were used to optimize a permeabilization protocol.  After an optimum 
permeabilization method was determined; it was used to test different fixation methods. 
Permeabilization 
Cells were centrifuged at 400-X g for 10 min at 4ºC, and the supernatant was 
discarded.  The cell pellet were resuspended in 750 µL of lysing buffer, modified from 
Langdberg and Roos (1991) containing 2% bovine serum albumin (Sigma) in PBS, 1% of 
the non-ionic detergent NP – 40 (Sigma), and 0.2 µg/mL of ethylenediamine tetra-acetic 
acid (EDTA) (Fisher Scientific Company, Pittsburgh, PA) for 15 min on ice.  The lysed 
cells were centrifuged at 400-X g for 10 min at 4ºC.  The lysis buffer was discarded and 
the pellet was washed twice with PBS by centrifugation.  The nuclei were resuspended in 
200 µL of PBS.   
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Fixations 
Nuclei were centrifuged at 400-X g for 10 min at 4ºC.  The supernatant was 
discarded and the nuclei resuspended using four different fixation methods: (1) 100% 
methanol for 10 min at -20ºC, (2) 70% ethanol for 10 min at -20ºC, (3) 70% acetone for 
10 min at -20ºC, followed by washing in PBS with 70% methanol for 15 min at -20ºC 
(70% acetone and 70% methanol), and (4) 2% paraformaldehyde for 15 min on ice. 
Monoclonal Antibody and Staining 
Nuclei were centrifuged at 400-X g for 10 min at 4ºC.  The fixative was discarded 
and the pellet was washed twice with PBS.  The nuclei were resuspended in 200 µL of 
PBS.  Fluorescein isothiocyanate (FITC)-conjugated monoclonal anti-PCNA (PC10) 
(Sigma Chemical Co., St. Louis, MO) was added to the nuclei at a dilution of 1:40 (µL: 
µL) and the samples were held in the dark for 45 min at room temperature.  The nuclei 
were resuspended with 200 µL of a DNA-staining solution containing 10 µg/mL 
propidium iodide (PI) and 1.8 Kunits/mL RNase (Sigma) and held in the dark for 30 min 
at room temperature until flow cytometric analysis. 
Flow Cytometry 
The nuclei were analyzed using a FACSCalibur flow cytometer equipped with an 
argon-ion laser (488 nm) (Becton-Dickinson Immunocytometry Systems, San Jose, CA) 
and data from at least 104 cells were stored in list mode.  Doublets and debris were 
discriminated by gating in a doublet discrimination mode (DDM) using a dot plot (FL-2A 
vs. FL-2W).  Fluorescence from FITC was detected in the FL-1 channel using a 560-nm 
beam splitter with a 510 to 540-nm bandpass filter and stored as a logarithmic 
amplification.  Fluorescence from PI staining of DNA was detected in the FL-2A channel 
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using a 610-nm long pass filter and stored as a linear amplification.  Data were analyzed 
using FACSCalibur software (BD CellQuest™).  Permeabilization was analyzed on a 









Figure 2.1.  Dual-parameter contour plot (PCNA fluorescence vs. DNA content) of heart 
cells of eastern oysters.  Showing the difference between the distributions of 
lysed and unlysed cells. (A) Contour plot of heart cells fixed with 2% 
paraformaldehyde but not permeabilized and lysed with a lysing buffer. 
There was a single distinguishable population of cells (left box).  (B) 
Contour plot of heart cells fixed with 2% para-formaldehyde, and 
permeabilized and lysed with lysing buffer.  There were two distinguishable 
populations of cells (boxes). The Y-axis (PCNA fluorescence) was recorded 
in logarithmic scale and the X-axis (DNA content) was recorded in linear 
scale. 
 
Analysis of the effects of fixation methods were analyzed using DNA histograms that 
were divided into three regions (Martinez et al. 1990): (1) Resting /Gap 1 phase (G0/G1), 
(2) Synthesis phase (S), and (3) Gap 2/Mitosis (G2/M); and the coefficient of variance for 
the G0 phase/G1 phase region was calculated (Fig. 2.2).  The CV of the G0/G1 region was 
used to optimize fixation because the G0/G1 peak was prominent, with a relatively low 





























Figure 2.2.  Typical flow cytometric histogram of heart nuclei from eastern oysters.  The 
leftmost peak represents the G0/G1 cells with a 2C resting diploid amount of 
DNA, the rightmost peak represents cells in G2/M phase with, 4C amount of 
DNA.  The nuclei between the peaks are in the S phase, undergoing DNA 
synthesis, and have amounts of DNA between 2C and 4C.  The coefficient 
of variance of the G0/G1 peak was calculated.  The Y-axis represents the cell 
numbers and the X-axis represents the propidium iodide fluorescence 
intensity that translates to the quantity of DNA per cell (channel number is 
the measured value of a parameter, representing the signal intensity of an 
event after amplification). 
 
The distribution of cells labeled with PCNA was analyzed on a dual-parameter dot plot 
(PCNA fluorescence vs. DNA content) by gating on the regions described above.  The 
lower limit of the PCNA-positive cell gate was set close to the upper border of the 
labeled cells G2/M (log 102) (Fig. 2.3).  The ratio of fluorescence increase of PCNA 
during the cell cycle was calculated (geometric mean of the S-phase PCNA-labeled cells 
by the geometric mean of the G0/G1-phase PCNA-labeled cells) from the gated dual-
parameter dot plot (PCNA fluorescence vs. DNA content). 
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Figure 2.3.  Dual-parameter contour plot (PCNA fluorescence vs. DNA content) of heart 
cells from eastern oysters used to determine cell cycle phases and PCNA-
positive cells. Three regions were gated: Gap 0/Gap 1 (G0/G1), Synthesis 
(S), Gap 2/Mitosis (G2/M) to determine PCNA distribution in the cell cycle. 
The Y-axis (PCNA fluorescence) was recorded in logarithmic scale, and the 
X-axis (DNA content) was recorded in linear scale. The region labeled as 
“S-phase” contained PCNA-positive cells. 
 
Histopathology Processing 
   The fixed specimens were sent to the Louisiana State University School of 
Veterinary Medicine (LSU-SVM) Department of Histopathology for paraffin 
embedment.  The embedded tissues were sectioned (3 µm thick) and mounted on       
poly-L-lysine-coated glass slides. 
Immunohistochemistry 
The presence of PCNA in the embedded oyster tissues was detected by the 
modified version of the PCNA Staining Kit procedure (Zymed Laboratories Inc. San 
Francisco, CA).  This assay was adapted from Nguyen et al. (Department of Veterinary 



















deparaffinized in two changes of 96% xylenes (Fisher) for 5 min each and rehydrated in 
one rinse of 100% ethanol and two rinse of 95% ethanol for 2 min each.  Endogenous 
peroxidase was blocked by incubating the slides in 3% hydrogen peroxide solution [30% 
hydrogen peroxide (Fisher) and 100% methanol (Fisher)] for 10 min.  The slides were 
rinsed in three changes of phosphate buffered saline (PBS) for 2 min each to remove the 
hydrogen peroxide solution.  The PBS (1.37 M NaCl, 0.03 M KCl, 0.009 M KH2PO4, 
0.06 M Na2HPO4) was prepared at 10-X and diluted with sterilized distilled deionized 
water to a 1-X concentration.  To reveal epitopes masked during fixation and to facilitate 
antigen retrieval, the slides were immersed in a 1% anhydrous zinc sulfate (Fisher) 
solution, and were heated in a microwave until the solution boiled for 1 min, cooled for 2 
min, and finally heated again until boiling for 1 min.  The slides were cooled for 6 min at 
room temperature, rinsed twice in distilled dionized water (ddH2O) and once in PBS.  
After the PBS rinse, the blocking solution (Reagent 1) was applied to the slides for 10 
min to block charged sites on proteins.  The primary antibody, biotinylated mouse anti-
PCNA (Reagent 2), was added to the slides.  The negative control slides received the 
mouse isotype control solution.  All slides were incubated for 1 h and were rinsed in three 
changes of PBS for 2 min each.  The slides were incubated for 10 min with streptavidin-
peroxidase (Reagent 3), and rinsed in three changes of PBS for 2 min each.  
Diaminobenzidine (DAB) solution (Reagents 4A-4C), the chromagen substrate, was 
applied to the slides for 2-5 min after the streptavidin-peroxidase reaction to biotin.  The 
slides were rinsed with ddH2O, counterstained with hematoxylin for 1-2 min, rinsed in 
tap water, washed in PBS for 30 sec or until the tissue sections turned blue, rinsed again 
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in ddH2O, dehydrated by rinsing twice in 95% ethanol for 5 min each, and twice in 100% 
ethanol for 15 min each, and finally the tissues were overlayed. 
Label Quantitation 
To determine the PCNA labeling indices (LI) in the labial palps of each oyster the 
procedure of Foley et al. (1991) was used.  Hearts were not used because the organ could 
not be sectioned.  Positive staining by PCNA in the tissues was indicated by the 
occurrence of a dark brown nucleus (Fig. 2.4).  A negative control was used to determine 
which nuclei were well stained and therefore were counted.  For the labial palps, an 
image analysis system (Meta Imaging Series 6.1, MetaVue™, Universal Imaging Corp., 
Downington, PA) was used to count 1000 nuclei at random at 40-X magnification.  The 






Figure 2.4.  Immunohistochemical 
detection of proliferating cell nuclear 
antigen (PCNA) in eastern oyster 
labial palps (brown nuclei). 
 
 
Flow Cytometry vs. Immunohistochemistry 
Of 110 oysters analyzed by flow cytometry, 10 were classified as having a high 
percentage of PCNA-positive cells (24.87 ± 4.86%) and another 10 oysters were 
classified as a low percentage of PCNA-positive cells (6.87 ± 1.41%) and were analyzed 
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by an image analysis system.  The embedded tissues for these oysters were sent without 
reference to their PCNA status LSU-SVM for histopathology processing. At the 
Department of Histopathology the original labels were coded to ensure non-biased 
analysis. We compared the percent PCNA positive cells detected by flow cytomery 
analysis against the PCNA LI determined by immunohistochemical staining for labial 
palps. 
Statistical Analysis 
Kruskal-Wallis nonparametric one-way analysis of variance (ANOVA) was 
performed to compare the coefficient of variance (CV) of the G0/G1 regions among the 
four different fixation methods.  Chi-square goodness-of-fit was used to determine if the 
distribution of PCNA during the cell cycle was homogeneous to the ratio of distribution 
of cells in the cell cycle. We used observed values for PCNA that were obtained from the 
gated dual-parameter dot plot (PCNA vs. DNA content) and the ratio of distribution of 
cells during the cell cycle was calculated using DNA histograms.  Kruskal-Wallis 
nonparametric ANOVA was performed to compare the difference in PCNA labeling 
indices of “high” against “low” cell proliferation for the immunohistochemistry slides.  
One-way analysis of variance (ANOVA) was performed to compare the %PCNA positive 
cells detected by flow cytomery analysis against the PCNA LI by immunohistochemical 
staining. 
RESULTS 
The dual-parameter analysis of PCNA fluorescence vs. DNA content dot plot of 
cells treated with the lysing buffer revealed a reverse “U” shape.  Two distinct 
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populations were present for lysed cells.  Some S-phase nuclei labeled with PCNA were 










Figure 2.5.  Dual-parameter contour plot (PCNA fluorescence vs. DNA content) of heart 
cells from eastern oysters.  The solid box area represents PCNA stained cells 
that were recognized in the S phase of the DNA content histogram but were 
not considered to be PCNA-positive cells. The dotted boxes represent the 
phases of the cell cycle.  The Y-axis (PCNA fluorescence) was recorded in 
logarithmic scale, and the X-axis (DNA content) was recorded in linear 
scale. 
 
The mean coefficient of variance (CV) of the G0/G1 peak for the cells fixed with 
70% acetone and 70% methanol was 6%, cells fixed with 100% methanol had a mean CV 
of 6%, cells fixed with 2% paraformaldehyde had a mean CV of 5%, and the cells fixed  
with 70% ethanol had a mean CV of 10%.  There were no significant differences among 
the CV’s of 70% acetone and 70% methanol, 100% methanol, and  
2% paraformaldehyde. The CV of the 70% ethanol fixation method was significantly 
higher than those of other methods (P < 0.0001).  The patterns of the flow cytometric 
dual-parameter dot plots (PCNA fluorescence vs. DNA content) were not different 


















among the fixation methods.  However, methanol and paraformaldehyde fixation yielded 
brighter PCNA fluorescence in the S phase than did 70% acetone and 70% methanol, and 
100% ethanol (Fig. 2.6).  
Proliferating cell antigen was expressed throughout the cell cycle in mitotic cells.  
The PCNA-labeled heart nuclei and labial palp nuclei were not distributed based on the 
observed frequency of nuclei in the various stages of the cell cycle (P < 0.0001). 
Fourteen percent of the total PCNA-labeled heart nuclei counts were considered to be 
PCNA positive. Of the PCNA-positive nuclei, 30% were in the S phase while 45% were 
in late G0/G1, and 25% were in early G2 phase/M phase (Fig. 2.7).   
Figure 2.7.  Dual-parameter 
contour plot (PCNA fluorescence 
vs. DNA content) of heart cells 
from eastern oysters.  The solid 
boxes area represents PCNA 
stained cells that were recognized 
in the late G0/G1 and early G2/M. 
The dotted boxes represent the 
phases of the cell cycle.  The Y-
axis (PCNA fluorescence) was 
recorded in logarithmic scale, and 
the X-axis (DNA content) was 
recorded in linear scale. 
 
 
In labial palp nuclei, fourteen percent of total PCNA-labeled cells were considered to be 
PCNA positive. Of the PCNA-positive nuclei, 30% were in S phase while 46% were in 
late G0/G1, and 24% were in early G2/M phase.  There was no significant difference in the 
distribution of the S phase nuclei of the two tissues.  
During the cell cycle in heart nuclei PCNA mean fluorescence increased about 13 
times from the G0/G1 to S phase.  The PCNA fluorescence decreased by half in G2/M 





















phase.  For labial palp nuclei, the mean fluorescence of PCNA increased about 9 times 
from G0/G1 to S phase.  The PCNA fluorescence decreased by half in G2/M phase (Table 
2.1).  The mean fluorescence of PCNA-positive heart nuclei in S phase was significantly 
higher than those of the labial palps (P < 0.0002). 
Table 2.1.  The geometric means (means ± SD) from the cell cycle phases were used to 
calculate the proliferating cell nuclear antigen fluorescence ratio of increase 
(means ± SD).  There was an increase in the ratio from G1/G0 phase to S 
phase and decrease by half into the G2/M phase for hearts and labial palps of 









Flow cytometry was significantly more sensitive than immunohistochemistry in 
detecting PCNA-positive nuclei (P < 0.0001).  When comparing flow cytometry and 
immunohistochemistry, there was a significant difference between the “high” and “low” 
PCNA-positive nuclei analyzed by flow cytometry (P < 0.0001).  There was no 
significant difference detected in the labeling indices between the “high” (0.71%) and 
“low” (0.79%) immunohistochemically stained labial palp samples.  
DISCUSSION 
The development of a flow cytometric assay to detect cell proliferation in somatic 
tissues of the eastern oyster would provide rapid and accurate information that could 
assist in maximizing cell survival and promote the development of an oyster cell line.  A 
primary consideration in cell growth is the cell cycle, the analysis of which can provide a 
reliable index for the prediction of growth potential and changes in cell number with time 
during cell culture(Leelavatcharamas et al. 1996).
  Geometric Mean 
Tissue G0/G1 S G2/M 
Heart 28.88 ± 8.63 355.27 ± 79.32 57.72 ± 18.08 
    
























Figure 2.6.  Dual-parameter dot plots of heart cells of the eastern oyster prepared using different fixation methods (Top).  The Y-axis 
represents the monoclonal antibody (PC10) and the X-axis represents the propidium iodide fluorescence intensity that is 
directly proportional to the quantity of DNA per cell (channel number is the measured value of a parameter, representing 
the signal intensity of an event after amplification) (Bottom).  DNA histograms for each fixation procedures are shown 
under the dual-parameter dot plot.  The Y-axis (PCNA fluorescence) was recorded in logarithmic scale and the X-axis 
(DNA content) was on a linear scale.  The Y and X axes of the DNA histograms were linear scales.













The analysis of the fraction of S-phase cells can provide reliable information on the 
proliferating dynamics of cell cultures.  By measuring the proportion of S-phase cells, it 
was possible to predict the change in cell number of hybridoma cells following a 
disturbance of the culture conditions (Al-Rubeai et al. 1991).  In Chinese hamster ovary 
cultures, it was found that the proportion of cells at any time in the S-phase could indicate 
future specific growth rates (Leelavatcharamas et al.1996).  
In the present study, PCNA was detected in all the phases of the cell cycle of the 
eastern oyster.  The concentrations of PCNA also increased from G0/G1 phase into the S 
phase, where they peaked in mid-S-phase, and decreased in G2 phase/M.  Proliferating 
cell nuclear antigen is found throughout the cell cycle of mammalian somatic tissues 
(Bravo and Macdonald-Bravo 1987; Toschi and Bravo 1988). In mouse fibroblasts and 
splenocytes, HeLa cells, and SP2/0 and MOLT-4 cell lines the concentration of PCNA 
increased as the cells progressed from G0/G1 phase, where it peaked in S phase, and 
decreased in G2 phase/M (Bravo 1986; Morris and Mathews 1989; Kurki et. al. 1986).   
In this study, oyster somatic tissue cells that were treated with a lysing buffer 
containing a non-ionic detergent showed three distinguishable regions that were verified 
using a DNA histogram to correspond to the cell cycle phases.  Oyster cells not lysed and 
not permeabilized did not show these regions.  Use of a lysing buffer containing 0.1% to 
1% (in PBS) of a non-ionic detergent (e.g. Nonidet P-40 or Triton X-100), will cause the 
plasma membrane of cells to lyse and will permeabilize the nuclear membrane (Taylor 
1980; Taylor and Milthorpe 1980; Thornthwait et al. 1980), allowing for the removal of 
loosely bound PCNA and an accurate measure of the S-phase cells (Landberg and Roos 
1991).  Dual-parameter dot plots (PCNA fluorescence vs. DNA content) of lysed 
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mammalian cells show distinguishable regions of the individual cell cycle phases, while 
unlysed cells had no defined regions of the individual cell cycle phases (Erlanson 1997).   
In this study, oyster somatic cells had S-phase cells that were stained with PCNA, 
but were not considered to be PCNA-positive.  Although these cells were included in the 
S-phase fraction of the DNA content histogram, these may have been quiescent S-phase 
cells or cellular debris.  In a study of malignant lymphomas cells with S-phase DNA 
content but negative for the monoclonal antibody (PC10) (Landberg and Roos 1991) 
these cells were found to be quiescent S-phase cells, aneuploid non-S-phase cells, or 
debris.  This problem was also encountered in material from solid tumors and especially 
with tumors containing large amounts of debris (Landberg and Roos 1991).   
Cells were fixed to allow highly polar fluorochromes to gain access to the interior, 
and to polymerize, precipitate, cross-link, and denature proteins. Fixatives have been 
described as coagulant (e.g., acetone, ethanol, and methanol) or non-coagulant (e.g., 
acetic acid, formaldehyde, and paraformaldehyde) because of the observations of the 
behavior of plasma proteins to the fixatives.  In this study methanol and 
paraformaldehyde fixation methods reacted similarly, but paraformaldehyde did not 
cause clumping of oyster somatic cells.  Methanol (Elias-Jones et al. 1986; Levitt and 
King 1987) and paraformaldehyde (Clevenger et al. 1985) have been used for staining of 
intracellular antigens.  Cells fixed using organic solvents caused PCNA staining to be 
localized at the intracellular sites where DNA synthesis was taking place (Bravo and 
Macdonald-Bravo 1987).  The distribution of PCNA appears to change with the stage of 
the cell cycle (Waseem and Lane 1990).  In early S-phase PCNA has a granular 
distribution and is absent from the nucleoli, while at late S-phase PCNA is found in the 
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nucleoli (Waseem and Lane 1990).  Cells fixed with aldehydes showed PCNA to have a 
different distribution and intense nuclear staining throughout the cell cycle (Bravo 1986; 
Bravo and Macdonald-Bravo 1987).   In previous studies of mammalian somatic tissues 
methanol fixation was essential for the detection of the anti-PCNA monoclonal antibody 
(PC10) (Kurki et. al. 1986; Hammond et. al. 1987, Ogata et. al. 1987; Landberg and Roos 
1991; Casasco et al. 1993).  While in other mammalian tissue studies, fixation of the cells 
with paraformaldehyde improved detection of the PCNA antibody (Kurki et al. 1988; 
Hall et al. 1990; Pollice et al.1992). 
In this study, flow cytometry was more sensitive in detecting PCNA-positive 
nuclei than was immunohistochemistry.  Flow cytometry has been shown to be more 
sensitive than immunohistochemistry in detecting antigens or epitopes present in low 
amounts (Villari et al. 1997).  A cell proliferation study, using PCNA (PC10) as a 
prognostic indicator of human prostatic carcinomas, found no significant associations 
between flow cytometric and the immunohistochemical measures of cell proliferation 
(Visakorpi 1992).  In a comparative study of flow cytometry and immunohistochemistry 
for the detection of human leukocyte antigens in human colorectal cancer, flow 
cytometry was superior to immunohistochemistry in detecting tumors identified as HLA-
ABC negative by immunohistochemistry that were actually weakly positive for HLA-
ABC in 33 out of 80 cases.  Flow cytometry was able to detect low amounts of the 
antigens and epitopes (He et al. 1994; Diederichsen et al. 1998).   
In the flow cytometric studies it was observed that in oyster somatic tissue cells 
anti-PCNA monoclonal antibody detected cells in the G0/G1, S and G2/M phases.  One 
advantage in estimating proliferating cells using anti-PCNA monoclonal antibody (PC10) 
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reactivity instead of DNA histograms is that it can provide an accurate value of S phase 
cells.  In conclusion, we have shown that the anti-PCNA monoclonal antibody (PC10) is 
a suitable reagent for the flow cytometric evaluation of replicating (G1, S and G2/M 
phases) cells in somatic cells of the eastern oyster and that flow cytometry was more 
sensitive than immunohistochemistry in detecting proliferating cells. 
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CHAPTER 3 – DEVELOPMENT OF A FLOW CYTOMETRIC ASSAY FOR THE DETECTION OF 
NUCLEAR RNA IN OYSTER SOMATIC TISSUES  
 
INTRODUCTION 
An oyster cell line would be a valuable tool for the study of pathology, 
toxicology, and endocrinology in oysters.  An important aspect of cell culture is to 
monitor the growth rate of the cells (Doyle et al. 1993).  Evaluation of cell growth 
kinetics can be done by flow cytometric measurement of RNA per cell.  Flow cytometric 
measurement of DNA content allows for the determination of position of a cell in the cell 
cycle.  Therefore, the simultaneous analysis of DNA and RNA content makes possible 
the correlation of changes in RNA content throughout the cell cycle.   
In the process of transcription, the genetic information stored in DNA is copied 
into RNA, which has three distinct roles in protein synthesis.  Messenger RNA (mRNA) 
specifies the order of amino acids and this information is interpreted in the cytoplasm by 
transfer RNA (tRNA) with the aid of ribosomal RNA (rRNA) and associated proteins.  
The tRNA brings the amino acids together for linkage through peptide bonds to make 
peptides (Lodish et al. 2000). 
Ribonucleic acid in human lymphocytes was one of the first cellular constituents 
measured by flow cytometry (Darzynkiewicz et al. 1975; Darzynkiewicz et al. 1976).  
Initial flow cytometric studies of cellular RNA in human lymphocytes and 3T3-Swiss 
albino mouse cells assumed that because rRNA makes up about 80% of the cellular RNA 




Table 3.1.  Cellular RNA content and the rate of cell progression of different cell types 
through various phases of the cell cycle.  These data were published and 
recalculated for comparison purposes (Darzynkiewicz 1988).  Unless 
otherwise indicated, all are human-derived cells (Adapted from 
Darzynkiewicz 1988). 
Cell type RNA  Content 




Lymphocytes 1.6 S 2.3 Darzynkiewicz et al. (1979a) Darzynkiewicz et al. (1979b) 
Lymphocytes 2.4 S 3.8 Darzynkiewicz et al. (1979a) Darzynkiewicz et al. (1979b) 
Lymphocytes 2.8 S 4.5 Darzynkiewicz et al. (1979a); Darzynkiewicz et al. (1979b) 
CHO* 1.7 G1 1.6 Darzynkiewicz et al. (1979a) 
CHO 1.7 S 1.3 Darzynkiewicz et al. (1979a) 
CHO 0.6 S 0.4 Traganos et al. (1987) 
HeLa-S3 1.3 G1 1.3 Traganos et al. (1987) 
HeLa-S3 1.3 G1, S, G2/M 1.3 Traganos et al. (1987) 
HeLa-S3 0.6 G1, S, G2/M 0.8 Bauer et al. (1981) 
V79 1.5 S 1.3 Fujikawa-Yamamoto (1982) 
Keratinocytes 3.0 G1, S, G2/M 3.3 
Staiano-Coico et al. (1986); 
Kimmel et al. (1986) 
*Chinese hamster ovary cells. 
 
These studies found a correlation between rRNA content and the ability of the cell to exit 
from a quiescent state and enter the cell cycle (Darzynkiewicz et al. 1976; Darzynkiewicz 
et al. 1980).  The rate of the cell cycle in human lymphocytes and Chinese hamster ovary 
(CHO) cells was also correlated with rRNA content (Darzynkiewicz et al. 1979a; 
Darzynkiewicz et al. 1979b).  Exponentially growing cultured cell populations (i.e. HeLa 
cells), normal human cells, or tumor cells accumulate a critical amount or threshold of 
rRNA in the G1 phase prior to entry into S phase (Darzynkiewicz et al. 1980). 
In a flow cytometric study correlating measurements of nuclear RNA and DNA 
content of cultured human keratinocytes, these cells were found to enter S-phase only 
after all cells accumulated a threshold amount of nuclear RNA; therefore there were only 
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single populations of S-phase, G2-phase, and M-phase cells.  Cells with low nuclear RNA 
content had distinctly longer residence times in G1 phase compared to cells with high 
nuclear RNA content, and cytoplasmic RNA content correlated more with differentiation 
while nuclear RNA content reflected primarily the kinetic properties (mechanisms that 
affect the rate of progression in the cell cycle) of the cell (Staiano-Coico et al. 1989).   
The many metabolic states related to the capacity of the cell to progress through the cell 
cycle can be discriminated by simultaneous measurement with an assessment of the ratio 
of nuclear RNA to DNA (Crissman et al. 1985).  Quiescent and cycling cells, cells in 
different stages of differentiation, and the relation between cell growth and DNA 
synthesis, can be distinguished by a multiparametric analysis of RNA and DNA 
(Darzynkiewicz et al. 1980). 
Although most of the past studies on the relationship between RNA content and 
cell kinetics have been done with cellular RNA, in this study development of a flow 
cytometric assay is reported that detects nuclear RNA in heart and labial palp tissues of 
the eastern oyster, Crassostrea virginica.  Heart cells were used in this study because 
these cells have been found to proliferate in vitro for the Pacific oyster (Wen et al. 1994).  
Labial palps are four triangular appendages attached on either side of the mouth and are 
used to sort food particles and move trapped food from the gills into the mouth.  Labial 
palps cells were used because the cells have been found to have high proliferation during 
the winter months (Nguyen et al. Department of Veterinary Sciences).    
To my knowledge, a method has not been developed to measure DNA and nuclear 
RNA content simultaneously in oyster somatic tissue cells.  In this study, the fluorescent 
dye SYBR Green II was used because of its high binding affinity for RNA, its 
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fluorescence enhancement and high quantum yield upon binding to RNA, and because 
nucleic acid-bound SYBR Green II exhibits spectral characteristics (excitation maximum 
~ 497 nm) similar to those of fluorescein (excitation maximum 494 nm), making it 
compatible with the most common filter sets in laser-based gel scanners, confocal laser-
scanning microscopy and flow cytometry (Haugland 2002).  The objectives of this paper 
were to: (1) detect nuclear RNA by flow cytometry; (2) determine the distribution of 
nuclear RNA throughout the cell cycle; and (3) develop a method for the direct 
determination and correlation of DNA and nuclear RNA in individual oyster cells.  
Nuclear RNA was detected throughout the cell cycle which was tracked simultaneously 
using propidium iodide staining of DNA. 
MATERIALS AND METHODS 
Oyster Collection and Dissection 
Eastern oysters (n = 30) were collected in January 2004 from the Louisiana Sea 
Grant Oyster Hatchery at Grand Isle, Louisiana, (90° 2’ 13.3” W, 29° 12’ 26” N) and 
were maintained for 2 d in an indoor temperature-controlled recirculating salt water (18 
ppt) system at 15°C until use.  The meats were shucked and the hearts and labial palps 
were surgically removed. 
Permeabilization and Fixation 
Hearts and labial palps were crushed using a glass-on-glass homogenizer.  The 
cells were suspended in 0.01M-phosphate buffered saline (PBS) (1.37 M NaCl, 0.03 M 
KCl, 0.009 M KH2PO4, 0.06 M Na2HPO4, pH 7.4) (Sigma Chemical Corp., St. Loius, 
MO) and filtered through 35-µm mesh to remove connective tissue. Heart and labial palp 
suspensions with a cell concentration of 2 X 106 cells/mL were collected and held at 4°C.  
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The cells were centrifuged at 400-X g (2800 rpm) for 10 min at 4ºC.  The supernatant 
was discarded and the pellet was resuspended for 15 min at 4°C in 750 µL of lysing 
buffer to permeabilize and free the nucleus from the cytoplasm (modified from 
Langdberg and Roos 1991) containing 2% bovine serum albumin in PBS (Sigma),       
1% NP-40 (Sigma), and 0.2 µg/mL of EDTA (Fisher Scientific Company, Pittsburgh, 
PA).  Nuclei were centrifuged again at 400-X g for 10 min at 4ºC.  The lysing buffer was 
discarded and the nuclei resuspended in 2% paraformaldehyde (Sigma) for 15 min on ice. 
Nuclear RNA Staining and DNA Staining 
Nuclei were centrifuged at 400- X g for 10 min at 4ºC.  The fixative was 
discarded and the pellets were washed twice by centrifugation with PBS.  The nuclei 
were resuspended in 200 µL of PBS, and SYBR Green II RNA gel stain (Molcular 
Probes, Inc., Eugene, OR) was added to the nuclei at a 1:2000 (µL:µL) concentration and 
the samples were incubated in the dark for 30 min at room temperature.  The nuclei were 
resuspended with 200 µL of a DNA-staining solution containing 10-µg/mL propidium 
iodide (PI) (Sigma) in 10 mL of PBS and held in the dark for an additional 30 min at 
room temperature until flow cytometric analysis. 
Flow cytometry Analysis of nuclear RNA and DNA 
The nuclei were analyzed using a FACSCalibur flow cytometer equipped with an argon 
ion laser (488 nm) (Becton-Dickinson Immunocytometry Systems, San Jose, CA) and 
data from at least 104 nuclei were stored in list mode.  Fluorescence from SYBR Green II 
was detected in the FL-1 channel using a 560-nm beam splitter with a 510 – 540-nm 
bandpass filter and stored as a logarithmic amplification.  Fluorescence from PI staining 
of DNA was detected in the FL-2 channel using a 610-nm long pass filter and stored as a 
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linear amplification.  Data were analyzed using FACS software (BD CellQuest™).  Cell 
cycle DNA was analyzed using histograms that were divided into three regions: Gap 0/ 
Gap1 phase (G0/G1), Synthesis phase (S), and Gap 2/Mitosis (G2/M) (Fig.3.1).  Nuclear 
RNA distribution was analyzed on a dual-parameter dot plot (nuclear RNA fluorescence 
vs. DNA content) (Fig. 3.2).  Damaged nuclei and debris were gated out from analysis on 
a plot of forward scatter versus side scatter, and aggregates were discriminated with 
doublet discrimination mode.  Using this gated dual-parameter plot, nuclear RNA during 
S phase was compared with that in G0/G1 phase by generating ratios of geometric means 
FL-1H from these gated regions.   Nuclear RNA/DNA ratio was calculated, using the 
gated histograms for the nuclear RNA fluorescence and DNA fluorescence, by dividing 
the geometric means of the nuclear RNA fluorescence (FL-1H) into the geometric means 
of the DNA fluorescence (FL-2H).  The ratio was calculated for each phase in the cell 
cycle.  
Statistical Analysis 
Chi-square goodness-of-fit was used to determine if the distribution of nuclear 
RNA during the cell cycle was homogeneous with respect to the ratios of distribution of 
cells in the cell cycle.  Observed values used for nuclear RNA were obtained from the 
gated dual-parameter dot plot (nuclear RNA fluorescence vs. DNA content) and the ratio 
of distribution of cells during the cell cycle was calculated using DNA histograms. 
 Kruskal-Wallis nonparametric analysis-of-variance (ANOVA) was used to 
determine differences between the nuclear RNA fluorescence increase from G0/G1 to S 














Figure 3.1.  Results of flow cytometric analysis of heart cells from the eastern oyster.  
The leftmost peak represents the G0/G1 cells with a 2C (resting diploid) 
amount of DNA, the rightmost peak represents cells in G2/M phase with a 
4C amount of DNA, and the cells in between the peaks are in the S phase 
undergoing DNA synthesis that have amounts of DNA between 2C and 4C.  
The Y-axis represents the cell numbers and the X-axis represents the 
propidium iodide fluorescence intensity that is directly proportional to the 
quantity of DNA per cell (channel number is the measured value of a 






























Figure 3.2.  Dual-parameter contour plot (nuclear RNA vs. DNA content) of heart cells 
of eastern oysters used to determine cell cycle phases and nuclear RNA-
positive cells. Three regions were gated to determine nuclear RNA 
distribution in the cell cycle: Gap 0/Gap 1 (G0/G1), Synthesis (S), Gap 
2/Mitosis (G2/M). The Y-axis (nuclear RNA) was recorded in logarithmic 
scale and the X-axis (DNA content) was recorded in linear scale. These 














Kruskal-Wallis nonparametric analysis-of-variance (ANOVA) was used to 
determine differences between nuclear RNA/DNA ratios in each phase of the cell cycle.  
RESULTS 
The stained nuclear RNA of heart and labial palp nuclei was detected at different 
intensities throughout the cell cycle.  The nuclei with RNA staining were not distributed 
homogenously throughout the cell cycle.  In heart an average of 71 ± 16% of the nuclei 
were in G0/G1 phase, 5 ± 3% of the nuclei were in S phase, and 24 ± 13% were in G2/M 
phases.  In labial palps nuclei an average of 88 ± 1% of the nuclei were in G0/G1 phase,   3 
± 2% of the nuclei were in S phase, and 9 ± 1% were in G2/M phases.  In the heart and 
labial palps nuclei, the mean fluorescence of nuclear RNA increased from G0/G1 phases 
into the S phase and decreased in the G2/M phases.  The mean fluorescence of the nuclear 
RNA in heart nuclei increased on average 52% from G0/G1 phases to S phase.  The nuclear 
RNA fluorescence decreased on average 20% from S phase to G2/M phases.  For labial 
palps nuclei the nuclear RNA fluorescence increased 69% from the G0/G1 to S phase.  The 
nuclear RNA fluorescence decreased on average 32% from S phase to G2/M phases.  There 
was no significant difference in the fluorescence increase from G0/G1 to S phase and the 
fluorescence decrease from S phase to G2/M for the heart and the labial palps nuclei. 
Analysis of the nuclear RNA/DNA ratio for heart and labial palp cells in relation to 
the cell cycle phases, as represented by DNA content, reveals an up-side-down “U” shape 
pattern of changing rates of DNA replication against transcription.  During G0/G1 phase, 
when DNA content was constant, cells accumulate increasing amounts of nuclear RNA; 




Table 3.2.  Deoxyribonucleic acid, nuclear RNA, and nuclear RNA/DNA ratios for G1/G0 
phases, S phase, and G2/M phases of heart and labial palps cells of eastern 
oyster as measured by flow cytometry.  The results are expressed as geometric 
means (standard deviation).  







 G1/G0 201 (14) 32 (12) 0.16 (0.05) 
Heart S 305 (32) 64 (26) 0.21 (0.06) 
 G2/M 388 (27) 55 (29) 0.14 (0.07) 
     
 G1/G0 193 (11) 34 (12) 0.17 (0.05) 
Labial Palps S 291 (17) 111 (18) 0.38 (0.06) 
 G2/M 373 (14) 75 (20) 0.20 (0.05) 
 
The nuclear RNA/DNA ratio in heart cells increased on average by 22 ± 16% from G0/G1 
phase to S phase and decreased by 34 ± 14% in the G2/M phases.  In labial palp cells, 
nuclear RNA/DNA ratio increased by 47 ± 19% and decreased by 53 ± 18% in the G2/M 
phases.  The cells in G2/M phases from the heart and labial palps had on average similar 
nuclear RNA/DNA ratios as those from G0/G1 phase. 
DISCUSSION 
 Accurate analysis of cell proliferation rates would provide information of cell 
kinetics and assist researchers in the development of an oyster cell line.  The relationship 
between RNA content and regulation of the cell cycle is still unclear but the accumulated 
evidence of cellular RNA content point out that RNA content is a marker strongly 
correlated with cell kinetics (the rates of change in the progression of the cell cycle)  
(Baserga 1984; Drazynkiewicz 1988).  The analysis of DNA content in single cells by flow 
cytometry provides a rapid and accurate method for determining the cell cycle frequency 
distribution of a given cell population (Dean 1985).  Cell cycle analysis by DNA content 
alone cannot discriminate among the many metabolic states related to the capacity to 
progress through the cell cycle.  Distinguishing between quiescent and cycling cells, cells 
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in various stages of differentiation, and the relation between DNA division and cell growth 
can be assessed by multi-parametric analysis of DNA and cellular RNA content 
(Drazynkiewicz et al. 1975; Drazynkiewicz et al. 1976; Bauer et al. 1980).   
Measurement of the ratio of RNA to DNA in somatic tissues in fish (Buckley 1984; 
Robinson and Ware 1988; McGurk and Kusser 1992), crustaceans (Sulkin et al. 1975; 
Anger and Hirche 1990; Juinio et al. 1992) and mollusks (Clarke et al. 1989; Kenchington 
1994; Lodeiros et al. 1996; Chicharo et al. 2001) has been used to detect the response of 
the organism to environmental changes, growth rate, stress due to disease, and nutritional 
condition.  This index is based on the assumption that the amount of DNA is stable under 
changing environmental conditions while RNA content is affected by these conditions.  
Therefore, the ratio of RNA to DNA is susceptible to change when the environment of the 
organism changes (Chicharo et al. 2001).  Organisms in good conditions tend to have 
higher RNA/DNA ratios while organisms in a poor condition tend to have lower 
RNA/DNA ratios.   
  In this study, nuclei from somatic tissue cells to allow for the detection of nuclear 
RNA.  Unlike fluorescence spectrophotometric analysis, which only detects total RNA and 
DNA in all cells, the flow cytometric analysis provided simultaneous information on the 
amount of nuclear RNA and DNA allows calculation of nuclear RNA/DNA ratios for each 
phase of the cell cycle for individual cells.  In a study of nuclei isolated plant protoplasts 
ratios of nuclear RNA/DNA were determined throughout the cell cycle and at G2 phase the 
ratio was similar to that of the G1 phase (Bergounioux et al. 1988).  In mammalian cell 
cultures where cells were arrested at G0 phase and stimulated with growth factors to enter 
S phase, there was a surge of nuclear RNA for about 30 min.   The level of nuclear RNA 
dropped, as inhibitors of protein synthesis blocked transcription, to a lower level that was 
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maintained as long as the growth factors were present in the culture medium (Reed 1997).  
The present study we found results similar to the plant protoplasts and mammalian cell 
culture in that the nuclear RNA/DNA ratio increased from G0/G1 phase to S phase and 
decreased to G2/M phase for oyster somatic cells. 
In conclusion, it was possible to detect nuclear RNA in somatic tissues of the 
eastern oyster by flow cytometry.  Nuclear RNA content distribution could assist in the 
improvement of oyster cell lines by determining if cells have accumulated a threshold 
amount of nuclear RNA to proceed into S phase and cell division.  The ability to calculate 
nuclear RNA/DNA ratio throughout the cell cycle can provide information of the condition 
of cultured cells due to environmental changes in the medium. 
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The phylum Mollusca is the second largest invertebrate phylum.  It comprises 
80,000 extant species with an enormous diversity of form, function, and adaptation.  The 
animals exploit marine, estuarine, freshwater and terrestrial systems.  Molluscs inhabit 
environmental conditions varying from abyssal depths of the ocean to high altitudes 
(Mulcahy 2001).   Physiological knowledge of molluscs is relatively limited and this 
narrow information is restricted to a few species of molluscs that are of commercial, 
medical, or ecological importance.   
The development of molluscan tissue culture would be an important step in 
answering questions and problems related to mollusca physiology and pathology.  The 
study of tissues isolated from molluscs has yet to proceed from tissue explants and primary 
cultures with limited mitosis, which may reflect the lack of understanding of the key 
influences on growth and proliferation of cells from these animals.  The first step in 
acquiring this knowledge is to understand the in vivo factors affecting the organism and the 
cell proliferation in tissues (Freshney 1987). 
A study of cell proliferation in somatic tissues of the eastern oyster, found that it 
was seasonal (Nguyen et al. Department of Veterinary Sciences).  Cell proliferation 
increased during the late fall and winter months (November-March) and steadily decreased 
in the spring to summer months (April-July).  Cell proliferation in somatic tissues was also 
determined to cease as gonadal tissue matured in during the late spring and late summer 
months before spawning (Frovola 1993; Leibson and Frovola 1994; Nguyen et al. 
Department of Veterinary Sciences). 
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Temperature has been determined to be a key influence in all aspects of eastern 
oyster biology.  The goal of this study was to determine the effect of temperature on 
somatic tissues of the eastern oyster.  In this report, the effects are disscused of constant 
water temperatures on the cell cycle, cell proliferation, and cell metabolism in heart and 
labial palp cells of the eastern oyster.  Cell proliferation in somatic tissues was measured 
by detecting proliferating cell nuclear antigen (PCNA) by use of a flow cytometer.  
Proliferating cell nuclear antigen is an auxiliary protein of DNA polymerase-δ that is 
closely linked with DNA synthesis and repair (Tan et al. 1986; Bravo et al. 1987).  Cell 
metabolism was measured by RNA/DNA ratios at all phases of the cell cycle.  This index 
is based on the assumption that amount of DNA is stable under changing environmental 
conditions while RNA content is affected by these conditions.  Therefore, the ratio of RNA 
to DNA is susceptible to change when the environment of the organism changes (Chicharo 
et al. 2001).  Organisms in good conditions tend to have higher RNA/DNA ratios while 
organisms in a poor condition tend to have lower ratios.  The objectives of this study were 
to determine by flow cytometry if constant water temperatures affected the: (1) cell cycle, 
(2) cell proliferation, and (3) cell metabolism. 
METHODS AND MATERIALS 
Oyster Collection and Maintenance 
Eastern oysters (n = 560) were collected in March 2004 from the Louisiana Sea 
Grant Oyster Hatchery at Grand Isle, Louisiana, (90° 2’ 13.3” W, 29° 12’ 26” N) and were 
maintained in an indoor temperature-controlled recirculating system (Kolar 2004) at the 
Louisiana State University Aquaculture Research Station for 15 weeks. 
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Experimental Design 
The oysters were distributed equally amongst all tanks in the recirculating system.  
Tanks were filled with 20 ppt of artificial saltwater (HW marine mix, Wiegandt GmbH 
Co., Krefeld, Germany).  Oysters were fed algal paste twice daily (1800 Instant algae®) at 
an amount recommended by the manufacturer (Reed Mariculture, Campbell, CA).  The 
oysters were placed in the tanks at an initial temperature of 20°C the same temperature as 
that of Grand Isle.  Water temperatures were held at 20 ± 0.5°C for 3 weeks to acclimate 
the animals to the new environmental conditions.  After 3 weeks the water temperatures 
were dropped at the rate of 1ºC per day until two tanks (9 and 11) were at 15ºC, and two 
tanks (14 and 16) were at 10ºC, while two tanks (1 and 7) were kept at 20ºC.  The 
temperature in three tanks (13, 17, and 18) was increased 1ºC per day to 27ºC and were 
used as control treatments.  Once the water reached the desired temperatures (10, 15, or 
20ºC), the temperatures were maintained for 3 weeks, for temperature acclimation.  After 3 
weeks, fluctuation was imposed on each of the temperature regimes (Table 4.1).   
Table 4.1.  Temperature fluctuations imposed on tanks. Each temperature regime was 
replicated twice. 
 
Tank Average temperature (ºC) Fluctuation (ºC) 
1 & 7 20 ± 1 
9 & 11 15 ± 1 
14 & 16 10 ± 1 
13, 17, & 18 27 ± 1 
 
The fluctuation was diurnal and was implemented for 5 weeks (Fig. 4.1).  During the span 
of this experiment oysters in the system were sampled at various times (Table 4.2).  
Oysters were kept in Grand Isle as a standard to determine the natural effects of 
temperature and were sampled at the same time as those from the system. 
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Figure 4.1.  Schematic of the temperature regimes imposed in this study. 
Cell Preparation 
Oysters were opened and the heart and labial palps were surgically removed.  
Hearts and labial palps from individual oysters were crushed using a homogenizer with a 
glass-on-glass pestle.  The cells were suspended in 0.01M-phosphate buffered saline (PBS) 
(1.37 M NaCl, 0.03 M KCl, 0.009 M KH2PO4, 0.06 M Na2HPO4, pH 7.4) and filtered 
through a 35-µm mesh to remove connective tissue. Samples were placed into 1.5-mL 
micro-centrifuge tubes at a concentration of 2 X 106 cells/mL and placed on ice. 
PCNA Labeling and DNA Staining 
Cells were centrifuged at 400-X g for 10 min at 4ºC.  The supernatant was discarded and 
the cells resuspended in 750 µL of lysing buffer, modified from Langdberg and Roos 
(1991) containing 2% bovine serum albumin (Sigma Chemical Co., St. Louis, MO) in 
PBS, 1% NP-40 (Sigma), and 0.2 µg/mL of ethylenediamine tetra-acetic acid (EDTA) 

















Table 4.2.  Times at which the animals were sampled to determine temperature effects in 
heart and labial palps cells. Total number of oysters sampled (number of 
oysters per temperature regime). 
Time Number of oysters Temperature regime (°C) 
Initial collection from 
Grand Isle 15 20 
3 Weeks after initial 
sampling 15 20 
Before fluctuation 75 (15) 20, 15, 10, 27, and  Grand Isle 
1 Week of fluctuation 60 (12) 20 ± 1, 15 ± 1, 10± 1, 27 ± 1, and Grand Isle 
2 Weeks of fluctuation 60 (12) 20 ± 1, 15 ± 1, 10 ± 1, 27 ± 1, and Grand Isle 
5 Weeks of fluctuation 60 (12) 20 ± 1, 15 ± 1, 10 ± 1, 27 ± 1, and Grand Isle 
 
Nuclei were centrifuged at 400-X g for 10 min at 4ºC, and the supernatant was discarded. 
The pelleted nuclei were resuspended and fixed in 1 mL of 2% paraformaldehyde for 15 
min on ice.  Cells were centrifuged at 400-X g for 10 min at 4ºC.  The fixative was 
discarded and the pellet was washed twice with PBS.  The cells were resuspended in 200 
µL of PBS.  Fluorescein isothiocyanate (FITC) conjugated monoclonal anti-proliferating 
cell nuclear antigen (PC10) (Sigma) was added to the cells at a dilution of 1:40 (µL: µL) 
and the samples were held in the dark for 45 min at room temperature.  The cells were 
resuspended with 200 µL of a DNA-staining solution containing 10 µg/mL propidium 
iodide (PI) and 1.8 Kunits/mL RNase (Sigma) and held in the dark for 30 min at room 
temperature until flow cytometric analysis. 
Cell Cycle Analysis and PCNA Detection by Flow Cytometry 
The cells were analyzed using a FACSCalibur flow cytometer equipped with an 
argon laser (488 nm) (Becton-Dickinson Immunocytometry Systems, San Jose, CA) and 
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data from at least 104 cells were stored in list mode.  Doublets and debris were 
discriminated by gating on doublet discrimination modes (FL-2A vs. FL-2W) dot plot.  
Fluorescein isothiocyanate fluorescence was detected in the FL-1H channel using a 560-
nm beam splitter with a 510 – 540-nm bandpass filter and stored as a logarithmic 
amplification.  Fluorescence from PI staining of DNA was detected in the FL-2A channel 
using a 610-nm long pass filter and stored as a linear amplification.  Data were analyzed 
using FACS software (BD CellQuest™).  The cell cycle was analyzed using DNA 
histograms which were divided into three regions: (1) Resting /Gap 1 phase (G0/G1), (2) 
Synthesis phase (S), and (3) Gap 2/Mitosis (G2/M) (Fig. 4.1).  The distribution of PCNA 
stained cells was analyzed on a dual-parameter dot plot (PCNA fluorescence vs. DNA 
content) by gating on the regions described above.  The lower limit of PCNA-positive cells 
gate was set on top of the upper border of the labeled cells G2/M.  The ratio of fluorescence 
increase of PCNA during the cell cycle was calculated (geometric mean of the S-phase 
PCNA stained cells by the geographic mean of the G0/G1-phase PCNA stained cells) from 
the gated dual-parameter dot plot (PCNA fluorescence vs. DNA content). 
Nuclear RNA and DNA Staining 
The supernatant was discarded and the pellet was resuspended for 15 min on ice in 
750 µL of lysing buffer, modified from Langdberg and Roos (1991) containing 2% bovine 
serum albumin in PBS (Sigma) 1% NP – 40 (Sigma), and 0.2 µg/mL of EDTA (Fisher).  
Cells were centrifuged again at 400-X g for 10 min at 4ºC.  The lysing buffer was 
discarded and the cells resuspended in 2% paraformaldehyde (Sigma) for 15 min on ice. 
Cells were centrifuged at 400-X g for 10 min at 4ºC.  The fixative was discarded and the 
pellets were washed twice by centrifugation with PBS.  The cells were resuspended in 200 
µL of PBS.  SYBR Green II RNA gel stain (Molcular Probes, Inc., Eugene, OR) was 
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added to the cells at a 1:2000 (µL:µL) ratio, and the samples were held in the dark for 30 
min at room temperature.  The cells were resuspended with 200 µL of a DNA-staining 
solution containing 10-µg/mL of PI (Sigma) in 10 mL of PBS and held in the dark for an 
additional 30 min at room temperature until flow cytometric analysis. 
Flow Cytometry Analysis of Nuclear RNA and DNA Ratio 
The cells were analyzed using the FACSCalibur flow cytometer described above 
and data from at least 104 cells were stored in list mode.  Damaged cells and debris were 
excluded from the analysis by gating on a forward and side scatter dot plot.  Doublets and 
debris were discriminated by gating on an area integral vs. a pulse width measurement dot 
plot.  Fluorescence from SYBR Green II was detected in the FL-1H channel as described 
above.  Fluorescence from PI staining of DNA was detected in the FL-2A channel using a 
610-nm long pass filter and stored as a linear amplification.  Data were analyzed using 
FACS software (BD CellQuest™).  DNA content was analyzed as described above.  
Nuclear RNA distribution was analyzed on a dual-parameter dot plot (nuclear RNA 
fluorescence vs. DNA content) by gating on the regions described above.  Nuclear 
RNA:DNA ratio was calculated, using the gated dual-parameter dot plot (nuclear RNA 
fluorescence vs. DNA content), by dividing the nuclear RNA fluorescence (geometric 
means) into the DNA fluorescence (geometric means).  The ratio was calculated for each 
phase of the cell cycle.    
Statistical Analysis 
 Friedman’s nonparametric two-way analysis of variance (ANOVA) was used to 
compare the effect of temperature regime over time and the effect of time over each 
temperature regime for each cell cycle phase (G0/G1, S, and G2/M phases).  Friedman’s 
nonparametric two-way ANOVA was used to compare the effect of temperature regime 
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over time and the effect of time over each temperature regime for the percent PCNA 
positive nuclei.  Friedman’s nonparametric two-way ANOVA was used to compare the 
effect of temperature regime over time and the effect of time over each temperature regime 
for the RNA/DNA ratios of each cell cycle phase (G0/G1, S, and G2/M phases). 
RESULTS 
Water Temperature 
 Water temperatures in the tanks were found to be within ± 0.5ºC of the target 
temperatures (Kolar 2004).  Because the mean of the constant temperatures were similar to 
those of the 1°C fluctuation temperatures, they were grouped them together for statistical 
analysis.  The system held the water temperature at 20°C for the initial 3 weeks of 
acclimation (Fig. 4.2).  Because the water was held at the different temperature regimes for 
3 weeks before imposing fluctuations, plotting of data became difficult (approximately 
19000 observations).  Hence, for high resolution, only a 48-hr period of data at the 
beginning of each temperature regime was plotted.  When the temperatures were dropped a 
1°C per day tanks with the target temperature of 15°C were able to maintain the 
temperature constant for 3 weeks.  The 10°C tanks did not attain the target temperature, 
except for the last two weeks of acclimation.  The 27°C tanks were able to maintain the 
temperature constant throughout the study.  During fluctuation of water temperature, the 
tanks with temperature regimes of 10 ± 1°C (Fig. 4.3), 15 ± 1°C (Fig. 4.4), and 20 ± 1°C 













































































































Figure 4.2.  Water temperatures in tanks 1 and 7 for a 48-hr period. Initial temperatures 
were maintained around 20°C for 3 weeks before imposing a variation of       
± 5°C. 
 
Means and variances of the differences between expected and actual temperatures for all 
regimes for a 48-hr period are provided (Table 4.3). 
Table 4.3.   Mean of differences between expected and actual temperatures for a 48-hr 
period.  Positive mean denotes that heat is required to maintain water at 
expected temperatures.  Negative mean denotes the mead of cooling to 




Mean of difference between 
expected and actual water 
temperatures (°C) 
Variance of differences between 
expected and actual water 
temperatures (°C) 
20 ± 1°C 0.11 0.015 
15 ± 1°C -0.03 0.004 







Temperature Effects on Cell Cycle Phases 
 In heart and labial palp nuclei, there were no significant differences on the cell 




































































































































Figure 4.3. Water temperatures in tanks 14 and 16 for a 2-day period. Temperatures were 
maintained at 10 ± 1°C for 5 weeks in tank 14 while temperature was kept at 





















































































































































Figure 4.4.  Water temperatures in tanks 3 and 10 for a 2-day period. Temperatures were 
maintained at 15 ± 1°C for 5 weeks.  The water could not be cooled to the 



















































































































































Figure 4.5.  Water temperatures in tanks 1 and 7 for a 2-day period. Temperatures were 
maintained at 20 ± 1°C for 5 weeks.  The water was able to attain the desired 
temperatures. 
 
Temperature Effects on PCNA Concentrations 
There were no significant differences in the levels of PCNA detected for heart and 
labial palp nuclei among temperature regimes. 
Temperature Effects on Nuclear RNA/DNA Ratio for each Cell Cycle Phase 
 
 All temperatures had a significant effect on heart nuclear RNA/DNA ratio at the 
G0/G1 (P < 0.0001), S (P < 0.0001), and G2/M phases (P < 0.0001).  Oysters held at 10°C 
had a significantly lower G0/G1 nuclear RNA/DNA ratio than those at 15°C (P < 0.0001), 
20°C (P < 0.0001), control (P < 0.001), and Grand Isle (P < 0.0141).  These oysters had a 
significantly lower S-phase nuclear RNA/DNA ratio than did those at 15°C (P = 0.0002), 
20°C (P = 0.0169), and control (P = 0.0009).  These oysters also had a significantly lower 
G2/M phase nuclear RNA/DNA ratio than did those at 15°C (P < 0.0001), 20°C   (P < 
0.0001), and control (P < 0.0001). 
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Oysters collected from Grand Isle had a significantly higher G0/G1 nuclear 
RNA/DNA ratio than did those of 10°C (P < 0.0141), but were significantly lower than 
15°C (P < 0.0001), 20°C (P < 0.0001), and control (P = 0.0002).  These oysters had 
significantly lower S-phase labial palp nuclear RNA/DNA ratio than did those at 15°C      
(P < 0.0001), 20°C (P = 0.004), and control (P = 0.0002).  These oysters also had a 
significantly lower G2/M phase nuclear RNA/DNA than did those at 15°C (P < 0.0001), 
20°C (P < 0.0001), and control (P = 0.0002). 
Effect of Time on Cell Cycle Phase 
 Through time the proportions of cells in the G0/G1 (P < 0.0001), S (P = 0.0156), 
and G2/M phases (P < 0.0001) of the cell cycle changed significantly for heart nuclei.  As 
the number of cells in the G0/G1 phase increased significantly, there were significant 
decreases in the S and the G2/M phases.  There was a significant increase in G0/G1 nuclei 
from before fluctuation to 5 weeks of fluctuation (P = 0.0030).  There were also significant 
increases in G0/G1 nuclei from 1 week of fluctuation to 2 weeks (P = 0.0069) and 5 weeks 
(P < 0.0001) of fluctuation.  In S-phase nuclei, there was a significant decrease from 
before fluctuation to after 2 weeks (P = 0.0245) and 5 weeks (P = 0.003) of fluctuation.  
For G2/M-phase nuclei, there was a significant increase from before fluctuation to 1 week 
(P = 0.0054) and 2 weeks (P < 0.0001) of fluctuation, and there was a significant decrease 
after 5 weeks of fluctuation (P = 0.0385).  There was a significant decrease of G2/M nuclei 
from 1 week to 2 weeks (P = 0.0154) and 5 weeks (P < 0.0001) of fluctuation.  There was 
also a significant decrease in G2/M nuclei from 2 weeks to 5 weeks (P < 0.0001) of 
fluctuation. 
 Through time the proportions of cells in the G0/G1 (P < 0.0001), S (P < 0.0001), 
and G2/M phases (P < 0.0001) of the cell cycle changed significantly for labial palp nuclei.  
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As the number of cells in the G0/G1 phase increased significantly, there were significant 
decreases in the S and the G2/M phases.  There was a significant decrease in G0/G1 nuclei 
from before to after 1 week (P = 0.0007) of fluctuation.  However there was a significant 
increase of G0/G1 nuclei from before fluctuation to after 2 weeks (P = 0.0101) and 5 weeks 
(P < 0.0001) of fluctuation.  There was a significant decrease of S-phase nuclei from 
before to 2 weeks (P < 0.0001) and 5 weeks of fluctuation (P < 0.0001).  There was also a 
significant decrease in S-phase nuclei from 1 week to 2 weeks (P < 0.0001) and 5 weeks 
(P < 0.0001) of fluctuation.  There was a significant increase of G2/M nuclei from before 
to 1 week (P = 0.0005) of fluctuation.  However there was a significant decrease of G2/M 
nuclei from before to 5 weeks (P = 0.0101) of fluctuation.  There was a significant 
decrease of G2/M nuclei from 1 week to 2 weeks    (P = 0.0014) and 5 weeks (P < 0.0001) 
of fluctuation.  There was a significant decrease of G2/M nuclei from 2 weeks to 5 weeks 
(P = 0.0093) of fluctuation. 
Effect of Time on PCNA Concentration 
There were significant differences in the levels of PCNA concentrations for heart 
(P < 0.0001) and labial palp nuclei (P < 0.0001) through time.  As the number of cells in 
the S phase in heart and labial palp nuclei decreased significantly, the PCNA concentration 
decreased significantly.  For the heart (P < 0.0001) and labial palp (P < 0.0006) nuclei 
there was a significant increase in PCNA levels from the sampling period before 
fluctuation of temperature to after 1 week of fluctuation.  After 2 weeks of fluctuation there 
was no significant difference in PCNA levels for heart and labial palp nuclei.  After 5 
weeks of fluctuation there was significant increase in PCNA leves in heart nuclei             
(P = 0.0217). 
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Effect of Time on Nuclear RNA/DNA ratio for each Cell Cycle Phase 
 
 Time had a significant effect on the heart nuclear RNA/DNA ratio at the G0/G1      
(P < 0.0001), S (P < 0.0001), and G2/M (P < 0.0001) phases of the cell cycle.  The nuclear 
RNA/DNA ratio for all phases of the cell cycle was significantly higher after 1 week of 
fluctuation.  The ratio decreased after 5 weeks of fluctuation at all cell cycle phases to the 
same ratio as before fluctuation.  There was a significant increase of the G0/G1 nuclear 
RNA/DNA ratio from before fluctuation to 1week (P < 0.0001) of fluctuation.  There was 
a significant decrease from 1 week to 2 weeks (P < 0.0001) and 5 weeks (P < 0.0001) of 
fluctuation.  The number of cells in S-phase significantly increased from before fluctuation 
to 1 week (P < 0.0001), 2 weeks (P < 0.0001), and 5 weeks       (P < 0.0001) of fluctuation.  
There was also a significant decrease from 1 week of fluctuation to 5 weeks (P = 0.0051) 
of fluctuation.  The G2/M-phase heart nuclei significantly increased from before fluctuation 
to 1 week (P < 0.0001), 2 weeks (P < 0.0001), and 5 weeks (P < 0.0001) of fluctuation.  
There was also a significant decrease from 1 week of fluctuation to 2 weeks (P = 0.0016) 
and 5 weeks of fluctuation (P = 0.0001). 
 Time had a significant effect on the labial palp nuclear RNA/DNA ratio at the 
G0/G1   (P < 0.0001), S (P < 0.0001), and G2/M (P < 0.0001) phases of the cell cycle.  The 
nuclear RNA/DNA ratio for all phases of the cell cycle was significantly higher after 1 
week of fluctuation.  There was a significant increase of the G0/G1 nuclear RNA/DNA 
ratio from before fluctuation to 1week (P < 0.0001) of fluctuation.  There was a significant 
decrease from 1 week to 2 weeks (P < 0.0001) and 5 weeks (P < 0.0001) of fluctuation.  
The number of cells in S-phase significantly increased from before fluctuation to 1 week 
(P < 0.0001), 2 weeks (P < 0.0001), and 5 weeks (P < 0.0001).   There was a significant 
decrease from 1 week to 5 weeks (P = 0.0051) of fluctuation.  The G2/M-phase labial palp 
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nuclei significantly increased from before fluctuation to 1 week (P < 0.0001), 2 weeks     
(P < 0.0001), and 5 weeks (P < 0.0001).  There was a significant decrease from 1 week to 
2 weeks (P = 0.0016) and 5 weeks (P = 0.0051) of fluctuation. 
DISCUSSION 
An improved understanding of the key influences on growth and proliferation of 
somatic tissue cells of the eastern oyster would assist in the development of tissue cultures.  
Temperature is the most important factor affecting almost all aspects of oyster biology 
(Shumway 1996), and cell proliferation in somatic tissues of the eastern oyster was 
affected by seasonal temperature changes, with cell proliferation increasing in the winter 
(Nguyen et al. Department of Veterinary Sciences).  To fully understand the effects of 
temperature on somatic tissues, it is necessary to first consider the effects of temperature 
on the cell cycle. 
The major consideration of growth is the cell cycle, the analysis of which can 
provide a reliable index for the prediction of growth potential and changes in cell number 
with time (Leelavatcharamas et al. 1996).  The cell cycle is a series of biochemical and 
structural events involving the growth, replication, and division of eukaryotic cells.  The 
cell cycle is divided into four parts: mitosis (cell divison), period between mitosis and the 
beginning of DNA synthesis (Gap 1 or G1 phase), period of DNA synthesis (S phase), and 
period between the end of DNA synthesis and the beginning of mitosis (Gap 2 or G2) 
(Klug and Cummings 1994).  Temperature affects all the phases of the cell cycle in ways 
characteristic of each period (Sisken et al. 1965). 
 In this study, constant temperature had no effect on the cell cycle phases and 
cellular proliferation of heart and labial palp cells.  It is possible that this occurred because 
temperature was decreased at a slow rate (1ºC per day for 5-10 days) and the cells were 
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able to acclimate to the change.  The cell cycle phases could have lengthened to equal 
proportions due to slowing down of biochemical reactions as suggested by studies in 
phytoplankton growth (Vaulot 1994).   In studies of mammalian cell cultures and human 
amnionic cells it was found that constant temperatures did not affect the G1-phase cells, but 
when temperature was increased or decreased, the cells in G1-phase were affected (Sisken 
et al. 1965; Watanabe and Okada 1967). 
Measurement of the ratio of RNA to DNA in somatic tissues in crustaceans (Sulkin 
et al. 1975; Anger and Hirche 1990; Juinio et al. 1992) and mollusks (Clarke et al. 1989; 
Kenchington 1994; Lodeiros et al. 1996; Chicharo et al. 2001) has been used to detect 
responses to environmental changes, growth rate, stress due to disease, and nutritional 
condition.  Although this study evaluated nuclear RNA/DNA ratios, our results are similar 
to studies on temperature effects using RNA/DNA ratios derived from tissues on a per 
gram basis.  In a study of seasonal variation of muscle and liver RNA/DNA ratios in 
bluegill Lepomis macrochirus, it was found that at warmer temperatures (20°C – 25°C) the 
muscle ratios were higher and at lower temperatures (10°C – 20°C) the liver ratios were 
higher (Bulow et al. 1981).  In a study of Gadus morhua larvae and juveniles of Atlantic 
cod, the RNA/DNA ratio also increased as temperature increased (Clemmesen et al. 2003). 
Constant temperature had an affect on metabolic condition of somatic tissue cells in 
the eastern oyster.  In the heart and labial palps cells temperatures between 15°C and 20°C 
might have decreased the amount of RNA present in cells because of increasing RNAase 
activity.  Although this study showed that temperature is a factor in cell metabolism of in 
vivo cells of the eastern oyster, future research should include water temperature 
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CHAPTER 5 – DIURNAL TEMPERATURE EFFECTS ON CELL PROLIFERATION OF EASTERN 
OYSTER SOMATIC TISSUES 
 
INTRODUCTION 
Eastern oysters, Crassostrea virginica, are found along the Atlantic and Gulf coasts 
of the United States, in shallow and semi-enclosed water bodies, where water temperatures 
can vary greatly.  Oysters are ectothermic organisms, having a body temperature that 
fluctuates with the temperature of its surroundings.  Temperature is the most important 
factor that affects almost all aspects of oyster biology including survival, feeding and 
growth, gonadal development and spawning, larval settlement, heart rate and respiration, 
disease outbreaks (Shumway 1996), and somatic tissue cell proliferation (Nguyen et al. 
Department of Veterinary Sciences).   
A study of cell proliferation in somatic tissues of the eastern oyster, found that it 
was seasonal (Nguyen et al. Department of Veterinary Sciences).  Cell proliferation 
increased during the late fall and winter months (November-March) and steadily decreased 
in the spring to summer months (April-July).  Cell proliferation in somatic tissues was also 
determined to cease as gonadal tissue matured in during the late spring and late summer 
months before spawning (Frovola 1993; Leibson and Frovola 1994; Nguyen et al. 
Department of Veterinary Sciences). 
The goal of this study was to determine the effect of fluctuating temperature on the 
somatic tissues of the eastern oyster.  In this report, the effects of fluctuating water 
temperatures are evaluated for the cell cycle, cell proliferation, and cell metabolism in 
heart and labial palps cells of the eastern oyster.  Cell proliferation in somatic tissues was 
measured by detection of proliferating cell nuclear antigen (PCNA) by use of a flow 
cytometer.  Proliferating cell nuclear antigen, an auxiliary protein of DNA polymerase-δ, is 
closely linked with DNA synthesis and repair (Tan et al. 1986; Bravo et al. 1987). Cell 
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metabolism was measured by nuclear RNA/DNA ratios at all phases of the cell cycle. This 
index is based on the assumption that amount of DNA is stable under changing 
environmental conditions while nuclear RNA content is affected by environmental 
fluctuation conditions.  Therefore, the ratio of nuclear RNA to DNA is susceptible to 
change when the environment of the organism changes (Chicharo et al. 2001).  The 
objectives of this study were to determine by flow cytometry if fluctuating water 
temperatures affected the: (1) cell cycle, (2) cell proliferation, and (3) cell metabolism.  
Temperature fluctuation had an effect on all phases of the cell cycle for the heart and labial 
palps.  We determined that temperature fluctuation increased cell proliferation and in turn 
increased cell metabolism. 
METHODS AND MATERIALS 
This study was conducted in conjunction with the study from Chapter 4 of this 
thesis.  The materials and methods (oyster collection, oyster maintenance, cell preparation, 
PCNA labeling and DNA staining, nuclear RNA and DNA staining, flow cytometric 
analysis of the cell cycle and PCNA, and flow cytometry analysis of nuclear RNA and 
DNA ratio) are similar, but the temperature fluctuations were of 5 or 10°C. 
Experimental Design 
After 3 weeks the water temperatures were dropped at the rate of 1ºC per day until 
four tanks (2, 3, 4, and 10) were at 15ºC, and two tanks (12 and 15) were at 10ºC, while 
two tanks (6 and 8) were kept at 20ºC.  The temperature in three tanks (13, 17, and 18) was 
increased 1ºC per day to 27ºC and the tanks were labeled as the control.  Once the water 
reached the target temperatures (10, 15 or 20ºC) they were maintained for 3 weeks, for 
temperature acclimation.  After 3 weeks, fluctuation was imposed on each of the 
temperature regimes (As described in table 5.1) (Fig. 5.1). 
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Table 5.1.  Temperature fluctuations imposed on tanks. Each temperature regime was 
replicated twice. 
 
Tank Average Temperature (ºC) Fluctuation (ºC) 
6 & 8 20 ± 5 
3 & 10 15 ± 5 
2 & 4 15 ± 10 
12 & 15 10 ± 5 
13, 17, & 18 27 ± 1 
 
 
Figure 5.1.  Schematic of the temperature regimes imposed in this study. 
 
The fluctuation was diurnal and was implemented for 5 weeks.  During the span of 
this experiment oysters in the system were sampled at various times (Table 5.2).  Oysters 
were kept in Grand Isle as a standard to determine the natural effects of temperature and 




















Table 5.2.  Times at which the animals were sampled to determine temperature effects in 
heart and labial palps cells. Total number of oysters sampled (number of 
oysters per temperature regime). 
Time Number of Oysters Temperature Regime (°C) 
1 Week of fluctuation 60 (12) 20 ± 5, 15 ± 10, 10± 5,     27, and Grand Isle 
2 Weeks of fluctuation 60 (12) 20 ± 5, 15 ± 10, 10 ± 5,   27, and Grand Isle 
5 Weeks of fluctuation 60 (12) 20 ± 5, 15 ± 10, 10 ± 5,     27, and Grand Isle 
 
Statistical Analysis 
Friedman’s nonparametric two-way analysis of variance (ANOVA) was used to 
compare the effect of temperature regime over time and the effect of time over each 
temperature regime for each cell cycle phase (G0/G1, S, and G2/M phases).  Friedman’s 
nonparametric two-way ANOVA was used to compare the effect of temperature regime 
over time and the effect of time over each temperature regime for the percent PCNA 
positive nuclei.  Friedman’s nonparametric two-way ANOVA was used to compare the 
effect of temperature regime over time and the effect of time over each temperature regime 
for the nuclear RNA/DNA ratios of each cell cycle phase (G0/G1, S, and G2/M phases). 
RESULTS 
Water Temperature 
 Water temperatures in the tanks were found to be within ± 0.5ºC from the expected 
temperatures.  The system held the water temperature at 20°C for the initial 3 weeks of 













































































































Figure 5.2.  Water temperatures in tanks 6 and 8 for a 48-hr period. Initial temperatures 
were maintained around 20°C for 3 weeks before imposing a variation of       
± 5°C. 
 
Because the water was held at the different temperature regimes for 3 weeks before 
imposing fluctuations, plotting of data became difficult (approximately 19000 
observations).  Hence, for high resolution, only a 48-hr period of data at the beginning of 
each temperature regime was plotted.  When the temperatures were dropped 1°C per day 
tanks with the target temperature of 15°C were able to maintain the temperature constant 
for 3 weeks (Fig. 5.3).  The 10°C tanks did not attain the target temperature, except for the 
last two weeks of acclimation (Fig. 5.4).  The control tanks were able to maintain the 
temperature constant throughout the study.  During fluctuation of water temperature, the 
tanks with temperature regimes of 10 ± 5°C (Fig. 5.5), 15 ± 5°C (Fig. 5.6), and 15 ± 10°C 














































































































Figure 5.3.  Water temperatures in tanks 3 and 10 for a 2-day period. Temperatures were 
maintained around 15°C for 3 weeks before imposing a fluctuations of ± 5°C 













































































































Figure 5.4.  Water temperatures in tanks 12 and 15 for a 2-day period. Temperatures were 




































































































































Figure 5.5.  Water temperatures in tanks 12 and 15 for a 2-day period. Temperatures were 
maintained at 10°C ± 5°C for 5 weeks.  The water was not able to be cooled 




















































































































































Figure 5.6.  Water temperatures in tanks 3 and 10 for a 2-day period. Temperatures were 
maintained at 15 ± 5°C for 5 weeks.  The water was not able to be cooled to 






















































































































































Figure 5.7.  Water temperatures in tanks 2 and 4 for a 2-day period. Temperatures were 
maintained at 15 ± 10°C for 5 weeks.  The water was not able to be warmed 
or cooled to the desired temperatures. 
 
 
Means and variances of the differences between expected and actual temperatures for all 
regimes for a 48-hr period are provided (Table 5.3).  Tanks with fluctuations of 20 ± 5°C 
attained the desire temperatures (Fig 5.8). 
Table 5.3. Mean of differences between expected and actual temperatures for a 48-hr 
period. Positive mean denotes that heat if required into the system to maintain 
water at expected temperatures.  Regimes 15 ± 5°C, and 15 ± 10°C needed to 
be cooled further to be maintained at expected temperatures. 
Regime Mean of difference between expected and actual water temperatures (°C) 
Variance of differences between expected 
and actual water temperatures (°C) 
20 ± 5°C 0.19 0.088 
15 ± 5°C -0.43 0.556 
15 ± 10°C -1.78 6.610 




















































































































































Figure 5.8.  Water temperatures in tanks 6 and 8 for a 2-day period. Temperatures were 
maintained at 20 ± 5°C for 5 weeks.  The water was able to attain the desired 
temperatures. 
 
Temperature Effects on Cell Cycle Phases 
 The temperature regimes had a significant effect on the proportions of cells in the 
heart G0/G1-phase (P = 0.009) and S-phase (P < 0.0001) nuclei.  Temperature regimes had 
no significant effects on the proportions of cells in the heart G2/M phase nuclei.  Oysters in 
10 ± 5°C had significantly greater proportion of cells in the heart G0/G1 nuclei than 15 ± 
10°C (P = 0.0427), control (P = 0.0014), and Grand Isle (P = 0.0171).  Oysters in 15 ± 5°C 
had significantly greater proportions of cells in the heart G0/G1 nuclei than control            
(P = 0.0033), and Grand Isle (P = 0.0347).  Oysters in 10 ± 5°C had significantly lower 
proportions of cells in the heart S-phase nuclei than 15 ± 10°C (P < 0.0001), 20 ± 5°C     
(P = 0.0001), control (P < 0.0001), and Grand Isle (P = 0.0091).  Oysters in 15 ± 5°C had 
significantly lower proportions of cells in the heart S-phase nuclei than 15 ± 10°C            
(P = 0.0013), 20 ± 5°C (P = 0.0026), and control (P < 0.0001).  Oysters collected from 
 92
Grand Isle had significantly lower proportions of cells in the S-phase heart nuclei than 
oysters at control (P = 0.0141).   
 The temperature regimes had a significant effect on the proportion of labial palps in 
S-phase (P < 0.0001) and G2/M-phase (P < 0.0001) nuclei.  Temperature regimes had no 
significant effects on the proportions of cells in the heart G0/G1 phase nuclei.  Oysters in 10 
± 5°C had significantly lower proportions of cells in the labial palp S phase nuclei than 15 
± 5°C (P = 0.0036), 15 ± 10°C (P = 0.001), 20 ± 5°C (P < 0.0001), and control                 
(P < 0.0001).  Control oysters had significantly lower proportions of cells in the labial palp 
S phase nuclei than 10 ± 5°C (P < 0.0001), 15 ± 5°C (P = 0.0003), 15 ± 10°C                   
(P = 0.0006), 20 ± 5°C (P < 0.0001), and those collected from Grand Isle (P < 0.0001). 
Temperature Effects on PCNA Concentrations 
 Temperature regimes had a significant effect (P = 0.0007) on the levels of PCNA 
detected in the heart nuclei.  Oysters in 10 ± 5°C had significantly lower levels of PCNA 
concentrations than those in 15 ± 10°C (P = 0.0005), 20 ± 5°C (P = 0.0004), control        
(P < 0.0001), and those collected from Grand Isle (P = 0.0102). 
 Temperature regimes had a significant effect (P < 0.0001) on the levels PCNA 
detected in labial palp nuclei.  Oysters in 10 ± 5°C had significantly lower levels of PCNA 
concentrations than those in 15 ± 5°C (P = 0.0087), 15 ± 10°C (P = 0.0007), 20 ± 5°C     
(P = 0.0005), control (P < 0.0001), and those collected from Grand Isle (P = 0.005).  
Control oysters had significantly higher levels of PCNA concentrations than those in 15 ± 
5°C (P = 0.011), 15 ± 10°C (P = 0.0012), 20 ± 5°C (P = 0.0144), and those collected from 




Temperature Effects on Nuclear RNA/DNA Ratio for each Cell Cycle Phase 
 
 The temperature regimes had a significant effect on nuclear RNA/DNA ratio of 
heart G0/G1 phase (P < 0.0001) and G2/M phase (P = 0.0007) nuclei.  We found that in all 
phases of the cell cycle, the nuclear RNA/DNA ratios were the highest between 15°C and 
20°C.  Oysters in 10 ± 5°C had significantly lower nuclear RNA/DNA ratio of heart G0/G1 
nuclei than 15 ± 5°C (P < 0.0001), 15 ± 10°C (P < 0.0001), 20 ± 5°C (P < 0.0001), and 
control (P < 0.0001).  Oysters collected from Grand Isle had significantly lower nuclear 
RNA/DNA ratio of heart G0/G1 nuclei than 15 ± 5°C (P = 0.0357).  Oysters in   10 ± 5°C 
had significantly lower nuclear RNA/DNA ratio of heart G0/G1 nuclei than 15 ± 5°C         
(P < 0.0001), 15 ± 10°C (P < 0.0001), 20 ± 5°C (P = 0.0262), and control (P = 0.0032). 
 The temperature regimes had a significant effect on nuclear RNA/DNA ratio of 
labial palp G0/G1 phase (P = 0.001) and G2/M phase (P = 0.0132) nuclei.  We found that in 
all phases of the cell cycle, the nuclear RNA/DNA ratios were the highest between 15°C 
and 20°C.  Oysters in 10 ± 5°C had significantly lower nuclear RNA/DNA ratio of labial 
palp G0/G1 nuclei than 15 ± 5°C (P = 0.0001), 15 ± 10°C (P = 0.0022), 20 ± 5°C              
(P = 0.0003), and control (P = 0.0169).  Oysters in 10 ± 5°C had significantly lower 
nuclear RNA/DNA ratio of labial palp G2/M nuclei than 15 ± 5°C (P = 0.0012), 15 ± 10°C 
(P = 0.0253), and 20 ± 5°C (P = 0.0049). 
Effect of Time on Cell Cycle Phase 
 Through time the proportions of cells in the heart G0/G1 (P < 0.0001), S                
(P = 0.0003), and G2/M (P < 0.0001) phase nuclei changed significantly.  As the number 
of cells in the G0/G1 phase increased significantly, the S and G2/M phase significantly 
decreased.  There were significantly lower proportions of cells in the G0/G1 phase heart 
nuclei after 1 week of fluctuation than after 2 weeks (P < 0.0001) and 5 weeks                  
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(P < 0.0001) of fluctuation.  There was also significantly lower proportions of cells in the 
G0/G1 phase heart nuclei after 2 weeks of fluctuation than after 5 weeks (P = 0.0022) of 
fluctuation.  The number of cells in the S-phase were significantly higher after 2 weeks       
(P < 0.0001) and 5 weeks (P = 0.0034) of fluctuation.  There were significantly higher 
proportions of cells in the G2/M phase heart nuclei after 1 week of fluctuation than after 2 
weeks (P < 0.0001) and 5 weeks (P < 0.0001) of fluctuation.  There were also significantly 
higher proportions of cells in the G0/G1 phase heart nuclei after 2 weeks of fluctuation than 
after 5 weeks (P < 0.0001) of fluctuation. 
 Through time the proportions of cells in the labial palp G0/G1 (P < 0.0001), S        
(P < 0.0001), and G2/M (P < 0.0001) phase nuclei change significantly.  As the number of 
cells in the G0/G1 phase significantly increased the S and G2/M phases significantly 
decreased.  There were significantly lower proportions of cells in the G0/G1 phase heart 
nuclei after 1 week of fluctuation than after 2 weeks (P < 0.0001) and 5 weeks                  
(P < 0.0001) of fluctuation.  The number of cells in the S-phase labial palp nuclei were 
significantly higher after 2 weeks (P < 0.0001) and 5 weeks (P < 0.0001) of fluctuation.  
There were significantly higher the proportions of cells in the G2/M phase labial palp 
nuclei after 1 week of fluctuation than after 2 weeks (P < 0.0001) and 5 weeks                   
(P < 0.0001) of fluctuation. 
Effect of Time on PCNA Concentration 
 Through time the levels of PCNA in the heart (P < 0.0001) changed significantly.  
As the proportions of cells in the S-phase decreased significantly, the PCNA levels 
decreased significantly.  There were significantly higher PCNA levels after 1 week of 
fluctuation than that of 2 weeks (P < 0.0001) and 5 weeks (P = 0.0033) of fluctuation. 
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 Through time the levels of PCNA in the labial palps (P < 0.0001) changed 
significantly.  As the proportions of cells in the S-phase decreased significantly, the PCNA 
levels decreased significantly.  There were significantly higher PCNA concentrations after 
1 week of fluctuation than after 2 weeks (P < 0.0001) and 5 weeks (P < 0.0001) of 
fluctuation. 
Effect of Time on Nuclear RNA/DNA ratio for Each Cell Cycle Phase 
 
 Through time the nuclear RNA/DNA ratio of heart G0/G1 (P < 0.0001), S              
(P = 0.0149), and G2/M (P = 0.0002) phase nuclei changed significantly.  After 5 weeks of 
fluctuation the conditions of the cells were similar to those as before fluctuation.  There 
was a significantly higher nuclear RNA/DNA ratio of the G0/G1 phase in heart nuclei after 
1 week of fluctuation than after 2 weeks (P < 0.0001) and 5 weeks (P < 0.0001) of 
fluctuation.  There was a significantly higher nuclear RNA/DNA ratio of the S phase in 
heart nuclei after 1 week of fluctuation than after 2 weeks (P = 0.0131) and 5 weeks          
(P = 0.0064) of fluctuation.  There was a significantly higher nuclear RNA/DNA ratio of 
the G2/M phase in heart nuclei after 1 week of fluctuation than after 2 weeks (P = 0.0008) 
and 5 weeks (P < 0.0001) of fluctuation. 
 Through time the nuclear RNA/DNA ratio of labial palps G0/G1 (P < 0.0001), S   
(P = 0.0002), and G2/M (P = 0.0017) phase nuclei changed significantly.  After 5 weeks of 
fluctuation the conditions of the cells were similar as those from before fluctuation of 
temperatures.  There was a significantly higher nuclear RNA/DNA ratio of the G0/G1 phase 
in labial palp nuclei after 1 week of fluctuation than after 2 weeks (P = 0.0201) and 5 
weeks (P < 0.0001) of fluctuation.  There was a significantly higher nuclear RNA/DNA 
ratio of the S-phase in labial palp nuclei after 2 weeks of fluctuation than after 1 week       
(P = 0.0007) and 5 weeks (P = 0.0002) of fluctuation.  There was a significantly lower 
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nuclear RNA/DNA ratio of the G2/M phase in labial palp nuclei after 5 weeks of 
fluctuation than after 1 week (P = 0.014) and 2 weeks (P = 0.0005) of fluctuation. 
DISCUSSION 
In Chapter 4 of this thesis, the initial decrease of water temperature and the 
consequent constant temperatures had no effect on phases of the cell cycle or cellular 
proliferation in the heart and labial palps cells.  Once temperature fluctuations were 
implemented, it was found that the cell cycle and cellular proliferation were affected.  
These results agree with a report of temperature effects on mammalian cell cultures.  A 
study of a recombinant Chinese hamster ovary (rCHO) cell line (CL-11G) producing pro-
urokinase (pro-UK) in batch cultures for temperature optimization, found that a decrease of 
the optimal temperature of 37°C to 31°C led to an increase of the number of cells at G0/G1 
phase from 56% to 83%, and cells in the S phase decreased from 35% to 12%.  The cell 
growth rate decreased from 0.024/h at 37°C to 0.006/h at 31°C (Chen et al. 2004). 
Although this study did not address cell cycle rates, the decrease of nuclei in the 
G0/G1 phase and the subsequent increase in the nuclei of S-phase and G2/M-phase after 5 
weeks of fluctuations suggests that the duration times in the G0/G1 phase might have 
increased with decrease in the other two phases.  A report on the effects of temperature on 
the kinetics of the mitotic cycle of mammalian cell cultures, found that below optimum 
temperatures (37-39°C) the progression through all phases of the cell cycle decreased 
(Sisken et al. 1965).  The progression through G1 phase was the slowest below 34°C, the 
optimum temperature.  Growth kinetics and antibody formation of an anti-interleukin-2 
producing hybridoma line were studied in a suspension culture at temperatures ranging 
from 34°C to 39°C (Bloemkolk et al. 1997).  When temperatures were lowered the cells 
stayed longer at the G1 phase of the cell cycle. 
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Measurement of the ratio of RNA to DNA in somatic tissues in fishes (Buckley 
1984; Robinson and Ware 1988; McGurk and Kusser 1992), crustaceans (Sulkin et al. 
1975; Anger and Hirche 1990; Juinio et al. 1992) and mollusks (Clarke et al. 1989; 
Kenchington 1994; Lodeiros et al. 1996; Chicharo et al. 2001) has been used to detect the 
responses to environmental changes, growth rate, stress due to disease, and nutritional 
condition.  Although the present study evaluated cell-specific nuclear RNA/DNA ratios, 
the results are similar to studies on temperature effects on RNA/DNA ratios derived on a 
per gram basis from tissues.  In eggs and larvae of walleye pollock Theragra 
chalcogramma cooler temperatures increased the RNA/DNA ratios (Canino 1994).  A 
study that investigated the effect of time of day on RNA/DNA ratios on starved and fed 
Pacific oysters, Crassostrea gigas, and juvenile clams, Ruditapes decussates, also found 
higher RNA/DNA ratios with cooler water temperatures in the holding tanks (Chicharo et 
al. 2001).  The high RNA/DNA ratios at lower temperatures have been found to be 
associated with the lower activity rate of the RNA, an increase in the amount of RNA 
present in cells, and the reduction of RNAase activity (Buckley 1982; Goolish 1984; 
Clemmesen 1994). 
In the present study, temperature fluctuation played a key role in the cell cycle, 
proliferation, and metabolic condition of somatic tissue cells in the eastern oyster.  
Temperatures below 15°C had an increase in the amount of cells in the G0/G1 phase for 
heart and labial palps nuclei, perhaps because of the decrease in progression rate through 
this phase.  Fluctuating temperatures with a mean of 15°C and 20°C increased the amount 
of cells in the S phase and the concentrations of PCNA in both tissues suggesting that 
progression of heart and labial palp cells through these phases might have increased.  The 
metabolic conditions in the heart and labial palp cells for oysters at 10 ± 5°C suggests that 
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the low temperatures increased the amount of RNA present in cells because of the 
reduction in RNAase activity.  Although this study showed that temperature is a factor in 
the growth and proliferation of in vivo cells of the eastern oyster, future research should 
include more sampling times and water temperatures higher than 27°C to determine if cell 
cycle rates and cellular proliferation at these temperatures are affected. 
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CHAPTER 6 – SUMMARY AND CONCLUSIONS 
 
The overall goal of these studies was to evaluate temperature effects on cell 
proliferation of eastern oyster somatic tissues for the development of an oyster cell line.  
Understanding the in vivo cell proliferation of an organism is essential for the development 
of cell culture.  Cell proliferation can be measured by identifying nuclear cellular proteins 
involved in growth regulation and cellular transformation.  To evaluate cell proliferation, 
analysis of nuclear RNA content can provide information on cell kinetics at each phase of 
the cell cycle.  The techniques developed herein include two flow cytometric methods: (1) 
detection of proliferating cells and (2) detection of nuclear RNA throughout the cell cycle 
for cells in vivo.  These techniques were used to evaluate the effects of constant and 
fluctuating temperatures on somatic tissues of the eastern oyster. 
In the first part of this work, (Chapter 3) a flow cytometric assay was developed 
and optimized to detect proliferating cell nuclear antigen (PCNA) in oyster somatic tissues.  
Oysters were collected in August from the Louisiana Sea Grant Oyster Hatchery at Grand 
Isle, Louisiana and were maintained in an indoor temperature-controlled recirculating 
system until use.  The hearts and labial palps of the oysters were surgically removed and 
for comparison of immunohistological methods and flow cytometry labial palps were 
embedded in paraffin, fixed, and sectioned for immunohistochemical analysis.  To 
optimize the flow cytometric assay, different cellular and nuclear permeabilization and 
fixation methods were tested and once optimized, the protocol was used throughout 
subsequent studies.   To evaluate proliferating cells, monoclonal anti-PCNA (PC10) 
conjugated with fluorescein isothiocyanate (FITC) was added to the cells, which were 
analyzed using flow cytometry and data from at least 104 cells were analyzed using 
FACSCalibur software (BD CellQuest™).  Proliferating cell nuclear antigen was detected 
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in all the phases of the cell cycle of the eastern oyster.  The levels of PCNA increased from 
G0/G1-phase into the S-phase, where it peaked in mid-S phase, and decreased in G2/M 
phase. 
  The fixed labial palps cross sections were processed and mounted onto glass 
slides.  The presence of PCNA in the embedded oyster tissues was detected by 
immunohistochemical staining using a modified version of procedures for a commercially 
available PCNA Staining Kit (Zymed).  The PCNA levels of somatic cells on stained slides 
were analyzed using image analysis and compared to the flow cytometric detection of 
PCNA.   Twice as many samples could be analyzed in 1 h by use of flow cytometry.   The 
cost per sample using flow cytometry was half that of image analysis.  Tissues analyzed by 
flow cytometry and classified as “high” and “low” PCNA-positive cells could not be 
distinguished by image analysis.  Overall, flow cytometry was superior to 
immunohistochemistry in time and cost efficiency, and in sensitivity to the detection of 
PCNA in oyster somatic tissues. 
To study another cellular parameter reflective of cell growth, (Chapter 3) a flow 
cytometric assay was developed to detect nuclear RNA in oyster somatic tissues.  Oysters 
were collected in January from the Louisiana Sea Grant Oyster Hatchery at Grand Isle, 
Louisiana and were maintained in a temperature-controlled recirculating system until use.  
The hearts and labial palps of the oysters were surgically removed, crushed to single cell 
suspensions, permeabilized, and fixed.  The fixed cells were stained with SYBR Green II 
to evaluate nuclear RNA throughout the cell cycle.  The cells were analyzed using flow 
cytometer and data from at least 104 cells were analyzed using FACSCalibur software (BD 
CellQuest™) and stored in list mode.  Nuclear RNA was detected in all the phases of the 
cell cycle of the eastern oyster.  The concentrations of nuclear RNA increased from G0/G1 
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phase into the S phase, where they peaked in mid-S-phase, and decreased in G2 phase/M.  
The ability to calculate the amount of nuclear RNA and the nuclear RNA/DNA ratio 
throughout the cell cycle can provide information on cellular kinetics and conditions of 
cultured cells due to environmental changes in the medium. 
In the final part of this work, (Chapters 4 and 5) temperature effects on cell cycle, 
proliferation, and cell metabolism of oyster somatic tissues were evaluated.  Oysters were 
collected in March from the Louisiana Sea Grant Oyster Hatchery at Grand Isle, Louisiana, 
and were maintained at different temperature regimes in an indoor temperature-controlled 
recirculating system.  The hearts and labial palps of the oysters were surgically removed 
and the two flow cytometric assays were used to analyze the cell cycle, proliferation, and 
metabolic condition for these cells.  Cell cycle analysis of the heart and labial palp cells 
showed that the proportions of G0/G1 phase cells decreased, the S phase and G2/M phase 
cells increased.  Heart and labial palp cells for oysters held between 15°C and 25°C 
increased in PCNA-positive cells after 1 week of temperature fluctuation.  The nuclear 
RNA/DNA ratio at all phases of the cell cycle for heart and labial palps cells for oysters 
between 10°C and 20°C was higher than at all other temperature regimes indicating 
increased metabolic activity at the lower temperatures.  Temperature variations affected the 
cell cycle, proliferation, and the metabolic condition of oyster somatic cells. 
Future research to improve the development of oyster cell lines include: (1) use 
other species of oysters, (2) use other markers that can determine temperature effects, (3) 
use of temperature regimes more reflective of the natural environment, (4) study of the 
effects of temperatures above 25°C, (5) study of the long-term effects of temperature 
fluctuation, and (6) study of the short-term effects of temperature fluctuation. 
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APPENDIX A – TEMPERATURE-CONTROL SYSTEM 
The system contained nineteen independently functioning cylindro-conical food-
grade holding tanks that had a capacity of 250 L (Aquatic Eco-Systems, Inc, Apopka, FL). 
The tanks were filled with 200 L of artificial seawater at a concentration of 20 ppt (HW 
marine mix, Wiegandt GmbH Co., Krefeld, Germany).  All the tanks were insulated with 
encapsulated fiberglass insulation (~10 cm) (Johns Manville, Denver, CO) to prevent the 
loss of heat (Fig. A.1).  Each tank had separate heating and cooling mechanisms that 
consisted of: two 300-W electric glass immersion heater (Model # 300, Commodity Axis, 
San Gabriel, CA) and a submersible water pump (Model # 306, Commodity Axis, San 
Gabriel, CA) that recirculated the water in the tank through a heat exchanger at 2 Lpm 
(liters per min) for cooling.  Two perforated plastic sacs filled with plastic bio balls (5 cm 
dia) [with a void space of approximately 94% and geometric surface area 31 ft2/ft3] 
(Keeton Industries, Inc., Wellington, CO) were placed at the bottom of each tank, which 
functioned as biological filters.  Aeration and circulation of the water were done by an 
airlift.  The airlift also functioned in water mixing to provide homogeneity of temperature.  
A T-type thermocouple (Omega Engineering Inc., Stamford, CT) was placed in each tank 











Figure A.1.  General schematic of the indoor temperature controlled system. The heat 
exchangers are placed in the chill tank were the water is cooled to ~ 4°C by 
two electric chillers.  
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Nine tanks were connected to one rectangular chill tank (Frigid Units, Toledo, OH).  
The chill tank was filled with fresh water and the water cooled to 4°C by a pair of 
electrically operated chillers (120 V AC and 2000 W approximately) (Fig. 1).  The heat 
exchangers were submerged in the chilled water and the submersible pump recirculated 
water in the oyster tank through the heat exchanger.  The heat exchangers were built from 
stainless steel trays (54 x 33 x 6 cm) with the lids sealed with silicone and held in place 
















Figure A.2. Tank components including:  an airlift to aerate and circulate water in the 
tank, an immersion heater, a water pump used for temperature control, heat 
exchanger to cool water and a thermocouple to sense the water temperature.  
Biological filters placed at the bottom of the tank to treat wastes generated by 
oysters. 
 
The temperatures were monitored and recorded by a personal computer.  The 
computer processed the signals from the thermocouples that were connected to a 32-
channel CIO EXP-32 multiplexer (Measurement Computing Inc., Middleboro, MA.).  The 
multiplexer converted the signal from analog to digital so that the personal computer could 
process the data and relayed the output signals to the solid-state relays (P/N 611489, 
























Figure A.3.  Thermocouples acted as temperature sensors and all thermocouples were 
connected to a multiplexer.  The personal computer processed the signals and 











APPENDIX B – UNANALYZED DATA 
 
Table B.1.  Data for hearts of initial experimentation of cell cycle analysis and PCNA 
detection (Chapter 2). 
Tissue %G0/G1 %S %G2/M % PCNA 
Heart 79.29 3.70 17.01 11.62 
Heart 74.90 5.43 19.67 15.64 
Heart 72.74 6.87 20.39 18.07 
Heart 78.88 3.68 17.44 13.18 
Heart 84.72 1.75 13.53 6.58 
Heart 76.91 4.17 18.92 15.20 
Heart 79.33 3.46 17.21 14.95 
Heart 82.53 2.55 14.92 12.82 
Heart 80.31 3.21 16.48 9.06 
Heart 78.75 3.93 17.32 10.58 
Heart 77.61 4.05 18.34 16.67 
Heart 80.75 2.43 16.82 12.66 
Heart 77.75 4.03 18.22 17.46 
Heart 72.60 6.73 20.67 18.85 
Heart 75.02 5.67 19.31 18.44 
Heart 75.60 5.38 19.02 17.85 
Heart 75.72 5.61 18.67 17.23 
Heart 79.10 3.57 17.33 11.50 
Heart 72.76 6.41 20.83 23.05 
Heart 80.96 2.13 16.91 9.58 
Heart 77.43 4.10 18.47 17.35 
Heart 80.69 2.53 16.78 10.61 
Heart 77.32 4.57 18.11 18.00 
Heart 80.85 2.43 16.72 7.91 
Heart 81.70 2.20 16.10 11.22 
Heart 78.34 3.67 17.99 18.48 
Heart 78.95 3.42 17.63 13.46 
Heart 72.15 7.20 20.65 17.60 
Heart 77.30 4.38 18.32 11.96 
Heart 73.78 6.21 20.01 14.44 
Heart 76.16 4.99 18.85 11.89 
Heart 77.77 4.24 17.99 11.20 
Heart 78.87 4.20 16.93 12.60 
Heart 78.08 4.38 17.54 11.56 
Heart 75.93 5.44 18.63 12.73 
Heart 77.95 4.23 17.82 10.05 
Heart 80.46 3.18 16.36 11.00 
Heart 81.27 2.85 15.88 9.81 
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Tissue %G0/G1 %S %G2/M % PCNA 
Heart 86.11 0.46 13.43 4.33 
Heart 79.68 3.65 16.67 10.95 
Heart 76.50 5.22 18.28 14.06 
Heart 74.89 6.06 19.05 17.43 
Heart 74.65 6.01 19.34 16.43 
Heart 79.18 3.28 17.54 14.30 
Heart 81.42 2.60 15.98 12.34 
Heart 61.20 14.36 24.44 32.26 
Heart 71.44 7.80 20.76 15.76 
Heart 69.89 8.72 21.39 15.12 
Heart 76.15 5.04 18.81 10.78 
Heart 74.48 6.48 19.04 11.34 
Heart 76.07 5.25 18.68 13.94 
Heart 68.82 9.20 21.98 21.00 
Heart 76.39 5.22 18.39 10.87 
Heart 75.61 5.75 18.64 11.20 
Heart 74.48 6.49 19.03 13.59 
Heart 72.29 7.02 20.69 11.37 
Heart 73.36 7.12 19.52 14.64 
Heart 80.21 3.07 16.72 7.89 
Heart 75.62 5.60 18.78 9.25 
Heart 80.53 3.06 16.41 8.80 
Heart 77.58 4.83 17.59 11.48 
Heart 81.74 2.58 15.68 6.55 
Heart 80.83 3.89 15.28 7.50 
Heart 82.10 2.56 15.34 6.96 
Heart 85.96 0.93 13.11 7.56 
Heart 84.79 1.26 13.95 9.30 
Heart 81.76 2.63 15.61 10.53 
Heart 81.50 3.32 15.18 13.20 
Heart 76.55 5.19 18.26 17.32 
Heart 76.76 5.88 17.36 14.71 
Heart 68.43 9.89 21.68 13.68 
Heart 78.36 4.09 17.55 9.71 
Heart 78.47 4.01 17.52 8.44 
Heart 80.48 3.27 16.25 6.58 








Table B.2.  Data for labial palps of initial experimentation of cell cycle analysis and 
PCNA detection (Chapter 2). 
Tissue %G0/G1 %S %G2/M % PCNA 
Labial Palp 76.24 5.85 17.91 17.79 
Labial Palp 69.19 10.22 20.59 21.88 
Labial Palp 79.42 4.56 16.02 13.59 
Labial Palp 79.17 4.36 16.47 14.23 
Labial Palp 76.29 5.72 17.99 15.93 
Labial Palp 76.14 5.99 17.87 16.83 
Labial Palp 79.40 4.21 16.39 13.09 
Labial Palp 82.58 2.61 14.81 11.38 
Labial Palp 82.79 2.98 14.23 10.88 
Labial Palp 84.47 1.89 13.64 12.90 
Labial Palp 84.41 1.67 13.92 10.42 
Labial Palp 77.14 5.53 17.33 18.59 
Labial Palp 81.27 3.71 15.02 18.07 
Labial Palp 79.29 4.46 16.25 16.62 
Labial Palp 79.09 4.04 16.87 15.35 
Labial Palp 85.27 1.64 13.09 10.19 
Labial Palp 84.93 1.96 13.11 12.49 
Labial Palp 83.19 2.02 14.79 14.13 
Labial Palp 83.06 2.37 14.57 11.66 
Labial Palp 73.04 7.31 19.65 20.39 
Labial Palp 78.99 4.81 16.20 16.49 
Labial Palp 83.51 2.36 14.13 13.07 
Labial Palp 84.96 1.18 13.86 9.72 
Labial Palp 75.46 6.25 18.29 20.83 
Labial Palp 81.09 3.24 15.67 14.89 
Labial Palp 79.10 4.09 16.81 14.79 
Labial Palp 77.14 5.83 17.03 16.63 
Labial Palp 83.23 2.24 14.53 10.75 
Labial Palp 79.61 4.05 16.34 14.19 
Labial Palp 72.83 7.44 19.73 20.63 
Labial Palp 79.18 4.19 16.63 18.40 
Labial Palp 81.02 3.56 15.42 18.01 
Labial Palp 73.47 7.44 19.09 23.26 
Labial Palp 78.87 4.65 16.48 18.54 
Labial Palp 76.84 5.87 17.29 18.91 
Labial Palp 82.63 2.69 14.68 11.00 
Labial Palp 83.31 2.27 14.42 9.09 
Labial Palp 81.86 3.03 15.11 12.12 
Labial Palp 82.59 2.63 14.78 7.89 
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Tissue %G0/G1 %S %G2/M % PCNA 
Labial Palp 84.68 1.76 13.56 7.04 
Labial Palp 85.37 1.15 13.48 5.75 
Labial Palp 79.47 4.25 16.28 13.00 
Labial Palp 81.14 3.13 15.73 9.38 
Labial Palp 75.40 6.41 18.19 17.95 
Labial Palp 86.46 0.60 12.94 5.74 
Labial Palp 78.95 4.58 16.47 9.80 
Labial Palp 73.15 7.02 19.83 15.79 
Labial Palp 80.84 3.40 15.76 9.67 
Labial Palp 81.70 3.08 15.22 8.95 
Labial Palp 76.93 5.12 17.95 10.60 
Labial Palp 78.82 5.16 16.02 9.74 
Labial Palp 78.58 4.64 16.78 11.11 
Labial Palp 78.63 5.04 16.33 13.38 
Labial Palp 71.07 8.02 20.91 11.95 
Labial Palp 72.23 7.02 20.75 11.20 
Labial Palp 71.34 7.89 20.77 12.65 
Labial Palp 70.23 8.41 21.36 14.49 
Labial Palp 78.24 4.80 16.96 8.28 
Labial Palp 76.60 5.56 17.84 11.39 
Labial Palp 79.27 4.29 16.44 10.63 
Labial Palp 68.62 9.17 22.21 13.76 
Labial Palp 77.49 5.02 17.49 10.46 
Labial Palp 82.90 2.33 14.77 9.30 
Labial Palp 81.73 3.23 15.04 9.68 
Labial Palp 84.65 1.82 13.53 5.45 
Labial Palp 87.72 0.59 11.69 1.18 
Labial Palp 82.81 2.38 14.81 4.76 
Labial Palp 81.74 3.17 15.09 7.67 
Labial Palp 74.08 6.45 19.47 12.90 
Labial Palp 80.77 3.51 15.72 10.53 
Labial Palp 80.11 4.00 15.89 8.00 
Labial Palp 84.04 2.33 13.63 9.3 









Table B.3.  Data for heart and labial palps for the analysis of PCNA distribution in relation to the cell cycle (Chapter 1). 
 
  Cell Cycle   Positive PCNA   Positive PCNA  
Tissue %G0/G1 %S %G2/M %G0/G1 %S %G2/M %Late G0/G1 %S %Early G2/M 
Heart 84.71 1.67 13.62 79.43 9.17 11.40 57.01 20.34 22.65 
Heart 81.33 2.54 16.13 74.66 15.45 9.89 38.77 35.29 25.94 
Heart 83.89 2.01 14.10 78.52 9.78 11.70 56.36 21.11 22.53 
Heart 85.22 1.27 13.51 81.92 8.56 9.52 60.32 19.67 20.01 
Heart 82.47 2.56 14.97 75.28 15.12 9.60 38.11 34.05 27.84 
Heart 78.96 3.98 17.06 72.77 20.23 7.00 32.42 39.21 28.37 
Heart 80.77 2.97 16.26 76.89 16.14 6.97 37.94 35.68 26.38 
Heart 80.49 2.37 17.14 79.72 9.46 10.82 59.03 19.17 21.80 
Heart 77.62 4.34 18.04 71.02 20.13 8.85 34.92 38.52 26.56 
Heart 84.97 2.29 12.74 76.17 17.13 6.70 32.98 36.76 30.26 
          
Labial Palps 85.98 1.76 12.26 78.14 12.17 9.69 37.18 33.49 29.33 
Labial Palps 80.21 2.87 16.92 75.31 16.45 8.24 43.62 36.52 19.86 
Labial Palps 84.78 2.21 13.01 77.61 13.78 8.61 38.71 32.67 28.62 
Labial Palps 86.21 1.39 12.40 79.39 11.56 9.05 41.85 27.56 30.59 
Labial Palps 80.75 2.01 17.24 76.28 14.12 9.60 53.17 26.99 19.84 
Labial Palps 79.10 3.65 17.25 74.37 17.23 8.40 45.82 36.76 17.42 
Labial Palps 80.67 2.69 16.64 76.78 13.14 10.08 50.36 29.45 20.19 
Labial Palps 80.82 2.04 17.14 78.36 12.46 9.18 45.26 24.98 29.76 
Labial Palps 78.86 3.21 17.93 74.77 16.13 9.10 55.23 25.78 18.99 
Labial Palps 83.53 2.47 14.00 76.89 15.13 7.98 53.44 26.11 20.45 
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Table B.4.  Data of heart nuclei for the analysis of temperature effects on cell cycle and PCNA (Chapter 4 and 5). 
Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Heart initial 10 75.16 11.14 13.70 16.23 
Heart initial 10 75.79 4.45 19.76 7.61 
Heart initial 10 76.32 9.06 14.62 10.06 
Heart initial 10 74.12 10.51 15.37 14.70 
Heart initial 10 81.59 4.81 13.61 6.54 
Heart initial 10 76.96 9.11 13.93 15.46 
Heart initial 10 75.32 9.31 15.37 12.29 
Heart initial 10 77.38 8.59 14.02 12.61 
Heart initial 10 75.56 8.47 15.97 11.91 
Heart initial 10 79.95 3.51 16.54 7.27 
Heart initial 10 80.87 4.58 14.55 7.76 
Heart initial 10 78.68 5.22 16.10 10.09 
Heart initial 10 78.68 6.36 14.96 10.16 
Heart 3 weeks after 10 81.55 7.26 11.19 10.21 
Heart 3 weeks after 10 80.96 6.12 12.92 7.17 
Heart 3 weeks after 10 76.87 4.05 19.09 8.34 
Heart 3 weeks after 10 72.96 10.66 16.38 12.96 
Heart 3 weeks after 10 71.82 10.97 17.21 14.12 
Heart 3 weeks after 10 70.68 6.69 22.63 10.92 
Heart 3 weeks after 10 77.76 7.93 14.30 13.76 
Heart 3 weeks after 10 73.61 9.73 16.66 15.79 
Heart 3 weeks after 10 73.60 8.46 17.94 14.09 
Heart 3 weeks after 10 79.25 7.13 13.62 12.05 
Heart 3 weeks after 10 78.20 7.17 14.63 13.73 
Heart 3 weeks after 10 77.95 4.76 17.29 8.44 
Heart 3 weeks after 10 75.33 9.64 15.03 16.06 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Heart 3 weeks after 10 78.42 4.24 17.34 8.12 
Heart 3 weeks after 10 78.66 9.73 11.62 17.64 
Heart before 10 82.80 6.48 10.71 8.72 
Heart before 10 80.84 5.64 13.51 8.32 
Heart before 10 75.30 5.86 18.85 8.54 
Heart before 10 75.23 8.26 16.52 13.72 
Heart before 10 72.36 9.46 18.19 21.13 
Heart before 10 71.61 9.54 18.85 15.85 
Heart before 10 79.47 5.13 15.40 11.67 
Heart before 10 74.70 8.28 17.02 15.39 
Heart before 10 72.51 10.71 16.78 22.01 
Heart before 10 78.48 7.78 13.74 13.17 
Heart before 10 76.87 10.03 13.10 22.26 
Heart before 10 78.49 6.06 15.46 14.21 
Heart before 10 79.71 8.14 12.16 16.37 
Heart before 10 77.52 5.08 17.40 9.31 
Heart before 10 78.83 7.73 13.43 15.08 
Heart 1week 10±1 73.16 9.93 16.91 20.74 
Heart 1week 10±1 80.33 3.09 16.58 13.49 
Heart 1week 10±1 82.43 3.34 14.23 14.62 
Heart 1week 10±1 81.81 3.24 14.95 13.75 
Heart 1week 10±1 69.76 14.00 16.23 31.41 
Heart 1week 10±1 81.91 2.52 15.57 7.23 
Heart 1week 10±1 77.47 3.72 18.81 15.93 
Heart 1week 10±1 80.26 2.64 17.09 12.80 
Heart 1week 10±1 81.38 3.82 14.80 15.26 
Heart 1week 10±1 85.21 2.03 12.76 9.85 
 114
Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Heart 2weeks 10±1 78.26 6.36 15.39 22.81 
Heart 2weeks 10±1 78.87 4.08 17.05 18.30 
Heart 2weeks 10±1 74.76 7.25 17.98 25.62 
Heart 2weeks 10±1 76.26 5.33 18.41 18.75 
Heart 2weeks 10±1 83.37 2.68 13.94 9.61 
Heart 2weeks 10±1 80.71 3.78 15.51 14.63 
Heart 2weeks 10±1 78.26 3.54 18.19 14.53 
Heart 2weeks 10±1 80.18 2.54 17.28 10.79 
Heart 2weeks 10±1 81.48 3.58 14.94 15.38 
Heart 2weeks 10±1 78.54 5.27 16.20 15.40 
Heart 2weeks 10±1 77.90 4.26 17.84 15.18 
Heart 2weeks 10±1 81.34 3.49 15.17 17.38 
Heart 5weeks 10±1 80.52 5.09 14.39 20.32 
Heart 5weeks 10±1 82.23 5.13 12.64 19.26 
Heart 5weeks 10±1 81.13 6.65 12.23 22.68 
Heart 5weeks 10±1 76.66 8.11 15.24 24.80 
Heart 5weeks 10±1 78.65 7.16 14.19 23.48 
Heart 5weeks 10±1 82.77 6.16 11.08 20.35 
Heart 5weeks 10±1 78.55 7.23 14.22 23.88 
Heart 5weeks 10±1 80.35 8.33 11.32 25.73 
Heart 5weeks 10±1 82.24 5.29 12.47 15.13 
Heart 5weeks 10±1 74.37 8.74 16.89 31.99 






Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Heart initial 15 75.16 11.14 13.70 16.23 
Heart initial 15 75.79 4.45 19.76 7.61 
Heart initial 15 76.32 9.06 14.62 10.06 
Heart initial 15 74.12 10.51 15.37 14.70 
Heart initial 15 81.59 4.81 13.61 6.54 
Heart initial 15 76.96 9.11 13.93 15.46 
Heart initial 15 75.32 9.31 15.37 12.29 
Heart initial 15 77.38 8.59 14.02 12.61 
Heart initial 15 75.56 8.47 15.97 11.91 
Heart initial 15 79.95 3.51 16.54 7.27 
Heart initial 15 80.87 4.58 14.55 7.76 
Heart initial 15 78.68 5.22 16.10 10.09 
Heart initial 15 78.68 6.36 14.96 10.16 
Heart 3 weeks after 15 81.55 7.26 11.19 10.21 
Heart 3 weeks after 15 80.96 6.12 12.92 7.17 
Heart 3 weeks after 15 76.87 4.05 19.09 8.34 
Heart 3 weeks after 15 72.96 10.66 16.38 12.96 
Heart 3 weeks after 15 71.82 10.97 17.21 14.12 
Heart 3 weeks after 15 70.68 6.69 22.63 10.92 
Heart 3 weeks after 15 77.76 7.93 14.30 13.76 
Heart 3 weeks after 15 73.61 9.73 16.66 15.79 
Heart 3 weeks after 15 73.60 8.46 17.94 14.09 
Heart 3 weeks after 15 79.25 7.13 13.62 12.05 
Heart 3 weeks after 15 78.20 7.17 14.63 13.73 
Heart 3 weeks after 15 77.95 4.76 17.29 8.44 
Heart 3 weeks after 15 75.33 9.64 15.03 16.06 
Heart 3 weeks after 15 78.42 4.24 17.34 8.12 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Heart 3 weeks after 15 78.66 9.73 11.62 17.64 
Heart before 15 76.15 9.68 14.17 16.32 
Heart before 15 86.62 4.63 8.75 7.54 
Heart before 15 81.06 7.01 11.93 15.20 
Heart before 15 83.76 4.47 11.77 8.83 
Heart before 15 81.30 5.40 13.31 11.24 
Heart before 15 80.99 5.06 13.96 10.39 
Heart before 15 79.65 7.93 12.42 14.34 
Heart before 15 77.50 5.25 17.25 9.93 
Heart before 15 81.99 6.61 11.41 12.38 
Heart before 15 76.12 6.26 17.62 12.11 
Heart before 15 79.60 5.17 15.23 9.88 
Heart before 15 80.29 9.20 10.51 16.00 
Heart before 15 79.86 7.47 12.66 14.46 
Heart before 15 83.15 6.79 10.06 13.36 
Heart before 15 80.37 8.65 10.98 16.46 
Heart 1week 15±1 78.07 5.44 16.49 16.70 
Heart 1week 15±1 65.22 11.92 22.86 30.80 
Heart 1week 15±1 78.54 6.74 14.72 22.99 
Heart 1week 15±1 72.76 7.67 19.57 23.44 
Heart 1week 15±1 71.42 8.73 19.85 22.86 
Heart 1week 15±1 70.80 8.98 20.23 24.60 
Heart 1week 15±1 72.39 8.58 19.04 24.30 
Heart 1week 15±1 82.07 5.82 12.10 14.66 
Heart 1week 15±1 76.87 5.64 17.48 16.70 
Heart 1week 15±1 76.75 6.29 16.96 17.86 
Heart 1week 15±1 80.44 6.20 13.36 14.06 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Heart 2weeks 15±1 75.42 6.12 18.46 17.90 
Heart 2weeks 15±1 72.41 10.65 16.94 22.07 
Heart 2weeks 15±1 66.94 12.18 20.88 23.59 
Heart 2weeks 15±1 79.54 5.89 14.57 16.86 
Heart 2weeks 15±1 73.58 9.89 16.53 24.41 
Heart 2weeks 15±1 81.66 7.10 11.24 16.91 
Heart 2weeks 15±1 81.64 4.30 14.06 14.03 
Heart 2weeks 15±1 78.18 4.49 17.33 15.64 
Heart 2weeks 15±1 81.55 4.76 13.69 18.52 
Heart 2weeks 15±1 84.36 3.98 11.66 12.79 
Heart 2weeks 15±1 82.33 3.85 13.82 16.10 
Heart 2weeks 15±1 80.33 3.96 15.71 16.26 
Heart 5weeks 15±1 85.44 2.62 11.94 10.56 
Heart 5weeks 15±1 76.90 7.16 15.94 17.95 
Heart 5weeks 15±1 82.85 4.50 12.65 13.31 
Heart 5weeks 15±1 89.18 3.84 6.98 11.13 
Heart 5weeks 15±1 80.40 4.54 15.06 12.57 
Heart 5weeks 15±1 76.59 10.65 12.76 22.53 
Heart 5weeks 15±1 80.93 4.81 14.26 9.62 
Heart 5weeks 15±1 76.26 9.68 14.06 24.65 
Heart 5weeks 15±1 82.96 3.78 13.26 15.24 








Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Heart initial 20 75.16 11.14 13.70 16.23 
Heart initial 20 75.79 4.45 19.76 7.61 
Heart initial 20 76.32 9.06 14.62 10.06 
Heart initial 20 74.12 10.51 15.37 14.70 
Heart initial 20 81.59 4.81 13.61 6.54 
Heart initial 20 76.96 9.11 13.93 15.46 
Heart initial 20 75.32 9.31 15.37 12.29 
Heart initial 20 77.38 8.59 14.02 12.61 
Heart initial 20 75.56 8.47 15.97 11.91 
Heart initial 20 79.95 3.51 16.54 7.27 
Heart initial 20 80.87 4.58 14.55 7.76 
Heart initial 20 78.68 5.22 16.10 10.09 
Heart initial 20 78.68 6.36 14.96 10.16 
Heart 3 weeks after 20 73.80 7.26 18.52 10.21 
Heart 3 weeks after 20 65.65 6.12 25.17 7.17 
Heart 3 weeks after 20 65.57 4.05 24.46 8.34 
Heart 3 weeks after 20 58.92 10.66 31.88 12.96 
Heart 3 weeks after 20 63.97 10.97 26.07 14.12 
Heart 3 weeks after 20 74.58 6.69 21.31 10.92 
Heart 3 weeks after 20 72.40 7.93 20.75 13.76 
Heart 3 weeks after 20 70.52 9.73 19.03 15.79 
Heart 3 weeks after 20 75.88 8.46 17.61 14.09 
Heart 3 weeks after 20 71.37 7.13 17.82 12.05 
Heart 3 weeks after 20 66.57 7.17 25.51 13.73 
Heart 3 weeks after 20 68.72 4.76 16.74 8.44 
Heart 3 weeks after 20 72.98 9.64 18.33 16.06 
Heart 3 weeks after 20 75.20 4.24 14.36 8.12 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Heart before 20 84.64 4.28 11.08 12.51 
Heart before 20 87.27 3.66 9.08 12.75 
Heart before 20 83.70 6.00 10.30 14.94 
Heart before 20 85.23 4.20 10.57 11.56 
Heart before 20 83.06 5.05 11.89 13.43 
Heart before 20 82.44 4.46 13.10 11.90 
Heart before 20 84.27 4.95 10.78 12.90 
Heart before 20 81.54 5.14 13.32 13.68 
Heart before 20 82.12 6.52 11.36 14.43 
Heart before 20 79.56 4.44 16.00 12.95 
Heart before 20 76.40 7.98 15.62 19.50 
Heart before 20 79.14 6.59 14.28 17.10 
Heart before 20 80.64 5.23 14.13 13.07 
Heart before 20 75.13 10.47 14.40 22.47 
Heart 1week 20±1 77.53 7.40 15.07 27.69 
Heart 1week 20±1 77.41 6.59 16.00 25.84 
Heart 1week 20±1 75.61 6.00 18.39 25.38 
Heart 1week 20±1 70.35 15.15 14.50 37.22 
Heart 1week 20±1 73.66 12.58 13.75 33.13 
Heart 1week 20±1 70.72 10.79 18.49 31.54 
Heart 1week 20±1 72.61 5.94 21.46 21.34 
Heart 1week 20±1 84.49 3.36 12.14 19.94 
Heart 1week 20±1 75.10 10.46 14.45 26.66 
Heart 1week 20±1 76.45 8.15 15.41 27.36 
Heart 1week 20±1 73.68 7.73 18.59 27.33 
Heart 1week 20±1 73.26 7.25 19.49 21.56 
Heart 2weeks 20±1 77.70 5.49 16.81 15.00 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Heart 2weeks 20±1 79.00 5.00 16.00 17.22 
Heart 2weeks 20±1 73.48 14.11 12.40 21.39 
Heart 2weeks 20±1 71.92 12.36 15.71 22.77 
Heart 2weeks 20±1 77.87 4.29 17.84 14.89 
Heart 2weeks 20±1 72.05 13.07 14.88 26.92 
Heart 2weeks 20±1 70.56 13.26 16.18 27.85 
Heart 2weeks 20±1 73.10 7.65 19.25 19.97 
Heart 2weeks 20±1 77.78 6.97 15.26 15.12 
Heart 2weeks 20±1 85.46 6.06 8.48 11.49 
Heart 2weeks 20±1 78.29 7.43 14.28 18.29 
Heart 2weeks 20±1 77.83 8.00 14.17 18.78 
Heart 5weeks 20±1 79.33 3.45 17.22 16.72 
Heart 5weeks 20±1 78.19 7.83 13.98 14.20 
Heart 5weeks 20±1 86.42 1.79 11.80 5.51 
Heart 5weeks 20±1 82.91 5.53 11.56 13.43 
Heart 5weeks 20±1 78.74 8.47 12.79 25.95 
Heart 5weeks 20±1 80.55 6.92 12.53 21.66 
Heart 5weeks 20±1 82.50 5.83 11.66 17.01 
Heart 5weeks 20±1 82.46 7.73 9.81 23.15 










Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Heart 1week 10±5 83.30 3.95 16.91 14.90 
Heart 1week 10±5 81.40 3.37 16.58 10.46 
Heart 1week 10±5 82.53 3.64 14.23 11.59 
Heart 1week 10±5 77.60 5.14 14.95 17.83 
Heart 1week 10±5 84.34 3.70 16.23 13.24 
Heart 1week 10±5 79.81 5.37 15.57 18.09 
Heart 1week 10±5 84.52 3.16 18.81 12.10 
Heart 1week 10±5 81.31 4.64 17.09 14.99 
Heart 1week 10±5 85.21 4.34 14.80 14.04 
Heart 1week 10±5 79.41 6.25 12.76 16.93 
Heart 1week 10±5 79.48 4.07 16.45 16.18 
Heart 1week 10±5 81.23 3.31 15.46 13.19 
Heart 2weeks 10±5 78.41 8.89 12.70 22.69 
Heart 2weeks 10±5 79.73 4.96 15.31 14.09 
Heart 2weeks 10±5 76.16 8.19 15.65 20.14 
Heart 2weeks 10±5 78.45 5.57 15.98 15.13 
Heart 2weeks 10±5 74.00 5.61 20.38 18.10 
Heart 2weeks 10±5 78.61 2.76 18.63 13.66 
Heart 2weeks 10±5 79.52 4.41 16.06 16.00 
Heart 2weeks 10±5 79.82 3.84 16.33 13.80 
Heart 2weeks 10±5 80.09 4.05 15.86 13.06 
Heart 2weeks 10±5 79.40 3.99 16.61 15.82 
Heart 2weeks 10±5 75.40 5.80 18.80 19.46 
Heart 2weeks 10±5 79.21 4.09 16.70 15.82 
Heart 5weeks 10±5 78.87 5.77 15.36 18.86 
Heart 5weeks 10±5 80.53 3.27 16.19 9.42 
Heart 5weeks 10±5 84.23 4.54 11.23 14.64 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Heart 5weeks 10±5 85.23 3.22 11.55 10.44 
Heart 5weeks 10±5 82.04 4.30 13.66 18.51 
Heart 5weeks 10±5 84.73 3.95 11.33 12.92 
Heart 5weeks 10±5 82.69 3.94 13.37 17.42 
Heart 5weeks 10±5 82.93 2.76 14.31 11.42 
Heart 5weeks 10±5 77.15 5.01 17.84 24.10 
Heart 5weeks 10±5 83.60 3.25 13.15 7.40 
Heart 5weeks 10±5 77.77 3.98 18.25 15.95 
Heart 5weeks 10±5 83.39 2.72 13.89 8.42 
 
Heart 1week 15±5 77.26 5.62 17.12 21.39 
Heart 1week 15±5 68.83 12.28 18.89 41.36 
Heart 1week 15±5 69.86 13.80 16.34 45.61 
Heart 1week 15±5 74.95 8.33 16.72 25.55 
Heart 1week 15±5 72.38 9.73 17.89 22.45 
Heart 1week 15±5 72.98 5.47 21.56 16.90 
Heart 1week 15±5 79.13 3.86 17.01 18.39 
Heart 1week 15±5 83.15 2.31 14.54 16.99 
Heart 1week 15±5 83.49 2.96 13.54 15.36 
Heart 2weeks 15±5 79.79 5.15 15.05 17.21 
Heart 2weeks 15±5 77.99 4.40 17.62 16.43 
Heart 2weeks 15±5 87.46 2.48 10.06 8.84 
Heart 2weeks 15±5 78.89 3.97 17.15 16.98 
Heart 2weeks 15±5 77.95 2.30 19.75 9.63 
Heart 2weeks 15±5 79.07 3.18 17.75 14.40 
Heart 2weeks 15±5 81.85 3.93 14.22 15.21 
Heart 2weeks 15±5 80.15 3.91 15.94 14.43 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Heart 2weeks 15±5 83.21 3.46 13.34 14.54 
Heart 2weeks 15±5 85.88 4.67 9.45 19.56 
Heart 2weeks 15±5 84.56 2.05 13.39 6.93 
Heart 2weeks 15±5 83.42 2.90 13.68 12.14 
Heart 5weeks 15±5 86.95 3.24 9.81 12.81 
Heart 5weeks 15±5 82.62 3.93 13.46 11.89 
Heart 5weeks 15±5 78.25 8.54 13.21 24.66 
Heart 5weeks 15±5 90.05 3.12 6.83 13.86 
Heart 5weeks 15±5 89.65 5.02 5.33 17.33 
Heart 5weeks 15±5 85.74 5.35 8.91 15.66 
Heart 5weeks 15±5 84.30 4.19 11.51 18.25 
Heart 5weeks 15±5 84.48 2.27 13.25 13.79 
Heart 5weeks 15±5 83.95 5.17 10.88 17.15 
Heart 5weeks 15±5 75.22 9.02 15.76 26.68 
Heart 5weeks 15±5 81.12 6.00 12.88 21.88 
Heart 5weeks 15±5 79.01 4.52 16.47 14.37 
 
Heart 1week 15±10 69.08 11.53 19.39 27.70 
Heart 1week 15±10 67.66 12.83 19.51 29.60 
Heart 1week 15±10 71.43 11.06 17.51 26.01 
Heart 1week 15±10 70.48 8.92 20.60 18.65 
Heart 1week 15±10 76.80 6.93 16.27 18.67 
Heart 1week 15±10 65.51 17.36 17.12 34.37 
Heart 1week 15±10 70.06 9.20 20.74 20.49 
Heart 1week 15±10 76.48 10.76 12.76 25.07 
Heart 1week 15±10 74.45 9.41 16.14 18.69 
Heart 2weeks 15±10 77.75 5.86 16.40 19.86 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Heart 2weeks 15±10 81.43 2.60 15.97 10.15 
Heart 2weeks 15±10 77.67 6.25 16.09 22.48 
Heart 2weeks 15±10 84.80 4.15 11.04 12.50 
Heart 2weeks 15±10 83.48 3.92 12.59 14.96 
Heart 2weeks 15±10 79.21 1.58 19.21 11.06 
Heart 2weeks 15±10 80.82 4.08 15.10 16.00 
Heart 2weeks 15±10 82.03 3.01 14.96 12.75 
Heart 2weeks 15±10 76.15 7.05 16.80 19.33 
Heart 2weeks 15±10 83.10 4.75 12.15 12.24 
Heart 2weeks 15±10 80.59 4.79 14.62 17.98 
Heart 2weeks 15±10 81.34 3.21 15.45 13.70 
Heart 5weeks 15±10 78.28 6.33 15.39 22.59 
Heart 5weeks 15±10 85.16 3.58 11.26 14.33 
Heart 5weeks 15±10 78.51 5.81 15.69 20.25 
Heart 5weeks 15±10 86.27 5.86 7.87 17.75 
Heart 5weeks 15±10 87.00 5.80 7.20 18.07 
Heart 5weeks 15±10 82.42 5.62 11.96 17.45 
Heart 5weeks 15±10 80.04 7.35 12.61 23.59 
Heart 5weeks 15±10 81.96 5.30 12.74 16.05 
Heart 5weeks 15±10 79.33 8.45 12.22 22.09 
Heart 5weeks 15±10 76.57 7.68 15.76 28.37 
 
Heart 1week 20±5 75.81 10.06 14.12 35.14 
Heart 1week 20±5 70.94 7.15 21.91 25.01 
Heart 1week 20±5 76.83 8.48 14.69 31.42 
Heart 1week 20±5 74.23 9.67 16.10 31.36 
Heart 1week 20±5 73.62 8.54 17.84 30.73 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Heart 1week 20±5 72.65 4.99 22.36 11.99 
Heart 1week 20±5 77.45 3.91 18.64 12.33 
Heart 1week 20±5 84.14 2.59 13.27 8.21 
Heart 1week 20±5 54.67 6.40 38.93 16.97 
Heart 1week 20±5 56.70 8.59 34.71 21.37 
Heart 2weeks 20±5 81.27 5.03 13.70 16.97 
Heart 2weeks 20±5 76.15 7.23 16.62 20.50 
Heart 2weeks 20±5 80.52 5.90 13.58 15.37 
Heart 2weeks 20±5 74.80 11.17 14.03 33.29 
Heart 2weeks 20±5 83.90 4.97 11.13 13.76 
Heart 2weeks 20±5 79.75 8.40 11.85 18.68 
Heart 2weeks 20±5 79.16 6.45 14.39 20.72 
Heart 2weeks 20±5 80.60 5.54 13.86 21.02 
Heart 2weeks 20±5 78.51 6.93 14.56 19.41 
Heart 2weeks 20±5 88.61 2.91 8.48 13.45 
Heart 2weeks 20±5 79.67 5.54 14.79 19.50 
Heart 2weeks 20±5 79.07 6.37 14.56 17.68 
Heart 5weeks 20±5 84.15 3.14 12.72 12.36 
Heart 5weeks 20±5 80.26 5.13 14.61 17.02 
Heart 5weeks 20±5 82.59 4.56 12.85 14.88 
Heart 5weeks 20±5 84.04 6.54 9.42 25.30 
Heart 5weeks 20±5 80.59 6.89 12.52 20.97 
Heart 5weeks 20±5 85.18 5.41 9.41 21.36 
Heart 5weeks 20±5 81.47 5.50 13.02 20.38 
Heart 5weeks 20±5 81.64 5.70 12.66 21.47 
Heart 5weeks 20±5 84.29 3.09 12.63 10.55 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Heart initial 27 75.16 11.14 13.70 16.23 
Heart initial 27 75.79 4.45 19.76 7.61 
Heart initial 27 76.32 9.06 14.62 10.06 
Heart initial 27 74.12 10.51 15.37 14.70 
Heart initial 27 81.59 4.81 13.61 6.54 
Heart initial 27 76.96 9.11 13.93 15.46 
Heart initial 27 75.32 9.31 15.37 12.29 
Heart initial 27 77.38 8.59 14.02 12.61 
Heart initial 27 75.56 8.47 15.97 11.91 
Heart initial 27 79.95 3.51 16.54 7.27 
Heart initial 27 80.87 4.58 14.55 7.76 
Heart initial 27 78.68 5.22 16.10 10.09 
Heart initial 27 78.68 6.36 14.96 10.16 
Heart 3 weeks after 27 81.55 7.26 11.19 10.21 
Heart 3 weeks after 27 80.96 6.12 12.92 7.17 
Heart 3 weeks after 27 76.87 4.05 19.09 8.34 
Heart 3 weeks after 27 72.96 10.66 16.38 12.96 
Heart 3 weeks after 27 71.82 10.97 17.21 14.12 
Heart 3 weeks after 27 70.68 6.69 22.63 10.92 
Heart 3 weeks after 27 77.76 7.93 14.30 13.76 
Heart 3 weeks after 27 73.61 9.73 16.66 15.79 
Heart 3 weeks after 27 73.60 8.46 17.94 14.09 
Heart 3 weeks after 27 79.25 7.13 13.62 12.05 
Heart 3 weeks after 27 78.20 7.17 14.63 13.73 
Heart 3 weeks after 27 77.95 4.76 17.29 8.44 
Heart 3 weeks after 27 75.33 9.64 15.03 16.06 
Heart 3 weeks after 27 78.42 4.24 17.34 8.12 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Heart 3 weeks after 27 78.66 9.73 11.62 17.64 
Heart before 27 84.87 4.95 10.18 14.66 
Heart before 27 81.90 5.12 12.98 17.83 
Heart before 27 77.99 9.58 12.43 22.56 
Heart before 27 82.33 6.34 11.33 16.45 
Heart before 27 82.04 9.25 8.70 20.78 
Heart before 27 83.48 2.92 13.60 12.49 
Heart before 27 75.46 6.39 18.15 16.05 
Heart before 27 75.73 5.90 18.37 16.90 
Heart before 27 72.28 8.76 18.96 19.49 
Heart before 27 68.93 12.33 18.74 27.04 
Heart before 27 79.42 4.18 16.40 14.91 
Heart before 27 76.08 7.25 16.67 18.27 
Heart before 27 76.87 10.19 12.94 19.08 
Heart before 27 71.37 11.33 17.30 23.27 
Heart before 27 80.26 8.61 11.13 20.09 
Heart 1week 27 73.05 9.29 17.66 30.62 
Heart 1week 27 67.82 9.49 22.68 26.33 
Heart 1week 27 67.82 13.99 18.19 33.43 
Heart 1week 27 69.63 12.95 17.42 34.74 
Heart 1week 27 72.53 10.87 16.60 31.32 
Heart 1week 27 70.40 15.57 14.03 36.39 
Heart 1week 27 74.38 6.01 19.61 20.27 
Heart 2weeks 27 83.39 2.58 14.03 6.02 
Heart 2weeks 27 74.62 8.34 17.04 19.82 
Heart 2weeks 27 79.19 5.71 15.10 16.74 
Heart 2weeks 27 80.66 5.31 14.02 14.19 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Heart 2weeks 27 75.79 6.60 17.61 15.07 
Heart 2weeks 27 79.26 7.48 13.26 22.72 
Heart 2weeks 27 77.06 5.75 17.19 14.65 
Heart 2weeks 27 69.18 16.49 14.33 34.07 
Heart 2weeks 27 82.25 4.18 13.57 15.50 
Heart 2weeks 27 80.91 4.69 14.40 14.34 
Heart 2weeks 27 84.04 5.63 10.33 18.23 
Heart 2weeks 27 73.29 11.47 15.24 24.70 
Heart 5weeks 27 79.60 6.37 14.04 19.32 
Heart 5weeks 27 79.08 6.13 14.79 18.82 
Heart 5weeks 27 85.99 3.77 10.24 11.05 
Heart 5weeks 27 85.21 3.31 11.47 9.81 
Heart 5weeks 27 80.75 5.80 13.45 17.31 
Heart 5weeks 27 79.10 4.91 15.99 19.63 
Heart 5weeks 27 83.67 3.96 12.38 14.68 
Heart 5weeks 27 70.82 10.53 18.65 25.17 
Heart 5weeks 27 78.86 5.94 15.20 19.94 
Heart 5weeks 27 78.53 6.33 15.14 17.90 
 
Heart initial GI 75.16 11.14 13.70 16.23 
Heart initial GI 75.79 4.45 19.76 7.61 
Heart initial GI 76.32 9.06 14.62 10.06 
Heart initial GI 74.12 10.51 15.37 14.70 
Heart initial GI 81.59 4.81 13.61 6.54 
Heart initial GI 76.96 9.11 13.93 15.46 
Heart initial GI 75.32 9.31 15.37 12.29 
Heart initial GI 77.38 8.59 14.02 12.61 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Heart initial GI 75.56 8.47 15.97 11.91 
Heart initial GI 79.95 3.51 16.54 7.27 
Heart initial GI 80.87 4.58 14.55 7.76 
Heart initial GI 78.68 5.22 16.10 10.09 
Heart initial GI 78.68 6.36 14.96 10.16 
Heart 3 weeks after GI 81.55 7.26 11.19 10.21 
Heart 3 weeks after GI 80.96 6.12 12.92 7.17 
Heart 3 weeks after GI 76.87 4.05 19.09 8.34 
Heart 3 weeks after GI 72.96 10.66 16.38 12.96 
Heart 3 weeks after GI 71.82 10.97 17.21 14.12 
Heart 3 weeks after GI 70.68 6.69 22.63 10.92 
Heart 3 weeks after GI 77.76 7.93 14.30 13.76 
Heart 3 weeks after GI 73.61 9.73 16.66 15.79 
Heart 3 weeks after GI 73.60 8.46 17.94 14.09 
Heart 3 weeks after GI 79.25 7.13 13.62 12.05 
Heart 3 weeks after GI 78.20 7.17 14.63 13.73 
Heart 3 weeks after GI 77.95 4.76 17.29 8.44 
Heart 3 weeks after GI 75.33 9.64 15.03 16.06 
Heart 3 weeks after GI 78.42 4.24 17.34 8.12 
Heart 3 weeks after GI 78.66 9.73 11.62 17.64 
Heart before GI 71.47 14.48 14.05 26.43 
Heart before GI 78.11 8.49 13.40 21.40 
Heart before GI 75.04 11.72 13.25 26.24 
Heart before GI 73.38 8.26 18.36 20.72 
Heart before GI 77.81 7.83 14.36 18.23 
Heart before GI 72.05 10.50 17.45 25.61 
Heart before GI 74.26 10.30 15.44 22.76 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Heart before GI 69.79 10.34 19.87 25.26 
Heart before GI 73.35 8.54 18.11 19.80 
Heart before GI 74.61 7.15 18.24 17.11 
Heart before GI 72.67 7.77 19.56 20.31 
Heart before GI 77.74 7.95 14.31 15.29 
Heart before GI 76.74 6.58 16.68 17.97 
Heart before GI 74.18 10.18 15.64 21.28 
Heart before GI 76.00 7.84 16.16 21.89 
Heart 1week GI 70.25 7.29 22.45 30.40 
Heart 1week GI 74.99 5.88 19.13 31.00 
Heart 1week GI 70.74 5.56 23.70 25.00 
Heart 1week GI 72.17 7.66 20.18 31.45 
Heart 1week GI 75.32 5.94 18.74 22.54 
Heart 1week GI 84.80 3.56 11.64 14.02 
Heart 1week GI 77.71 4.28 18.00 16.94 
Heart 1week GI 80.31 4.80 14.88 15.37 
Heart 1week GI 83.94 4.10 11.96 9.79 
Heart 1week GI 76.37 4.08 19.55 19.33 
Heart 2weeks GI 70.06 14.57 15.38 28.93 
Heart 2weeks GI 80.11 3.91 15.98 14.03 
Heart 2weeks GI 77.47 4.43 18.10 13.66 
Heart 2weeks GI 75.65 8.86 15.49 30.04 
Heart 2weeks GI 81.01 2.99 16.00 10.88 
Heart 2weeks GI 78.08 4.61 17.30 11.46 
Heart 2weeks GI 83.66 4.33 12.01 12.42 
Heart 2weeks GI 80.78 5.05 14.17 19.58 
Heart 2weeks GI 78.97 2.27 18.76 7.71 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Heart 2weeks GI 77.55 6.45 16.00 22.10 
Heart 2weeks GI 80.82 4.67 14.50 13.89 
Heart 2weeks GI 78.27 3.77 17.97 16.29 
Heart 5weeks GI 78.47 9.55 11.98 21.33 
Heart 5weeks GI 74.17 9.74 16.08 21.60 
Heart 5weeks GI 80.38 6.91 12.71 20.70 
Heart 5weeks GI 91.22 3.25 5.53 7.80 
Heart 5weeks GI 90.65 2.94 6.41 8.16 
Heart 5weeks GI 79.24 7.85 12.91 20.22 
Heart 5weeks GI 79.42 6.53 14.05 18.44 
Heart 5weeks GI 80.99 6.46 12.55 21.17 
Heart 5weeks GI 77.60 4.63 17.77 18.17 
Heart 5weeks GI 80.02 5.21 14.77 15.75 
















Table B.5.  Data of labial palp nuclei for the analysis of temperature effects on cell cycle and PCNA (Chapter 4 and 5). 
Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Labial palps initial 10 89.23 2.03 8.74 9.96 
Labial palps initial 10 80.89 8.61 10.51 19.92 
Labial palps initial 10 83.30 6.15 10.54 17.07 
Labial palps initial 10 84.17 5.81 10.02 15.53 
Labial palps initial 10 87.36 3.88 8.76 13.11 
Labial palps initial 10 91.54 1.80 6.66 11.22 
Labial palps initial 10 90.89 2.03 7.08 12.92 
Labial palps initial 10 89.75 1.87 8.38 10.53 
Labial palps initial 10 89.61 3.54 6.85 11.45 
Labial palps initial 10 84.38 6.15 9.47 17.79 
Labial palps initial 10 80.98 4.39 14.64 11.18 
Labial palps initial 10 81.80 4.82 13.38 13.12 
Labial palps initial 10 85.69 4.15 10.16 10.12 
Labial palps initial 10 69.03 9.33 21.64 26.02 
Labial palps initial 10 76.33 7.50 16.17 14.51 
Labial palps 3 weeks after 10 73.80 7.68 18.52 12.31 
Labial palps 3 weeks after 10 65.65 9.18 25.17 14.44 
Labial palps 3 weeks after 10 65.57 9.97 24.46 15.81 
Labial palps 3 weeks after 10 58.92 9.20 31.88 15.76 
Labial palps 3 weeks after 10 63.97 9.96 26.07 16.11 
Labial palps 3 weeks after 10 74.58 4.11 21.31 8.18 
Labial palps 3 weeks after 10 72.40 6.85 20.75 12.40 
Labial palps 3 weeks after 10 70.52 10.44 19.03 22.15 
Labial palps 3 weeks after 10 75.88 6.51 17.61 11.96 
Labial palps 3 weeks after 10 71.37 10.81 17.82 20.28 
Labial palps 3 weeks after 10 66.57 7.92 25.51 14.35 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Labial palps 3 weeks after 10 68.72 14.54 16.74 23.26 
Labial palps 3 weeks after 10 72.98 8.69 18.33 16.97 
Labial palps 3 weeks after 10 75.20 10.44 14.36 20.27 
Labial palps before 10±1 74.03 4.65 21.32 9.96 
Labial palps before 10±1 69.15 5.34 25.51 11.34 
Labial palps before 10±1 69.29 5.81 24.91 11.17 
Labial palps before 10±1 78.55 9.34 12.12 17.82 
Labial palps before 10±1 63.07 10.20 26.73 18.20 
Labial palps before 10±1 74.68 3.09 22.22 9.14 
Labial palps before 10±1 73.48 8.14 18.38 14.26 
Labial palps before 10±1 69.43 11.52 19.05 20.70 
Labial palps before 10±1 78.50 4.46 17.04 8.91 
Labial palps before 10±1 72.02 8.56 19.42 16.29 
Labial palps before 10±1 66.02 13.03 20.95 19.30 
Labial palps before 10±1 67.46 14.34 18.20 21.51 
Labial palps before 10±1 72.79 8.44 18.76 13.71 
Labial palps before 10±1 77.26 10.69 12.05 16.47 
Labial palps 1week 10±1 71.18 7.22 21.60 20.37 
Labial palps 1week 10±1 74.77 5.35 19.88 15.82 
Labial palps 1week 10±1 71.77 6.12 22.10 14.75 
Labial palps 1week 10±1 80.20 4.11 15.69 8.90 
Labial palps 1week 10±1 72.57 6.95 20.48 15.41 
Labial palps 1week 10±1 82.24 2.52 15.24 9.86 
Labial palps 1week 10±1 69.86 5.61 24.53 16.22 
Labial palps 1week 10±1 80.04 1.88 18.09 5.37 
Labial palps 1week 10±1 79.42 2.61 17.97 13.62 
Labial palps 1week 10±1 76.78 3.80 19.42 10.11 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Labial palps 1week 10±1 83.62 1.70 14.68 4.76 
Labial palps 1week 10±1 74.42 2.96 22.63 10.38 
Labial palps 2weeks 10±1 76.93 3.03 20.05 8.93 
Labial palps 2weeks 10±1 78.65 2.39 18.96 9.16 
Labial palps 2weeks 10±1 73.60 5.80 20.59 16.35 
Labial palps 2weeks 10±1 77.17 3.83 19.00 8.84 
Labial palps 2weeks 10±1 75.92 4.12 19.95 13.44 
Labial palps 2weeks 10±1 72.61 6.31 21.07 17.44 
Labial palps 2weeks 10±1 76.92 2.03 21.04 8.27 
Labial palps 2weeks 10±1 71.42 6.55 22.04 17.69 
Labial palps 2weeks 10±1 74.74 3.41 21.85 15.27 
Labial palps 2weeks 10±1 70.84 7.81 21.35 20.38 
Labial palps 2weeks 10±1 82.74 3.74 13.51 9.20 
Labial palps 2weeks 10±1 80.92 2.85 16.23 8.74 
Labial palps 5weeks 10±1 74.82 6.86 18.32 15.20 
Labial palps 5weeks 10±1 73.26 5.50 21.24 17.21 
Labial palps 5weeks 10±1 72.45 7.46 20.09 22.33 
Labial palps 5weeks 10±1 74.58 5.06 20.36 14.67 
Labial palps 5weeks 10±1 79.08 3.07 17.85 12.27 
Labial palps 5weeks 10±1 74.72 6.76 18.52 16.64 
Labial palps 5weeks 10±1 72.31 7.40 20.29 18.27 
Labial palps 5weeks 10±1 69.64 10.50 19.86 29.33 
Labial palps 5weeks 10±1 78.71 4.69 16.61 16.04 
Labial palps 5weeks 10±1 74.21 7.09 18.70 20.56 




Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Labial palps initial 15 89.23 2.03 8.74 9.96 
Labial palps initial 15 80.89 8.61 10.51 19.92 
Labial palps initial 15 83.30 6.15 10.54 17.07 
Labial palps initial 15 84.17 5.81 10.02 15.53 
Labial palps initial 15 87.36 3.88 8.76 13.11 
Labial palps initial 15 91.54 1.80 6.66 11.22 
Labial palps initial 15 90.89 2.03 7.08 12.92 
Labial palps initial 15 89.75 1.87 8.38 10.53 
Labial palps initial 15 89.61 3.54 6.85 11.45 
Labial palps initial 15 84.38 6.15 9.47 17.79 
Labial palps initial 15 80.98 4.39 14.64 11.18 
Labial palps initial 15 81.80 4.82 13.38 13.12 
Labial palps initial 15 85.69 4.15 10.16 10.12 
Labial palps initial 15 69.03 9.33 21.64 26.02 
Labial palps initial 15 76.33 7.50 16.17 14.51 
Labial palps 3 weeks after 15 73.80 7.68 18.52 12.31 
Labial palps 3 weeks after 15 65.65 9.18 25.17 14.44 
Labial palps 3 weeks after 15 65.57 9.97 24.46 15.81 
Labial palps 3 weeks after 15 58.92 9.20 31.88 15.76 
Labial palps 3 weeks after 15 63.97 9.96 26.07 16.11 
Labial palps 3 weeks after 15 74.58 4.11 21.31 8.18 
Labial palps 3 weeks after 15 72.40 6.85 20.75 12.40 
Labial palps 3 weeks after 15 70.52 10.44 19.03 22.15 
Labial palps 3 weeks after 15 75.88 6.51 17.61 11.96 
Labial palps 3 weeks after 15 71.37 10.81 17.82 20.28 
Labial palps 3 weeks after 15 66.57 7.92 25.51 14.35 
Labial palps 3 weeks after 15 68.72 14.54 16.74 23.26 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Labial palps 3 weeks after 15 72.98 8.69 18.33 16.97 
Labial palps 3 weeks after 15 75.20 10.44 14.36 20.27 
Labial palps before 15 77.81 6.95 15.24 15.92 
Labial palps before 15 91.33 2.00 6.67 8.01 
Labial palps before 15 84.34 3.74 11.91 9.71 
Labial palps before 15 74.23 6.86 18.91 16.96 
Labial palps before 15 76.88 7.42 15.69 17.44 
Labial palps before 15 83.16 4.66 12.18 13.28 
Labial palps before 15 70.23 6.88 22.90 16.71 
Labial palps before 15 75.40 4.57 20.03 11.79 
Labial palps before 15 73.21 7.85 18.94 16.76 
Labial palps before 15 81.80 5.79 12.41 13.89 
Labial palps before 15 74.89 9.08 16.03 20.60 
Labial palps before 15 75.19 6.76 18.05 13.90 
Labial palps before 15 76.49 5.49 18.02 10.57 
Labial palps before 15 73.58 6.43 19.99 11.76 
Labial palps before 15 74.59 7.45 17.96 13.49 
Labial palps 1week 15±1 62.46 11.57 25.97 24.33 
Labial palps 1week 15±1 67.41 6.36 26.23 17.75 
Labial palps 1week 15±1 62.91 9.31 27.78 21.83 
Labial palps 1week 15±1 74.43 12.63 12.94 22.52 
Labial palps 1week 15±1 67.94 11.15 20.92 24.83 
Labial palps 1week 15±1 62.26 14.07 23.67 25.21 
Labial palps 1week 15±1 72.93 14.88 12.19 24.74 
Labial palps 1week 15±1 72.43 14.85 12.72 26.77 
Labial palps 2weeks 15±1 70.38 9.35 20.27 28.43 
Labial palps 2weeks 15±1 78.21 4.60 17.19 14.07 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Labial palps 2weeks 15±1 74.27 8.10 17.63 22.78 
Labial palps 2weeks 15±1 78.73 3.22 18.05 10.41 
Labial palps 2weeks 15±1 78.93 3.41 17.66 9.33 
Labial palps 2weeks 15±1 67.22 7.54 25.24 23.59 
Labial palps 2weeks 15±1 80.96 3.07 15.97 8.69 
Labial palps 2weeks 15±1 81.04 3.52 15.45 13.22 
Labial palps 2weeks 15±1 80.14 1.61 18.25 7.81 
Labial palps 2weeks 15±1 80.74 3.45 15.81 7.51 
Labial palps 2weeks 15±1 75.87 3.27 20.86 11.37 
Labial palps 2weeks 15±1 76.57 5.13 18.29 12.91 
Labial palps 5weeks 15±1 82.71 2.60 14.69 7.71 
Labial palps 5weeks 15±1 82.78 2.05 15.17 5.26 
Labial palps 5weeks 15±1 82.21 2.33 15.47 5.28 
Labial palps 5weeks 15±1 80.07 3.28 16.65 9.81 
Labial palps 5weeks 15±1 81.57 4.49 13.94 12.26 
Labial palps 5weeks 15±1 84.82 2.23 12.95 9.12 
Labial palps 5weeks 15±1 82.95 3.57 13.48 11.32 
Labial palps 5weeks 15±1 76.19 3.18 20.64 11.43 
Labial palps 5weeks 15±1 79.85 5.09 15.06 14.54 
 
Labial palps initial 20 89.23 2.03 8.74 9.96 
Labial palps initial 20 80.89 8.61 10.51 19.92 
Labial palps initial 20 83.30 6.15 10.54 17.07 
Labial palps initial 20 84.17 5.81 10.02 15.53 
Labial palps initial 20 87.36 3.88 8.76 13.11 
Labial palps initial 20 91.54 1.80 6.66 11.22 
Labial palps initial 20 90.89 2.03 7.08 12.92 
 138
Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Labial palps initial 20 89.75 1.87 8.38 10.53 
Labial palps initial 20 89.61 3.54 6.85 11.45 
Labial palps initial 20 84.38 6.15 9.47 17.79 
Labial palps initial 20 80.98 4.39 14.64 11.18 
Labial palps initial 20 81.80 4.82 13.38 13.12 
Labial palps initial 20 85.69 4.15 10.16 10.12 
Labial palps initial 20 69.03 9.33 21.64 26.02 
Labial palps initial 20 76.33 7.50 16.17 14.51 
Labial palps 3 weeks after 20 73.80 7.68 18.52 12.31 
Labial palps 3 weeks after 20 65.65 9.18 25.17 14.44 
Labial palps 3 weeks after 20 65.57 9.97 24.46 15.81 
Labial palps 3 weeks after 20 58.92 9.20 31.88 15.76 
Labial palps 3 weeks after 20 63.97 9.96 26.07 16.11 
Labial palps 3 weeks after 20 74.58 4.11 21.31 8.18 
Labial palps 3 weeks after 20 72.40 6.85 20.75 12.40 
Labial palps 3 weeks after 20 70.52 10.44 19.03 22.15 
Labial palps 3 weeks after 20 75.88 6.51 17.61 11.96 
Labial palps 3 weeks after 20 71.37 10.81 17.82 20.28 
Labial palps 3 weeks after 20 66.57 7.92 25.51 14.35 
Labial palps 3 weeks after 20 68.72 14.54 16.74 23.26 
Labial palps 3 weeks after 20 72.98 8.69 18.33 16.97 
Labial palps 3 weeks after 20 75.20 10.44 14.36 20.27 
Labial palps before 20 86.36 2.84 10.80 7.85 
Labial palps before 20 83.54 3.75 12.71 9.14 
Labial palps before 20 75.85 10.11 14.04 18.57 
Labial palps before 20 80.63 3.29 16.08 10.06 
Labial palps before 20 84.25 6.51 9.24 17.56 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Labial palps before 20 80.14 3.56 16.30 10.85 
Labial palps before 20 74.97 6.37 18.66 16.57 
Labial palps before 20 69.53 9.93 20.54 20.55 
Labial palps before 20 74.72 4.07 21.22 11.63 
Labial palps before 20 70.01 6.10 23.89 15.68 
Labial palps before 20 72.71 6.07 21.22 17.97 
Labial palps before 20 65.87 7.31 26.82 18.67 
Labial palps before 20 70.23 7.43 22.33 16.31 
Labial palps before 20 79.31 3.85 16.84 9.23 
Labial palps before 20 70.33 7.00 22.66 16.23 
Labial palps 1week 20±1 67.46 7.51 25.03 13.49 
Labial palps 1week 20±1 62.47 12.55 24.99 24.88 
Labial palps 1week 20±1 61.66 13.72 24.61 26.31 
Labial palps 1week 20±1 68.29 13.39 18.33 29.52 
Labial palps 1week 20±1 66.72 15.53 17.75 36.53 
Labial palps 1week 20±1 63.63 10.83 25.53 24.17 
Labial palps 1week 20±1 70.59 5.30 24.10 15.06 
Labial palps 1week 20±1 64.94 9.59 25.47 26.94 
Labial palps 1week 20±1 69.72 4.23 26.05 14.07 
Labial palps 1week 20±1 65.73 10.99 23.28 22.68 
Labial palps 1week 20±1 66.77 11.02 22.20 25.43 
Labial palps 1week 20±1 64.49 10.78 24.72 24.19 
Labial palps 2weeks 20±1 72.86 8.72 18.42 22.05 
Labial palps 2weeks 20±1 73.52 6.23 20.24 13.44 
Labial palps 2weeks 20±1 74.95 4.58 20.48 11.68 
Labial palps 2weeks 20±1 77.40 2.72 19.88 10.72 
Labial palps 2weeks 20±1 78.28 5.58 16.14 17.24 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Labial palps 2weeks 20±1 76.99 4.01 19.00 12.74 
Labial palps 2weeks 20±1 69.92 7.35 22.73 16.58 
Labial palps 2weeks 20±1 76.69 5.25 18.06 13.72 
Labial palps 2weeks 20±1 72.38 5.99 21.64 17.51 
Labial palps 2weeks 20±1 76.28 6.77 16.95 16.45 
Labial palps 2weeks 20±1 79.11 4.33 16.56 9.63 
Labial palps 2weeks 20±1 77.64 3.05 19.31 9.34 
Labial palps 5weeks 20±1 84.83 2.76 12.41 10.01 
Labial palps 5weeks 20±1 79.64 3.52 16.84 10.53 
Labial palps 5weeks 20±1 82.23 2.28 15.49 8.57 
Labial palps 5weeks 20±1 73.27 5.73 21.00 19.50 
Labial palps 5weeks 20±1 78.51 5.48 16.01 17.51 
Labial palps 5weeks 20±1 75.79 4.79 19.42 17.89 
Labial palps 5weeks 20±1 79.95 5.20 14.85 17.01 
Labial palps 5weeks 20±1 77.41 5.51 17.08 14.50 
Labial palps 5weeks 20±1 73.04 6.99 19.97 21.65 
 
Labial palps 1week 10±5 76.54 4.34 19.11 13.26 
Labial palps 1week 10±5 77.99 2.36 19.64 10.10 
Labial palps 1week 10±5 74.34 5.75 19.91 14.16 
Labial palps 1week 10±5 81.21 2.24 16.54 11.60 
Labial palps 1week 10±5 73.59 5.03 21.36 15.61 
Labial palps 1week 10±5 76.68 4.02 19.29 12.77 
Labial palps 1week 10±5 77.55 2.51 19.94 9.42 
Labial palps 1week 10±5 78.64 3.38 17.98 10.59 
Labial palps 1week 10±5 78.32 3.83 17.84 13.14 
Labial palps 1week 10±5 76.50 4.12 19.38 13.53 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Labial palps 1week 10±5 75.22 2.89 21.88 9.81 
Labial palps 1week 10±5 77.25 2.57 20.18 10.42 
Labial palps 2weeks 10±5 71.33 7.31 21.35 17.98 
Labial palps 2weeks 10±5 75.84 3.28 20.88 14.51 
Labial palps 2weeks 10±5 83.33 1.60 15.06 5.57 
Labial palps 2weeks 10±5 77.30 2.81 19.88 10.26 
Labial palps 2weeks 10±5 75.43 3.11 21.45 12.01 
Labial palps 2weeks 10±5 80.86 1.77 17.36 8.10 
Labial palps 2weeks 10±5 73.33 6.51 20.15 17.30 
Labial palps 2weeks 10±5 82.09 1.91 15.99 6.94 
Labial palps 2weeks 10±5 82.59 3.24 14.17 7.62 
Labial palps 2weeks 10±5 75.54 3.50 20.96 9.33 
Labial palps 2weeks 10±5 76.78 3.53 19.69 11.95 
Labial palps 2weeks 10±5 81.20 4.44 14.36 15.62 
Labial palps 5weeks 10±5 70.38 8.81 20.80 22.03 
Labial palps 5weeks 10±5 78.77 6.61 14.60 12.06 
Labial palps 5weeks 10±5 74.39 6.93 18.68 11.85 
Labial palps 5weeks 10±5 74.12 6.56 19.31 15.22 
Labial palps 5weeks 10±5 75.13 5.14 19.72 11.42 
Labial palps 5weeks 10±5 69.72 12.34 17.93 21.97 
Labial palps 5weeks 10±5 79.63 2.11 18.25 7.66 
Labial palps 5weeks 10±5 73.13 6.40 20.45 13.08 
Labial palps 5weeks 10±5 69.43 10.81 19.75 25.51 
Labial palps 5weeks 10±5 75.49 6.55 17.95 10.11 
Labial palps 5weeks 10±5 75.48 4.13 20.38 11.62 
Labial palps 5weeks 10±5 76.31 2.85 20.82 8.29 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Labial palps 1week 15±5 62.84 10.55 26.61 23.79 
Labial palps 1week 15±5 66.67 8.64 24.69 22.84 
Labial palps 1week 15±5 66.52 7.92 25.56 19.81 
Labial palps 1week 15±5 73.98 7.18 18.84 17.78 
Labial palps 1week 15±5 66.15 9.52 24.33 21.31 
Labial palps 1week 15±5 62.87 8.06 29.07 20.14 
Labial palps 1week 15±5 67.49 13.82 18.69 27.21 
Labial palps 1week 15±5 70.89 10.78 18.33 23.03 
Labial palps 2weeks 15±5 77.96 7.78 14.26 20.22 
Labial palps 2weeks 15±5 79.28 5.03 15.69 14.61 
Labial palps 2weeks 15±5 77.79 2.74 19.48 11.54 
Labial palps 2weeks 15±5 78.65 4.84 16.51 18.30 
Labial palps 2weeks 15±5 79.66 3.33 17.01 11.82 
Labial palps 2weeks 15±5 77.72 4.70 17.59 14.84 
Labial palps 2weeks 15±5 80.96 2.35 16.69 6.35 
Labial palps 2weeks 15±5 79.46 6.29 14.25 18.19 
Labial palps 2weeks 15±5 79.50 3.54 16.97 11.49 
Labial palps 2weeks 15±5 80.22 3.36 16.42 12.06 
Labial palps 2weeks 15±5 76.48 3.67 19.85 12.72 
Labial palps 5weeks 15±5 74.00 8.02 17.98 13.83 
Labial palps 5weeks 15±5 83.36 4.65 11.99 8.62 
Labial palps 5weeks 15±5 73.86 4.40 21.74 8.96 
Labial palps 5weeks 15±5 78.48 3.93 17.59 9.24 
Labial palps 5weeks 15±5 81.57 4.16 14.27 10.87 
Labial palps 5weeks 15±5 74.24 5.64 20.12 11.22 
Labial palps 5weeks 15±5 80.54 5.45 14.01 10.50 
Labial palps 5weeks 15±5 78.67 3.75 17.57 8.37 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Labial palps 5weeks 15±5 72.79 11.20 16.01 25.13 
 
Labial palps 1week 15±10 65.19 11.08 23.73 27.77 
Labial palps 1week 15±10 68.47 10.43 21.11 26.36 
Labial palps 1week 15±10 63.97 9.26 26.77 24.26 
Labial palps 1week 15±10 61.86 14.76 23.38 36.09 
Labial palps 1week 15±10 68.92 7.02 24.07 16.97 
Labial palps 1week 15±10 63.94 11.32 24.73 26.92 
Labial palps 1week 15±10 66.16 11.82 22.02 24.72 
Labial palps 1week 15±10 63.77 12.67 23.57 29.41 
Labial palps 2weeks 15±10 75.53 10.88 13.58 23.24 
Labial palps 2weeks 15±10 79.13 1.84 19.03 5.90 
Labial palps 2weeks 15±10 77.42 5.56 17.02 20.23 
Labial palps 2weeks 15±10 75.66 2.93 21.42 11.19 
Labial palps 2weeks 15±10 79.28 3.80 16.93 13.09 
Labial palps 2weeks 15±10 80.71 5.35 13.94 12.05 
Labial palps 2weeks 15±10 78.54 6.16 15.30 19.10 
Labial palps 2weeks 15±10 79.31 3.13 17.56 12.04 
Labial palps 2weeks 15±10 78.08 5.99 15.93 14.78 
Labial palps 2weeks 15±10 80.97 2.28 16.76 7.58 
Labial palps 2weeks 15±10 80.45 4.29 15.25 10.00 
Labial palps 2weeks 15±10 77.53 3.06 19.41 11.13 
Labial palps 5weeks 15±10 81.14 4.31 14.55 10.17 
Labial palps 5weeks 15±10 78.51 8.47 13.02 23.33 
Labial palps 5weeks 15±10 79.51 5.37 15.11 12.81 
Labial palps 5weeks 15±10 75.88 6.25 17.87 18.07 
Labial palps 5weeks 15±10 77.13 6.00 16.88 14.53 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Labial palps 5weeks 15±10 77.61 5.03 17.36 9.14 
Labial palps 5weeks 15±10 84.29 4.46 11.24 10.35 
Labial palps 5weeks 15±10 77.89 3.97 18.15 15.86 
Labial palps 5weeks 15±10 80.04 4.48 15.47 11.26 
 
Labial palps 1week 20±5 65.67 8.64 25.68 13.65 
Labial palps 1week 20±5 66.30 8.67 25.03 14.84 
Labial palps 1week 20±5 63.13 10.38 26.48 21.87 
Labial palps 1week 20±5 67.60 8.23 24.17 17.70 
Labial palps 1week 20±5 65.10 9.35 25.55 18.38 
Labial palps 1week 20±5 62.17 10.13 27.70 20.13 
Labial palps 1week 20±5 75.97 12.38 11.65 29.94 
Labial palps 1week 20±5 79.62 9.13 11.25 14.19 
Labial palps 2weeks 20±5 73.35 4.58 22.07 14.23 
Labial palps 2weeks 20±5 75.33 4.60 20.06 12.13 
Labial palps 2weeks 20±5 73.14 5.71 21.16 15.98 
Labial palps 2weeks 20±5 72.03 9.32 18.65 23.11 
Labial palps 2weeks 20±5 78.11 5.06 16.83 11.62 
Labial palps 2weeks 20±5 76.77 7.27 15.96 17.37 
Labial palps 2weeks 20±5 70.73 7.99 21.28 21.22 
Labial palps 2weeks 20±5 74.52 6.81 18.67 12.82 
Labial palps 2weeks 20±5 78.83 5.57 15.60 16.55 
Labial palps 2weeks 20±5 74.44 6.25 19.31 15.81 
Labial palps 2weeks 20±5 75.45 7.03 17.52 18.12 
Labial palps 2weeks 20±5 75.12 4.92 19.96 13.73 
Labial palps 5weeks 20±5 79.27 2.41 18.32 12.94 
Labial palps 5weeks 20±5 79.13 3.65 17.22 11.33 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Labial palps 5weeks 20±5 85.58 0.99 13.43 6.09 
Labial palps 5weeks 20±5 73.23 8.82 17.94 16.87 
Labial palps 5weeks 20±5 76.33 5.82 17.84 15.79 
Labial palps 5weeks 20±5 76.89 5.57 17.54 15.23 
Labial palps 5weeks 20±5 76.55 6.63 16.82 18.48 
Labial palps 5weeks 20±5 79.93 3.89 16.17 11.60 
Labial palps 5weeks 20±5 78.85 2.92 18.24 13.70 
 
Labial palps initial 27 75.16 11.14 13.70 16.23 
Labial palps initial 27 75.79 4.45 19.76 7.61 
Labial palps initial 27 76.32 9.06 14.62 10.06 
Labial palps initial 27 74.12 10.51 15.37 14.70 
Labial palps initial 27 81.59 4.81 13.61 6.54 
Labial palps initial 27 76.96 9.11 13.93 15.46 
Labial palps initial 27 75.32 9.31 15.37 12.29 
Labial palps initial 27 77.38 8.59 14.02 12.61 
Labial palps initial 27 75.56 8.47 15.97 11.91 
Labial palps initial 27 79.95 3.51 16.54 7.27 
Labial palps initial 27 80.87 4.58 14.55 7.76 
Labial palps initial 27 78.68 5.22 16.10 10.09 
Labial palps initial 27 78.68 6.36 14.96 10.16 
Labial palps 3 weeks after 27 81.55 7.26 11.19 10.21 
Labial palps 3 weeks after 27 80.96 6.12 12.92 7.17 
Labial palps 3 weeks after 27 76.87 4.05 19.09 8.34 
Labial palps 3 weeks after 27 72.96 10.66 16.38 12.96 
Labial palps 3 weeks after 27 71.82 10.97 17.21 14.12 
Labial palps 3 weeks after 27 70.68 6.69 22.63 10.92 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Labial palps 3 weeks after 27 77.76 7.93 14.30 13.76 
Labial palps 3 weeks after 27 73.61 9.73 16.66 15.79 
Labial palps 3 weeks after 27 73.60 8.46 17.94 14.09 
Labial palps 3 weeks after 27 79.25 7.13 13.62 12.05 
Labial palps 3 weeks after 27 78.20 7.17 14.63 13.73 
Labial palps 3 weeks after 27 77.95 4.76 17.29 8.44 
Labial palps 3 weeks after 27 75.33 9.64 15.03 16.06 
Labial palps 3 weeks after 27 78.42 4.24 17.34 8.12 
Labial palps 3 weeks after 27 78.66 9.73 11.62 17.64 
Labial palps before 27 84.87 4.95 10.18 14.66 
Labial palps before 27 81.90 5.12 12.98 17.83 
Labial palps before 27 77.99 9.58 12.43 22.56 
Labial palps before 27 82.33 6.34 11.33 16.45 
Labial palps before 27 82.04 9.25 8.70 20.78 
Labial palps before 27 83.48 2.92 13.60 12.49 
Labial palps before 27 75.46 6.39 18.15 16.05 
Labial palps before 27 75.73 5.90 18.37 16.90 
Labial palps before 27 72.28 8.76 18.96 19.49 
Labial palps before 27 68.93 12.33 18.74 27.04 
Labial palps before 27 79.42 4.18 16.40 14.91 
Labial palps before 27 76.08 7.25 16.67 18.27 
Labial palps before 27 76.87 10.19 12.94 19.08 
Labial palps before 27 71.37 11.33 17.30 23.27 
Labial palps before 27 80.26 8.61 11.13 20.09 
Labial palps 1week 27 73.05 9.29 17.66 30.62 
Labial palps 1week 27 67.82 9.49 22.68 26.33 
Labial palps 1week 27 67.82 13.99 18.19 33.43 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Labial palps 1week 27 69.63 12.95 17.42 34.74 
Labial palps 1week 27 72.53 10.87 16.60 31.32 
Labial palps 1week 27 70.40 15.57 14.03 36.39 
Labial palps 1week 27 74.38 6.01 19.61 20.27 
Labial palps 2weeks 27 83.39 2.58 14.03 6.02 
Labial palps 2weeks 27 74.62 8.34 17.04 19.82 
Labial palps 2weeks 27 79.19 5.71 15.10 16.74 
Labial palps 2weeks 27 80.66 5.31 14.02 14.19 
Labial palps 2weeks 27 75.79 6.60 17.61 15.07 
Labial palps 2weeks 27 79.26 7.48 13.26 22.72 
Labial palps 2weeks 27 77.06 5.75 17.19 14.65 
Labial palps 2weeks 27 69.18 16.49 14.33 34.07 
Labial palps 2weeks 27 82.25 4.18 13.57 15.50 
Labial palps 2weeks 27 80.91 4.69 14.40 14.34 
Labial palps 2weeks 27 84.04 5.63 10.33 18.23 
Labial palps 2weeks 27 73.29 11.47 15.24 24.70 
Labial palps 5weeks 27 79.60 6.37 14.04 19.32 
Labial palps 5weeks 27 79.08 6.13 14.79 18.82 
Labial palps 5weeks 27 85.99 3.77 10.24 11.05 
Labial palps 5weeks 27 85.21 3.31 11.47 9.81 
Labial palps 5weeks 27 80.75 5.80 13.45 17.31 
Labial palps 5weeks 27 79.10 4.91 15.99 19.63 
Labial palps 5weeks 27 83.67 3.96 12.38 14.68 
Labial palps 5weeks 27 70.82 10.53 18.65 25.17 
Labial palps 5weeks 27 78.86 5.94 15.20 19.94 
Labial palps 5weeks 27 78.53 6.33 15.14 17.90 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Labial palps initial GI 89.23 2.03 8.74 9.96 
Labial palps initial GI 80.89 8.61 10.51 19.92 
Labial palps initial GI 83.30 6.15 10.54 17.07 
Labial palps initial GI 84.17 5.81 10.02 15.53 
Labial palps initial GI 87.36 3.88 8.76 13.11 
Labial palps initial GI 91.54 1.80 6.66 11.22 
Labial palps initial GI 90.89 2.03 7.08 12.92 
Labial palps initial GI 89.75 1.87 8.38 10.53 
Labial palps initial GI 89.61 3.54 6.85 11.45 
Labial palps initial GI 84.38 6.15 9.47 17.79 
Labial palps initial GI 80.98 4.39 14.64 11.18 
Labial palps initial GI 81.80 4.82 13.38 13.12 
Labial palps initial GI 85.69 4.15 10.16 10.12 
Labial palps initial GI 69.03 9.33 21.64 26.02 
Labial palps initial GI 76.33 7.50 16.17 14.51 
Labial palps 3 weeks after GI 73.80 7.68 18.52 12.31 
Labial palps 3 weeks after GI 65.65 9.18 25.17 14.44 
Labial palps 3 weeks after GI 65.57 9.97 24.46 15.81 
Labial palps 3 weeks after GI 58.92 9.20 31.88 15.76 
Labial palps 3 weeks after GI 63.97 9.96 26.07 16.11 
Labial palps 3 weeks after GI 74.58 4.11 21.31 8.18 
Labial palps 3 weeks after GI 72.40 6.85 20.75 12.40 
Labial palps 3 weeks after GI 70.52 10.44 19.03 22.15 
Labial palps 3 weeks after GI 75.88 6.51 17.61 11.96 
Labial palps 3 weeks after GI 71.37 10.81 17.82 20.28 
Labial palps 3 weeks after GI 66.57 7.92 25.51 14.35 
Labial palps 3 weeks after GI 68.72 14.54 16.74 23.26 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Labial palps 3 weeks after GI 72.98 8.69 18.33 16.97 
Labial palps 3 weeks after GI 75.20 10.44 14.36 20.27 
Labial palps before GI 71.34 11.13 17.52 20.04 
Labial palps before GI 71.13 7.51 21.37 16.70 
Labial palps before GI 80.33 5.15 14.52 14.35 
Labial palps before GI 70.74 9.11 20.15 19.00 
Labial palps before GI 71.89 8.36 19.74 17.26 
Labial palps before GI 65.99 12.44 21.58 26.06 
Labial palps before GI 69.32 5.58 25.10 11.24 
Labial palps before GI 67.08 11.23 21.70 22.62 
Labial palps before GI 64.63 7.10 28.27 12.46 
Labial palps before GI 67.54 8.79 23.66 16.44 
Labial palps before GI 73.21 5.67 21.12 11.77 
Labial palps before GI 73.89 6.26 19.85 12.49 
Labial palps before GI 72.10 8.60 19.30 17.61 
Labial palps before GI 73.09 6.27 20.64 16.95 
Labial palps before GI 66.11 10.07 23.82 19.17 
Labial palps 1week GI 67.25 7.04 25.72 17.20 
Labial palps 1week GI 69.39 7.32 23.29 17.42 
Labial palps 1week GI 63.21 9.98 26.82 26.01 
Labial palps 1week GI 66.84 7.53 25.63 20.33 
Labial palps 1week GI 64.95 9.05 26.01 23.12 
Labial palps 1week GI 64.69 9.23 26.08 20.76 
Labial palps 1week GI 81.26 2.40 16.34 6.59 
Labial palps 1week GI 73.10 7.85 19.05 15.60 
Labial palps 1week GI 77.87 8.06 14.07 15.20 
Labial palps 1week GI 68.56 5.59 25.85 18.11 
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Tissue Time Temperature %G0/G1 %S %G2/M %PCNA 
Labial palps 1week GI 71.00 5.76 23.25 18.46 
Labial palps 1week GI 72.35 5.97 21.68 16.98 
Labial palps 2weeks GI 72.42 5.88 21.70 19.32 
Labial palps 2weeks GI 69.09 8.54 22.37 20.48 
Labial palps 2weeks GI 75.07 6.16 18.77 18.32 
Labial palps 2weeks GI 73.09 10.43 16.48 24.61 
Labial palps 2weeks GI 77.04 3.68 19.28 8.20 
Labial palps 2weeks GI 75.39 3.61 21.00 13.36 
Labial palps 2weeks GI 78.12 3.74 18.14 14.51 
Labial palps 2weeks GI 77.24 2.62 20.15 10.38 
Labial palps 2weeks GI 75.93 4.87 19.20 11.70 
Labial palps 2weeks GI 75.63 4.32 20.06 13.39 
Labial palps 2weeks GI 84.57 2.82 12.60 12.73 
Labial palps 2weeks GI 73.75 5.52 20.73 17.00 
Labial palps 5weeks GI 73.34 5.53 21.13 17.44 
Labial palps 5weeks GI 79.44 3.43 17.13 14.45 
Labial palps 5weeks GI 79.11 2.50 18.39 9.52 
Labial palps 5weeks GI 85.22 3.02 11.77 9.25 
Labial palps 5weeks GI 82.13 2.89 14.99 10.10 
Labial palps 5weeks GI 79.80 3.13 17.07 10.96 
Labial palps 5weeks GI 70.97 5.67 23.36 19.01 
Labial palps 5weeks GI 84.69 1.97 13.34 8.81 







Table B.6.  Data of heart nuclei for the analysis of temperature effects on nuclear RNA/DNA ratios at each phase of the cell cycle 
(Chapter 4 and 5). 
Tissue Time Temperature G0/G1 S G2/M 
Heart 3 weeks after 10 0.11 0.20 0.13 
Heart 3 weeks after 10 0.09 0.15 0.10 
Heart 3 weeks after 10 0.10 0.13 0.10 
Heart 3 weeks after 10 0.09 0.11 0.07 
Heart 3 weeks after 10 0.07 0.08 0.07 
Heart 3 weeks after 10 0.09 0.25 0.03 
Heart 3 weeks after 10 0.11 0.27 0.10 
Heart 3 weeks after 10 0.09 0.16 0.10 
Heart 3 weeks after 10 0.06 0.14 0.07 
Heart 3 weeks after 10 0.06 0.14 0.07 
Heart 3 weeks after 10 0.07 0.16 0.08 
Heart 3 weeks after 10 0.06 0.13 0.06 
Heart 3 weeks after 10 0.08 0.11 0.08 
Heart before 10 0.07 0.17 0.07 
Heart before 10 0.08 0.19 0.08 
Heart before 10 0.09 0.19 0.09 
Heart before 10 0.06 0.19 0.06 
Heart before 10 0.08 0.19 0.07 
Heart before 10 0.07 0.14 0.07 
Heart before 10 0.07 0.19 0.07 
Heart before 10 0.07 0.16 0.07 
Heart before 10 0.05 0.10 0.06 
Heart before 10 0.06 0.13 0.06 
Heart before 10 0.07 0.21 0.08 
Heart before 10 0.06 0.11 0.06 
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Tissue Time Temperature G0/G1 S G2/M 
Heart before 10 0.06 0.19 0.06 
Heart before 10 0.07 0.21 0.07 
Heart before 10 0.06 0.14 0.07 
Heart 1week 10±1 0.26 0.77 0.40 
Heart 1week 10±1 0.07 0.31 0.08 
Heart 1week 10±1 0.08 0.33 0.10 
Heart 1week 10±1 0.08 0.31 0.11 
Heart 1week 10±1 0.14 0.40 0.21 
Heart 1week 10±1 0.06 0.19 0.09 
Heart 1week 10±1 0.12 0.49 0.15 
Heart 1week 10±1 0.11 0.33 0.15 
Heart 1week 10±1 0.14 0.54 0.21 
Heart 1week 10±1 0.09 0.28 0.12 
Heart 2weeks 10±1 0.05 0.16 0.07 
Heart 2weeks 10±1 0.03 0.09 0.04 
Heart 2weeks 10±1 0.15 0.55 0.23 
Heart 2weeks 10±1 0.07 0.37 0.09 
Heart 2weeks 10±1 0.08 0.66 0.10 
Heart 2weeks 10±1 0.05 0.30 0.08 
Heart 2weeks 10±1 0.04 0.12 0.05 
Heart 2weeks 10±1 0.05 0.12 0.06 
Heart 2weeks 10±1 0.05 0.27 0.07 
Heart 2weeks 10±1 0.05 0.16 0.09 
Heart 2weeks 10±1 0.05 0.20 0.07 
Heart 2weeks 10±1 0.04 0.12 0.05 
Heart 5weeks 10±1 0.14 0.64 0.15 
Heart 5weeks 10±1 0.13 0.46 0.18 
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Tissue Time Temperature G0/G1 S G2/M 
Heart 5weeks 10±1 0.19 0.69 0.27 
Heart 5weeks 10±1 0.22 0.81 0.33 
Heart 5weeks 10±1 0.19 1.02 0.33 
Heart 5weeks 10±1 0.14 0.59 0.23 
Heart 5weeks 10±1 0.15 0.49 0.20 
Heart 5weeks 10±1 0.21 0.81 0.32 
Heart 5weeks 10±1 0.11 0.53 0.15 
Heart 5weeks 10±1 0.13 0.41 0.17 
 
Heart 3 weeks after 15 0.11 0.20 0.13 
Heart 3 weeks after 15 0.09 0.15 0.10 
Heart 3 weeks after 15 0.10 0.13 0.10 
Heart 3 weeks after 15 0.09 0.11 0.07 
Heart 3 weeks after 15 0.07 0.08 0.07 
Heart 3 weeks after 15 0.09 0.25 0.03 
Heart 3 weeks after 15 0.11 0.27 0.10 
Heart 3 weeks after 15 0.09 0.16 0.10 
Heart 3 weeks after 15 0.06 0.14 0.07 
Heart 3 weeks after 15 0.06 0.14 0.07 
Heart 3 weeks after 15 0.07 0.16 0.08 
Heart 3 weeks after 15 0.06 0.13 0.06 
Heart 3 weeks after 15 0.08 0.11 0.08 
Heart before 15 0.20 0.34 0.19 
Heart before 15 0.37 0.70 0.49 
Heart before 15 0.18 0.35 0.17 
Heart before 15 0.11 0.40 0.12 
Heart before 15 0.14 0.41 0.16 
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Tissue Time Temperature G0/G1 S G2/M 
Heart before 15 0.17 0.65 0.19 
Heart before 15 0.17 0.28 0.16 
Heart before 15 0.19 0.23 0.17 
Heart before 15 0.17 0.27 0.15 
Heart before 15 0.26 0.42 0.25 
Heart before 15 0.15 0.30 0.15 
Heart before 15 0.15 0.31 0.13 
Heart before 15 0.11 0.26 0.11 
Heart before 15 0.09 0.18 0.08 
Heart before 15 0.08 0.14 0.07 
Heart 1week 15±1 0.34 0.59 0.35 
Heart 1week 15±1 0.34 0.79 0.37 
Heart 1week 15±1 0.23 0.57 0.27 
Heart 1week 15±1 0.74 1.68 0.88 
Heart 1week 15±1 0.23 0.57 0.22 
Heart 1week 15±1 0.38 0.86 0.37 
Heart 1week 15±1 0.44 0.58 0.44 
Heart 2weeks 15±1 0.50 0.98 0.67 
Heart 2weeks 15±1 0.35 0.80 0.40 
Heart 2weeks 15±1 0.37 1.02 0.43 
Heart 2weeks 15±1 0.12 0.23 0.14 
Heart 2weeks 15±1 0.19 0.36 0.25 
Heart 2weeks 15±1 0.16 0.35 0.22 
Heart 2weeks 15±1 0.18 0.83 0.30 
Heart 2weeks 15±1 0.44 0.93 0.59 
Heart 2weeks 15±1 0.34 1.44 0.72 
Heart 2weeks 15±1 0.19 0.78 0.27 
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Tissue Time Temperature G0/G1 S G2/M 
Heart 2weeks 15±1 0.16 0.47 0.23 
Heart 5weeks 15±1 0.11 0.25 0.12 
Heart 5weeks 15±1 0.09 0.22 0.10 
Heart 5weeks 15±1 0.12 0.29 0.14 
Heart 5weeks 15±1 0.13 0.17 0.17 
Heart 5weeks 15±1 0.10 0.22 0.12 
Heart 5weeks 15±1 0.11 0.27 0.14 
Heart 5weeks 15±1 0.02 0.03 0.02 
Heart 5weeks 15±1 0.15 0.34 0.15 
Heart 5weeks 15±1 0.11 0.31 0.12 
Heart 5weeks 15±1 0.15 0.34 0.15 
 
Heart 3 weeks after 20 0.11 0.20 0.13 
Heart 3 weeks after 20 0.09 0.15 0.10 
Heart 3 weeks after 20 0.10 0.13 0.10 
Heart 3 weeks after 20 0.09 0.11 0.07 
Heart 3 weeks after 20 0.07 0.08 0.07 
Heart 3 weeks after 20 0.09 0.25 0.03 
Heart 3 weeks after 20 0.11 0.27 0.10 
Heart 3 weeks after 20 0.09 0.16 0.10 
Heart 3 weeks after 20 0.06 0.14 0.07 
Heart 3 weeks after 20 0.06 0.14 0.07 
Heart 3 weeks after 20 0.07 0.16 0.08 
Heart 3 weeks after 20 0.06 0.13 0.06 
Heart 3 weeks after 20 0.08 0.11 0.08 
Heart before 20 0.09 0.17 0.09 
Heart before 20 0.13 0.41 0.14 
 156
Tissue Time Temperature G0/G1 S G2/M 
Heart before 20 0.13 0.20 0.14 
Heart before 20 0.13 0.29 0.14 
Heart before 20 0.16 0.35 0.17 
Heart before 20 0.24 0.43 0.27 
Heart before 20 0.11 0.18 0.11 
Heart before 20 0.16 0.27 0.16 
Heart before 20 0.11 0.21 0.11 
Heart before 20 0.15 0.20 0.13 
Heart before 20 0.17 0.27 0.16 
Heart before 20 0.16 0.20 0.14 
Heart before 20 0.09 0.17 0.09 
Heart before 20 0.07 0.15 0.07 
Heart before 20 0.10 0.18 0.09 
Heart 1week 20±1 0.21 0.37 0.20 
Heart 1week 20±1 0.21 0.39 0.30 
Heart 1week 20±1 0.21 0.42 0.20 
Heart 1week 20±1 0.24 0.68 0.21 
Heart 1week 20±1 0.25 0.51 0.21 
Heart 1week 20±1 0.35 0.63 0.29 
Heart 1week 20±1 0.41 0.96 0.45 
Heart 1week 20±1 0.23 0.58 0.23 
Heart 1week 20±1 0.29 0.57 0.28 
Heart 1week 20±1 0.30 0.71 0.27 
Heart 1week 20±1 0.40 0.75 0.41 
Heart 1week 20±1 0.45 0.94 0.52 
Heart 2weeks 20±1 0.12 0.30 0.14 
Heart 2weeks 20±1 0.08 0.35 0.11 
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Tissue Time Temperature G0/G1 S G2/M 
Heart 2weeks 20±1 0.22 0.63 0.28 
Heart 2weeks 20±1 0.31 0.98 0.46 
Heart 2weeks 20±1 0.16 0.72 0.21 
Heart 2weeks 20±1 0.33 1.47 0.51 
Heart 2weeks 20±1 0.21 0.39 0.31 
Heart 2weeks 20±1 0.20 0.38 0.23 
Heart 2weeks 20±1 0.42 0.89 0.64 
Heart 2weeks 20±1 0.19 0.30 0.26 
Heart 2weeks 20±1 0.16 0.29 0.19 
Heart 2weeks 20±1 0.17 0.42 0.21 
Heart 5weeks 20±1 0.10 0.20 0.12 
Heart 5weeks 20±1 0.17 0.46 0.17 
Heart 5weeks 20±1 0.09 0.14 0.10 
Heart 5weeks 20±1 0.08 0.19 0.10 
Heart 5weeks 20±1 0.16 0.29 0.18 
Heart 5weeks 20±1 0.11 0.24 0.14 
Heart 5weeks 20±1 0.10 0.22 0.10 
Heart 5weeks 20±1 0.13 0.29 0.15 
Heart 5weeks 20±1 0.15 0.32 0.18 
 
Heart 1week 10±5 0.10 0.41 0.15 
Heart 1week 10±5 0.07 0.26 0.10 
Heart 1week 10±5 0.06 0.42 0.10 
Heart 1week 10±5 0.09 0.55 0.13 
Heart 1week 10±5 0.10 0.72 0.17 
Heart 1week 10±5 0.09 0.31 0.11 
Heart 1week 10±5 0.12 0.51 0.18 
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Tissue Time Temperature G0/G1 S G2/M 
Heart 1week 10±5 0.14 0.97 0.24 
Heart 1week 10±5 0.09 0.37 0.15 
Heart 1week 10±5 0.12 0.65 0.17 
Heart 1week 10±5 0.11 0.31 0.15 
Heart 1week 10±5 0.09 0.25 0.12 
Heart 2weeks 10±5 0.11 0.46 0.17 
Heart 2weeks 10±5 0.04 0.12 0.06 
Heart 2weeks 10±5 0.05 0.13 0.07 
Heart 2weeks 10±5 0.03 0.08 0.04 
Heart 2weeks 10±5 0.05 0.16 0.07 
Heart 2weeks 10±5 0.04 0.09 0.05 
Heart 2weeks 10±5 0.03 0.10 0.05 
Heart 2weeks 10±5 0.03 0.11 0.05 
Heart 2weeks 10±5 0.04 0.07 0.05 
Heart 2weeks 10±5 0.04 0.13 0.06 
Heart 2weeks 10±5 0.02 0.03 0.02 
Heart 2weeks 10±5 0.04 0.12 0.05 
Heart 5weeks 10±5 0.23 0.60 0.31 
Heart 5weeks 10±5 0.14 0.42 0.20 
Heart 5weeks 10±5 0.20 0.68 0.29 
Heart 5weeks 10±5 0.23 0.87 0.30 
Heart 5weeks 10±5 0.24 0.92 0.50 
Heart 5weeks 10±5 0.06 0.27 0.11 
Heart 5weeks 10±5 0.04 0.19 0.06 
Heart 5weeks 10±5 0.12 0.38 0.18 
Heart 5weeks 10±5 0.13 0.38 0.16 
Heart 5weeks 10±5 0.15 0.49 0.20 
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Tissue Time Temperature G0/G1 S G2/M 
Heart 5weeks 10±5 0.09 0.26 0.12 
Heart 1week 15±5 0.22 0.35 0.20 
Heart 1week 15±5 0.26 0.39 0.20 
Heart 1week 15±5 0.31 0.46 0.27 
Heart 1week 15±5 0.18 0.30 0.18 
Heart 1week 15±5 0.25 0.40 0.24 
Heart 2weeks 15±5 0.23 0.60 0.32 
Heart 2weeks 15±5 0.26 0.74 0.40 
Heart 2weeks 15±5 0.21 0.76 0.30 
Heart 2weeks 15±5 0.18 0.37 0.23 
Heart 2weeks 15±5 0.13 0.24 0.17 
Heart 2weeks 15±5 0.26 0.60 0.37 
Heart 2weeks 15±5 0.15 0.44 0.21 
Heart 2weeks 15±5 0.13 0.30 0.17 
Heart 2weeks 15±5 0.17 0.41 0.23 
Heart 2weeks 15±5 0.19 0.43 0.28 
Heart 2weeks 15±5 0.27 0.50 0.20 
Heart 2weeks 15±5 0.27 0.48 0.29 
Heart 5weeks 15±5 0.11 0.34 0.14 
Heart 5weeks 15±5 0.09 0.14 0.10 
Heart 5weeks 15±5 0.15 0.54 0.17 
Heart 5weeks 15±5 0.11 0.29 0.13 
Heart 5weeks 15±5 0.08 0.19 0.10 
Heart 5weeks 15±5 0.10 0.26 0.12 
Heart 5weeks 15±5 0.17 0.59 0.18 
Heart 5weeks 15±5 0.11 0.21 0.12 
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Tissue Time Temperature G0/G1 S G2/M 
Heart 1week 15±10 0.20 0.44 0.21 
Heart 1week 15±10 0.30 0.70 0.37 
Heart 1week 15±10 0.27 0.51 0.22 
Heart 1week 15±10 0.44 1.05 0.55 
Heart 1week 15±10 0.23 0.61 0.22 
Heart 1week 15±10 0.66 1.35 0.70 
Heart 2weeks 15±10 0.20 0.67 0.36 
Heart 2weeks 15±10 0.07 0.17 0.09 
Heart 2weeks 15±10 0.35 0.89 0.47 
Heart 2weeks 15±10 0.18 0.59 0.36 
Heart 2weeks 15±10 0.18 0.74 0.26 
Heart 2weeks 15±10 0.08 0.14 0.09 
Heart 2weeks 15±10 0.11 0.29 0.13 
Heart 2weeks 15±10 0.13 0.33 0.16 
Heart 2weeks 15±10 0.17 0.51 0.23 
Heart 2weeks 15±10 0.17 0.33 0.24 
Heart 2weeks 15±10 0.20 0.78 0.30 
Heart 2weeks 15±10 0.14 0.33 0.17 
Heart 5weeks 15±10 0.16 0.63 0.21 
Heart 5weeks 15±10 0.10 0.16 0.12 
Heart 5weeks 15±10 0.12 0.33 0.14 
Heart 5weeks 15±10 0.13 0.23 0.18 
Heart 5weeks 15±10 0.11 0.21 0.16 
Heart 5weeks 15±10 0.11 0.25 0.16 
Heart 5weeks 15±10 0.07 0.18 0.11 
Heart 5weeks 15±10 0.10 0.30 0.12 
Heart 5weeks 15±10 0.08 0.26 0.10 
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Tissue Time Temperature G0/G1 S G2/M 
Heart 5weeks 15±10 0.11 0.32 0.14 
Heart 5weeks 15±10 0.17 0.80 0.20 
 
Heart 1week 20±5 0.16 0.29 0.20 
Heart 1week 20±5 0.22 0.35 0.19 
Heart 1week 20±5 0.44 1.06 0.43 
Heart 1week 20±5 0.37 1.21 0.34 
Heart 1week 20±5 0.26 0.38 0.22 
Heart 2weeks 20±5 0.13 0.31 0.16 
Heart 2weeks 20±5 0.15 0.76 0.19 
Heart 2weeks 20±5 0.15 0.36 0.19 
Heart 2weeks 20±5 0.22 0.57 0.30 
Heart 2weeks 20±5 0.08 0.13 0.10 
Heart 2weeks 20±5 0.14 0.32 0.19 
Heart 2weeks 20±5 0.07 0.18 0.08 
Heart 2weeks 20±5 0.07 0.20 0.09 
Heart 2weeks 20±5 0.13 0.36 0.15 
Heart 2weeks 20±5 0.16 0.49 0.18 
Heart 2weeks 20±5 0.22 0.48 0.24 
Heart 5weeks 20±5 0.14 0.32 0.15 
Heart 5weeks 20±5 0.11 0.44 0.12 
Heart 5weeks 20±5 0.11 0.29 0.12 
Heart 5weeks 20±5 0.11 0.22 0.14 
Heart 5weeks 20±5 0.09 0.22 0.11 
Heart 5weeks 20±5 0.09 0.26 0.11 
Heart 5weeks 20±5 0.14 0.28 0.15 
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Tissue Time Temperature G0/G1 S G2/M 
Heart 5weeks 20±5 0.12 0.31 0.14 
Heart 5weeks 20±5 0.08 0.21 0.09 
 
Heart 3 weeks after 27 0.11 0.20 0.13 
Heart 3 weeks after 27 0.09 0.15 0.10 
Heart 3 weeks after 27 0.10 0.13 0.10 
Heart 3 weeks after 27 0.09 0.11 0.07 
Heart 3 weeks after 27 0.07 0.08 0.07 
Heart 3 weeks after 27 0.09 0.25 0.03 
Heart 3 weeks after 27 0.11 0.27 0.10 
Heart 3 weeks after 27 0.09 0.16 0.10 
Heart 3 weeks after 27 0.06 0.14 0.07 
Heart 3 weeks after 27 0.06 0.14 0.07 
Heart 3 weeks after 27 0.07 0.16 0.08 
Heart 3 weeks after 27 0.06 0.13 0.06 
Heart 3 weeks after 27 0.08 0.11 0.08 
Heart before 27 0.23 0.58 0.23 
Heart before 27 0.18 0.40 0.17 
Heart before 27 0.19 0.27 0.17 
Heart before 27 0.28 0.40 0.30 
Heart before 27 0.38 0.89 0.47 
Heart before 27 0.15 0.29 0.16 
Heart before 27 0.15 0.35 0.13 
Heart before 27 0.16 0.24 0.14 
Heart before 27 0.11 0.19 0.10 
Heart before 27 0.14 0.23 0.12 
Heart before 27 0.16 0.26 0.15 
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Tissue Time Temperature G0/G1 S G2/M 
Heart before 27 0.14 0.20 0.12 
Heart before 27 0.12 0.23 0.10 
Heart before 27 0.16 0.30 0.12 
Heart before 27 0.08 0.14 0.07 
Heart 1week 27 0.15 0.18 0.14 
Heart 1week 27 0.13 0.20 0.12 
Heart 1week 27 0.22 0.34 0.22 
Heart 1week 27 0.24 0.36 0.23 
Heart 1week 27 0.26 0.48 0.27 
Heart 1week 27 0.25 0.47 0.28 
Heart 2weeks 27 0.08 0.23 0.10 
Heart 2weeks 27 0.13 0.80 0.20 
Heart 2weeks 27 0.12 0.51 0.17 
Heart 2weeks 27 0.10 0.37 0.13 
Heart 2weeks 27 0.19 0.54 0.31 
Heart 2weeks 27 0.15 0.68 0.22 
Heart 2weeks 27 0.11 0.39 0.14 
Heart 2weeks 27 0.30 1.67 0.55 
Heart 2weeks 27 0.07 0.28 0.09 
Heart 2weeks 27 0.16 0.52 0.20 
Heart 2weeks 27 0.14 0.47 0.18 
Heart 2weeks 27 0.17 0.71 0.25 
Heart 5weeks 27 0.10 0.47 0.12 
Heart 5weeks 27 0.10 0.38 0.12 
Heart 5weeks 27 0.10 0.41 0.12 
Heart 5weeks 27 0.10 0.45 0.15 
Heart 5weeks 27 0.16 0.67 0.23 
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Tissue Time Temperature G0/G1 S G2/M 
Heart 5weeks 27 0.07 0.26 0.10 
Heart 5weeks 27 0.13 0.61 0.20 
Heart 5weeks 27 0.15 0.33 0.17 
Heart 5weeks 27 0.10 0.36 0.12 
 
Heart 3 weeks after GI 0.11 0.20 0.13 
Heart 3 weeks after GI 0.09 0.15 0.10 
Heart 3 weeks after GI 0.10 0.13 0.10 
Heart 3 weeks after GI 0.09 0.11 0.07 
Heart 3 weeks after GI 0.07 0.08 0.07 
Heart 3 weeks after GI 0.09 0.25 0.03 
Heart 3 weeks after GI 0.11 0.27 0.10 
Heart 3 weeks after GI 0.09 0.16 0.10 
Heart 3 weeks after GI 0.06 0.14 0.07 
Heart 3 weeks after GI 0.06 0.14 0.07 
Heart 3 weeks after GI 0.07 0.16 0.08 
Heart 3 weeks after GI 0.06 0.13 0.06 
Heart 3 weeks after GI 0.08 0.11 0.08 
Heart before GI 0.20 0.29 0.14 
Heart before GI 0.12 0.17 0.10 
Heart before GI 0.08 0.14 0.07 
Heart before GI 0.09 0.20 0.08 
Heart before GI 0.09 0.15 0.07 
Heart before GI 0.08 0.15 0.07 
Heart before GI 0.08 0.15 0.07 
Heart before GI 0.09 0.16 0.07 
Heart before GI 0.07 0.17 0.06 
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Tissue Time Temperature G0/G1 S G2/M 
Heart before GI 0.07 0.13 0.07 
Heart before GI 0.08 0.14 0.07 
Heart before GI 0.07 0.15 0.10 
Heart before GI 0.06 0.19 0.05 
Heart before GI 0.06 0.19 0.05 
Heart 1week GI 0.12 0.17 0.13 
Heart 1week GI 0.19 0.49 0.19 
Heart 1week GI 0.22 0.46 0.20 
Heart 1week GI 0.40 0.61 0.36 
Heart 1week GI 0.27 0.35 0.25 
Heart 2weeks GI 0.20 0.65 0.24 
Heart 2weeks GI 0.17 0.53 0.26 
Heart 2weeks GI 0.09 0.20 0.10 
Heart 2weeks GI 0.06 0.20 0.07 
Heart 2weeks GI 0.12 0.35 0.15 
Heart 2weeks GI 0.11 0.25 0.13 
Heart 2weeks GI 0.08 0.25 0.11 
Heart 2weeks GI 0.07 0.28 0.10 
Heart 2weeks GI 0.07 0.16 0.09 
Heart 2weeks GI 0.11 0.43 0.17 
Heart 2weeks GI 0.08 0.31 0.09 
Heart 2weeks GI 0.08 0.26 0.09 
Heart 5weeks GI 0.12 0.39 0.16 
Heart 5weeks GI 0.08 0.29 0.10 
Heart 5weeks GI 0.05 0.19 0.05 
Heart 5weeks GI 0.09 0.28 0.12 
Heart 5weeks GI 0.08 0.24 0.10 
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Tissue Time Temperature G0/G1 S G2/M 
Heart 5weeks GI 0.27 0.79 0.37 
Heart 5weeks GI 0.17 0.35 0.28 
Heart 5weeks GI 0.09 0.25 0.12 
Heart 5weeks GI 0.13 0.45 0.18 
 
Table B.7.  Data of labial palp nuclei for the analysis of temperature effects on nuclear RNA/DNA ratios at each phase of the cell 
cycle (Chapter 4 and 5). 
Tissue Time Temperature G0/G1 S G2/M 
Labial palps 3 weeks after 10 0.12 0.22 0.11 
Labial palps 3 weeks after 10 0.10 0.21 0.09 
Labial palps 3 weeks after 10 0.10 0.21 0.10 
Labial palps 3 weeks after 10 0.13 0.13 0.13 
Labial palps 3 weeks after 10 0.12 0.20 0.11 
Labial palps 3 weeks after 10 0.12 0.21 0.10 
Labial palps 3 weeks after 10 0.20 0.35 0.20 
Labial palps 3 weeks after 10 0.13 0.30 0.15 
Labial palps 3 weeks after 10 0.06 0.11 0.06 
Labial palps 3 weeks after 10 0.10 0.12 0.08 
Labial palps 3 weeks after 10 0.09 0.13 0.07 
Labial palps 3 weeks after 10 0.07 0.12 0.07 
Labial palps 3 weeks after 10 0.07 0.10 0.06 
Labial palps 3 weeks after 10 0.08 0.09 0.07 
Labial palps before 10 0.08 0.15 0.08 
Labial palps before 10 0.08 0.20 0.08 
Labial palps before 10 0.07 0.26 0.07 
Labial palps before 10 0.08 0.15 0.08 
Labial palps before 10 0.07 0.22 0.07 
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Tissue Time Temperature G0/G1 S G2/M 
Labial palps before 10 0.06 0.20 0.06 
Labial palps before 10 0.09 0.38 0.09 
Labial palps before 10 0.06 0.32 0.07 
Labial palps before 10 0.10 0.32 0.10 
Labial palps before 10 0.10 0.35 0.10 
Labial palps before 10 0.08 0.25 0.09 
Labial palps before 10 0.07 0.22 0.08 
Labial palps before 10 0.06 0.21 0.07 
Labial palps before 10 0.07 0.27 0.08 
Labial palps before 10 0.05 0.12 0.05 
Labial palps 1week 10±1 0.14 0.68 0.19 
Labial palps 1week 10±1 0.16 0.49 0.20 
Labial palps 1week 10±1 0.14 0.69 0.17 
Labial palps 1week 10±1 0.10 0.16 0.11 
Labial palps 1week 10±1 0.13 0.50 0.15 
Labial palps 1week 10±1 0.08 0.51 0.11 
Labial palps 1week 10±1 0.10 0.31 0.12 
Labial palps 1week 10±1 0.11 0.43 0.12 
Labial palps 1week 10±1 0.19 0.99 0.21 
Labial palps 1week 10±1 0.12 0.55 0.14 
Labial palps 1week 10±1 0.10 0.29 0.11 
Labial palps 1week 10±1 0.16 0.83 0.19 
Labial palps 2weeks 10±1 0.07 0.26 0.08 
Labial palps 2weeks 10±1 0.07 0.41 0.08 
Labial palps 2weeks 10±1 0.10 0.27 0.11 
Labial palps 2weeks 10±1 0.05 0.15 0.05 
Labial palps 2weeks 10±1 0.06 0.18 0.07 
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Tissue Time Temperature G0/G1 S G2/M 
Labial palps 2weeks 10±1 0.08 0.17 0.08 
Labial palps 2weeks 10±1 0.06 0.10 0.06 
Labial palps 2weeks 10±1 0.07 0.29 0.08 
Labial palps 2weeks 10±1 0.07 0.12 0.07 
Labial palps 2weeks 10±1 0.07 0.29 0.07 
Labial palps 2weeks 10±1 0.07 0.21 0.08 
Labial palps 2weeks 10±1 0.05 0.08 0.06 
Labial palps 5weeks 10±1 0.34 0.58 0.40 
Labial palps 5weeks 10±1 0.25 1.48 0.31 
Labial palps 5weeks 10±1 0.29 1.29 0.33 
Labial palps 5weeks 10±1 0.28 0.50 0.32 
Labial palps 5weeks 10±1 0.25 1.19 0.29 
Labial palps 5weeks 10±1 0.31 0.52 0.34 
Labial palps 5weeks 10±1 0.29 0.76 0.27 
Labial palps 5weeks 10±1 0.26 0.74 0.39 
Labial palps 5weeks 10±1 0.20 0.59 0.27 
Labial palps 5weeks 10±1 0.28 0.66 0.30 
 
Labial palps 3 weeks after 15 0.12 0.22 0.11 
Labial palps 3 weeks after 15 0.10 0.21 0.09 
Labial palps 3 weeks after 15 0.10 0.21 0.10 
Labial palps 3 weeks after 15 0.13 0.13 0.13 
Labial palps 3 weeks after 15 0.12 0.20 0.11 
Labial palps 3 weeks after 15 0.12 0.21 0.10 
Labial palps 3 weeks after 15 0.20 0.35 0.20 
Labial palps 3 weeks after 15 0.13 0.30 0.15 
Labial palps 3 weeks after 15 0.06 0.11 0.06 
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Tissue Time Temperature G0/G1 S G2/M 
Labial palps 3 weeks after 15 0.10 0.12 0.08 
Labial palps 3 weeks after 15 0.09 0.13 0.07 
Labial palps 3 weeks after 15 0.07 0.12 0.07 
Labial palps 3 weeks after 15 0.07 0.10 0.06 
Labial palps 3 weeks after 15 0.08 0.09 0.07 
Labial palps before 15 0.20 0.48 0.23 
Labial palps before 15 0.25 0.55 0.30 
Labial palps before 15 0.20 0.42 0.26 
Labial palps before 15 0.12 0.30 0.14 
Labial palps before 15 0.20 0.34 0.20 
Labial palps before 15 0.22 0.42 0.23 
Labial palps before 15 0.18 0.44 0.17 
Labial palps before 15 0.14 0.42 0.12 
Labial palps before 15 0.11 0.23 0.11 
Labial palps before 15 0.20 0.52 0.21 
Labial palps before 15 0.17 0.56 0.18 
Labial palps before 15 0.16 0.48 0.15 
Labial palps before 15 0.07 0.21 0.07 
Labial palps before 15 0.07 0.18 0.07 
Labial palps before 15 0.07 0.32 0.08 
Labial palps 1week 15±1 0.30 0.70 0.28 
Labial palps 1week 15±1 0.30 0.66 0.29 
Labial palps 1week 15±1 0.28 0.58 0.27 
Labial palps 1week 15±1 0.27 0.41 0.19 
Labial palps 1week 15±1 0.19 0.37 0.17 
Labial palps 1week 15±1 0.46 0.90 0.46 
Labial palps 2weeks 15±1 0.20 1.02 0.33 
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Tissue Time Temperature G0/G1 S G2/M 
Labial palps 2weeks 15±1 0.23 1.25 0.24 
Labial palps 2weeks 15±1 0.28 1.07 0.28 
Labial palps 2weeks 15±1 0.13 0.46 0.15 
Labial palps 2weeks 15±1 0.20 0.81 0.24 
Labial palps 2weeks 15±1 0.23 0.65 0.24 
Labial palps 2weeks 15±1 0.12 0.57 0.15 
Labial palps 2weeks 15±1 0.15 0.61 0.21 
Labial palps 2weeks 15±1 0.14 0.47 0.16 
Labial palps 2weeks 15±1 0.25 0.59 0.28 
Labial palps 2weeks 15±1 0.12 0.56 0.14 
Labial palps 2weeks 15±1 0.15 0.72 0.19 
Labial palps 5weeks 15±1 0.15 0.29 0.17 
Labial palps 5weeks 15±1 0.13 0.22 0.13 
Labial palps 5weeks 15±1 0.12 0.21 0.13 
Labial palps 5weeks 15±1 0.09 0.28 0.10 
Labial palps 5weeks 15±1 0.09 0.27 0.10 
Labial palps 5weeks 15±1 0.10 0.24 0.11 
Labial palps 5weeks 15±1 0.09 0.17 0.10 
Labial palps 5weeks 15±1 0.06 0.31 0.07 
Labial palps 5weeks 15±1 0.10 0.33 0.10 
 
Labial palps 3 weeks after 20 0.12 0.22 0.11 
Labial palps 3 weeks after 20 0.10 0.21 0.09 
Labial palps 3 weeks after 20 0.10 0.21 0.10 
Labial palps 3 weeks after 20 0.13 0.13 0.13 
Labial palps 3 weeks after 20 0.12 0.20 0.11 
Labial palps 3 weeks after 20 0.12 0.21 0.10 
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Tissue Time Temperature G0/G1 S G2/M 
Labial palps 3 weeks after 20 0.20 0.35 0.20 
Labial palps 3 weeks after 20 0.13 0.30 0.15 
Labial palps 3 weeks after 20 0.06 0.11 0.06 
Labial palps 3 weeks after 20 0.10 0.12 0.08 
Labial palps 3 weeks after 20 0.09 0.13 0.07 
Labial palps 3 weeks after 20 0.07 0.12 0.07 
Labial palps 3 weeks after 20 0.07 0.10 0.06 
Labial palps 3 weeks after 20 0.08 0.09 0.07 
Labial palps before 20 0.24 0.50 0.29 
Labial palps before 20 0.27 0.67 0.31 
Labial palps before 20 0.25 0.33 0.26 
Labial palps before 20 0.22 0.58 0.22 
Labial palps before 20 0.25 0.44 0.30 
Labial palps before 20 0.19 0.51 0.18 
Labial palps before 20 0.29 0.54 0.26 
Labial palps before 20 0.37 1.06 0.51 
Labial palps before 20 0.22 0.56 0.23 
Labial palps before 20 0.17 0.37 0.19 
Labial palps before 20 0.37 0.63 0.38 
Labial palps before 20 0.38 0.59 0.32 
Labial palps before 20 0.16 0.37 0.14 
Labial palps before 20 0.09 0.24 0.09 
Labial palps before 20 0.08 0.13 0.07 
Labial palps 1week 20±1 0.17 0.25 0.12 
Labial palps 1week 20±1 0.21 0.47 0.20 
Labial palps 1week 20±1 0.22 0.57 0.20 
Labial palps 1week 20±1 0.23 0.80 0.21 
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Tissue Time Temperature G0/G1 S G2/M 
Labial palps 1week 20±1 0.29 0.85 0.26 
Labial palps 1week 20±1 0.16 0.57 0.13 
Labial palps 1week 20±1 0.17 0.30 0.15 
Labial palps 1week 20±1 0.19 0.51 0.17 
Labial palps 1week 20±1 0.24 0.42 0.21 
Labial palps 1week 20±1 0.31 0.60 0.28 
Labial palps 1week 20±1 0.34 0.64 0.27 
Labial palps 1week 20±1 0.30 0.53 0.28 
Labial palps 2weeks 20±1 0.37 2.31 0.47 
Labial palps 2weeks 20±1 0.26 0.64 0.28 
Labial palps 2weeks 20±1 0.21 0.62 0.26 
Labial palps 2weeks 20±1 0.20 0.31 0.23 
Labial palps 2weeks 20±1 0.24 0.91 0.31 
Labial palps 2weeks 20±1 0.19 0.51 0.21 
Labial palps 2weeks 20±1 0.20 0.44 0.23 
Labial palps 2weeks 20±1 0.17 0.37 0.19 
Labial palps 2weeks 20±1 0.21 0.39 0.23 
Labial palps 2weeks 20±1 0.17 0.42 0.18 
Labial palps 2weeks 20±1 0.18 0.50 0.21 
Labial palps 2weeks 20±1 0.19 0.63 0.24 
Labial palps 5weeks 20±1 0.16 0.41 0.19 
Labial palps 5weeks 20±1 0.10 0.23 0.11 
Labial palps 5weeks 20±1 0.18 0.39 0.20 
Labial palps 5weeks 20±1 0.08 0.21 0.09 
Labial palps 5weeks 20±1 0.08 0.19 0.09 
Labial palps 5weeks 20±1 0.11 0.24 0.12 
Labial palps 5weeks 20±1 0.14 0.46 0.16 
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Tissue Time Temperature G0/G1 S G2/M 
Labial palps 5weeks 20±1 0.09 0.15 0.09 
Labial palps 5weeks 20±1 0.14 0.40 0.14 
 
Labial palps 1week 10±5 0.11 0.33 0.14 
Labial palps 1week 10±5 0.11 0.57 0.13 
Labial palps 1week 10±5 0.09 0.43 0.11 
Labial palps 1week 10±5 0.10 0.46 0.13 
Labial palps 1week 10±5 0.12 0.62 0.15 
Labial palps 1week 10±5 0.09 0.49 0.10 
Labial palps 1week 10±5 0.11 0.39 0.12 
Labial palps 1week 10±5 0.12 0.65 0.16 
Labial palps 1week 10±5 0.09 0.65 0.12 
Labial palps 1week 10±5 0.12 0.62 0.14 
Labial palps 1week 10±5 0.09 0.31 0.10 
Labial palps 1week 10±5 0.13 0.52 0.16 
Labial palps 2weeks 10±5 0.06 0.05 0.07 
Labial palps 2weeks 10±5 0.09 0.07 0.10 
Labial palps 2weeks 10±5 0.09 0.22 0.10 
Labial palps 2weeks 10±5 0.05 0.14 0.06 
Labial palps 2weeks 10±5 0.08 0.27 0.08 
Labial palps 2weeks 10±5 0.07 0.33 0.08 
Labial palps 2weeks 10±5 0.06 0.26 0.07 
Labial palps 2weeks 10±5 0.08 0.22 0.08 
Labial palps 2weeks 10±5 0.10 0.46 0.12 
Labial palps 2weeks 10±5 0.06 0.41 0.07 
Labial palps 2weeks 10±5 0.06 0.18 0.07 
Labial palps 2weeks 10±5 0.12 0.49 0.16 
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Tissue Time Temperature G0/G1 S G2/M 
Labial palps 5weeks 10±5 0.50 1.06 0.56 
Labial palps 5weeks 10±5 0.50 1.13 0.59 
Labial palps 5weeks 10±5 0.42 0.84 0.45 
Labial palps 5weeks 10±5 0.51 1.50 0.49 
Labial palps 5weeks 10±5 0.33 0.71 0.33 
Labial palps 5weeks 10±5 0.40 1.35 0.60 
Labial palps 5weeks 10±5 0.12 0.46 0.15 
Labial palps 5weeks 10±5 0.08 0.40 0.10 
Labial palps 5weeks 10±5 0.14 0.62 0.15 
Labial palps 5weeks 10±5 0.15 0.35 0.16 
Labial palps 5weeks 10±5 0.06 0.31 0.07 
Labial palps 5weeks 10±5 0.10 0.41 0.10 
 
Labial plaps 1week 15±5 0.21 0.27 0.17 
Labial plaps 1week 15±5 0.20 0.27 0.18 
Labial plaps 1week 15±5 0.17 0.23 0.14 
Labial plaps 1week 15±5 0.27 0.44 0.27 
Labial plaps 1week 15±5 0.17 0.28 0.14 
Labial plaps 1week 15±5 0.33 0.60 0.23 
Labial plaps 1week 15±5 0.15 0.18 0.11 
Labial plaps 1week 15±5 0.22 0.35 0.19 
Labial plaps 1week 15±5 0.26 0.30 0.27 
Labial plaps 1week 15±5 0.23 0.26 0.22 
Labial plaps 1week 15±5 0.17 0.18 0.16 
Labial plaps 1week 15±5 0.22 0.23 0.20 
Labial plaps 2weeks 15±5 0.39 2.28 0.53 
Labial plaps 2weeks 15±5 0.21 0.61 0.25 
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Tissue Time Temperature G0/G1 S G2/M 
Labial plaps 2weeks 15±5 0.13 0.48 0.14 
Labial plaps 2weeks 15±5 0.17 0.75 0.19 
Labial plaps 2weeks 15±5 0.18 0.58 0.23 
Labial plaps 2weeks 15±5 0.14 0.53 0.16 
Labial plaps 2weeks 15±5 0.18 0.30 0.20 
Labial plaps 2weeks 15±5 0.19 0.50 0.22 
Labial plaps 2weeks 15±5 0.22 0.65 0.26 
Labial plaps 2weeks 15±5 0.13 0.38 0.15 
Labial plaps 5weeks 15±5 0.14 0.43 0.17 
Labial plaps 5weeks 15±5 0.15 0.36 0.20 
Labial plaps 5weeks 15±5 0.10 0.18 0.10 
Labial plaps 5weeks 15±5 0.12 0.27 0.24 
Labial plaps 5weeks 15±5 0.12 0.18 0.12 
Labial plaps 5weeks 15±5 0.13 0.48 0.16 
Labial plaps 5weeks 15±5 0.08 0.23 0.09 
Labial plaps 5weeks 15±5 0.07 0.27 0.09 
Labial plaps 5weeks 15±5 0.11 0.35 0.11 
Labial plaps 5weeks 15±5 0.14 0.25 0.13 
 
Labial palps 1week 15±10 0.19 0.38 0.17 
Labial palps 1week 15±10 0.19 0.34 0.16 
Labial palps 1week 15±10 0.20 0.32 0.17 
Labial palps 1week 15±10 0.22 0.35 0.18 
Labial palps 1week 15±10 0.15 0.33 0.13 
Labial palps 1week 15±10 0.15 0.24 0.13 
Labial palps 1week 15±10 0.18 0.23 0.15 
Labial palps 1week 15±10 0.14 0.26 0.12 
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Tissue Time Temperature G0/G1 S G2/M 
Labial palps 1week 15±10 0.15 0.26 0.12 
Labial palps 1week 15±10 0.11 0.18 0.10 
Labial palps 1week 15±10 0.08 0.13 0.07 
Labial palps 2weeks 15±10 0.47 0.90 0.50 
Labial palps 2weeks 15±10 0.20 0.57 0.22 
Labial palps 2weeks 15±10 0.13 0.39 0.16 
Labial palps 2weeks 15±10 0.16 0.62 0.19 
Labial palps 2weeks 15±10 0.18 0.34 0.22 
Labial palps 2weeks 15±10 0.21 0.45 0.27 
Labial palps 2weeks 15±10 0.16 0.39 0.19 
Labial palps 2weeks 15±10 0.15 0.38 0.19 
Labial palps 2weeks 15±10 0.16 0.40 0.17 
Labial palps 2weeks 15±10 0.18 0.40 0.26 
Labial palps 2weeks 15±10 0.13 0.33 0.15 
Labial palps 5weeks 15±10 0.12 0.30 0.13 
Labial palps 5weeks 15±10 0.20 0.36 0.24 
Labial palps 5weeks 15±10 0.15 0.36 0.17 
Labial palps 5weeks 15±10 0.11 0.26 0.13 
Labial palps 5weeks 15±10 0.08 0.30 0.10 
Labial palps 5weeks 15±10 0.16 0.33 0.16 
Labial palps 5weeks 15±10 0.07 0.20 0.08 
Labial palps 5weeks 15±10 0.08 0.21 0.08 
Labial palps 5weeks 15±10 0.33 0.50 0.40 
 
Labial palps 1week 20±5 0.27 0.65 0.29 
Labial palps 1week 20±5 0.22 0.50 0.22 
Labial palps 1week 20±5 0.28 0.52 0.28 
 177
Tissue Time Temperature G0/G1 S G2/M 
Labial palps 1week 20±5 0.21 0.53 0.21 
Labial palps 1week 20±5 0.23 0.67 0.23 
Labial palps 1week 20±5 0.21 0.34 0.17 
Labial palps 1week 20±5 0.26 0.35 0.24 
Labial palps 2weeks 20±5 0.24 0.95 0.26 
Labial palps 2weeks 20±5 0.18 0.60 0.20 
Labial palps 2weeks 20±5 0.13 0.43 0.13 
Labial palps 2weeks 20±5 0.34 1.09 0.46 
Labial palps 2weeks 20±5 0.16 0.30 0.19 
Labial palps 2weeks 20±5 0.17 0.36 0.21 
Labial palps 2weeks 20±5 0.17 1.04 0.18 
Labial palps 2weeks 20±5 0.12 0.35 0.13 
Labial palps 2weeks 20±5 0.19 0.61 0.26 
Labial palps 2weeks 20±5 0.29 0.98 0.33 
Labial palps 2weeks 20±5 0.15 0.44 0.22 
Labial palps 2weeks 20±5 0.20 0.66 0.23 
Labial palps 5weeks 20±5 0.11 0.19 0.13 
Labial palps 5weeks 20±5 0.09 0.21 0.10 
Labial palps 5weeks 20±5 0.10 0.18 0.11 
Labial palps 5weeks 20±5 0.13 0.27 0.12 
Labial palps 5weeks 20±5 0.09 0.24 0.10 
Labial palps 5weeks 20±5 0.14 0.21 0.10 
Labial palps 5weeks 20±5 0.09 0.40 0.09 
Labial palps 5weeks 20±5 0.05 0.15 0.05 




Tissue Time Temperature G0/G1 S G2/M 
Labial palps 3 weeks after 27 0.12 0.22 0.11 
Labial palps 3 weeks after 27 0.10 0.21 0.09 
Labial palps 3 weeks after 27 0.10 0.21 0.10 
Labial palps 3 weeks after 27 0.13 0.13 0.13 
Labial palps 3 weeks after 27 0.12 0.20 0.11 
Labial palps 3 weeks after 27 0.12 0.21 0.10 
Labial palps 3 weeks after 27 0.20 0.35 0.20 
Labial palps 3 weeks after 27 0.13 0.30 0.15 
Labial palps 3 weeks after 27 0.06 0.11 0.06 
Labial palps 3 weeks after 27 0.10 0.12 0.08 
Labial palps 3 weeks after 27 0.09 0.13 0.07 
Labial palps 3 weeks after 27 0.07 0.12 0.07 
Labial palps 3 weeks after 27 0.07 0.10 0.06 
Labial palps 3 weeks after 27 0.08 0.09 0.07 
Labial palps before 27 0.25 0.55 0.27 
Labial palps before 27 0.19 0.50 0.22 
Labial palps before 27 0.24 0.49 0.27 
Labial palps before 27 0.25 0.58 0.26 
Labial palps before 27 0.26 0.36 0.30 
Labial palps before 27 0.22 0.35 0.21 
Labial palps before 27 0.12 0.39 0.11 
Labial palps before 27 0.21 0.51 0.21 
Labial palps before 27 0.28 0.55 0.24 
Labial palps before 27 0.13 0.21 0.12 
Labial palps before 27 0.15 0.24 0.13 
Labial palps before 27 0.15 0.26 0.13 
Labial palps before 27 0.08 0.24 0.08 
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Tissue Time Temperature G0/G1 S G2/M 
Labial palps before 27 0.11 0.28 0.10 
Labial palps before 27 0.06 0.14 0.06 
Labial palps 1week 27 0.13 0.19 0.12 
Labial palps 1week 27 0.15 0.21 0.14 
Labial palps 1week 27 0.14 0.19 0.12 
Labial palps 1week 27 0.16 0.27 0.13 
Labial palps 1week 27 0.20 0.35 0.17 
Labial palps 1week 27 0.18 0.32 0.15 
Labial palps 1week 27 0.10 0.18 0.09 
Labial palps 2weeks 27 0.29 0.76 0.29 
Labial palps 2weeks 27 0.26 0.95 0.30 
Labial palps 2weeks 27 0.19 0.26 0.21 
Labial palps 2weeks 27 0.18 0.59 0.18 
Labial palps 2weeks 27 0.16 0.28 0.16 
Labial palps 2weeks 27 0.19 0.51 0.20 
Labial palps 2weeks 27 0.14 0.37 0.15 
Labial palps 2weeks 27 0.23 0.61 0.26 
Labial palps 2weeks 27 0.13 0.62 0.17 
Labial palps 2weeks 27 0.11 0.39 0.13 
Labial palps 2weeks 27 0.16 1.00 0.18 
Labial palps 5weeks 27 0.14 0.50 0.16 
Labial palps 5weeks 27 0.12 0.37 0.13 
Labial palps 5weeks 27 0.13 0.55 0.20 
Labial palps 5weeks 27 0.13 0.41 0.19 
Labial palps 5weeks 27 0.07 0.22 0.09 
Labial palps 5weeks 27 0.08 0.48 0.12 
Labial palps 5weeks 27 0.13 0.24 0.17 
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Tissue Time Temperature G0/G1 S G2/M 
Labial palps 5weeks 27 0.07 0.31 0.08 
Labial palps 5weeks 27 0.10 0.32 0.13 
Labial palps 5weeks 27 0.10 0.39 0.12 
 
Labial palps 3 weeks after GI 0.12 0.22 0.11 
Labial palps 3 weeks after GI 0.10 0.21 0.09 
Labial palps 3 weeks after GI 0.10 0.21 0.10 
Labial palps 3 weeks after GI 0.13 0.13 0.13 
Labial palps 3 weeks after GI 0.12 0.20 0.11 
Labial palps 3 weeks after GI 0.12 0.21 0.10 
Labial palps 3 weeks after GI 0.20 0.35 0.20 
Labial palps 3 weeks after GI 0.13 0.30 0.15 
Labial palps 3 weeks after GI 0.06 0.11 0.06 
Labial palps 3 weeks after GI 0.10 0.12 0.08 
Labial palps 3 weeks after GI 0.09 0.13 0.07 
Labial palps 3 weeks after GI 0.07 0.12 0.07 
Labial palps 3 weeks after GI 0.07 0.10 0.06 
Labial palps 3 weeks after GI 0.08 0.09 0.07 
Labial palps before GI 0.08 0.18 0.07 
Labial palps before GI 0.08 0.15 0.07 
Labial palps before GI 0.05 0.11 0.05 
Labial palps before GI 0.10 0.17 0.09 
Labial palps before GI 0.10 0.18 0.09 
Labial palps before GI 0.09 0.23 0.07 
Labial palps before GI 0.05 0.11 0.05 
Labial palps before GI 0.08 0.17 0.07 
Labial palps before GI 0.07 0.11 0.07 
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Tissue Time Temperature G0/G1 S G2/M 
Labial palps before GI 0.07 0.14 0.07 
Labial palps before GI 0.07 0.15 0.07 
Labial palps before GI 0.07 0.18 0.06 
Labial palps before GI 0.07 0.18 0.06 
Labial palps before GI 0.08 0.20 0.07 
Labial palps before GI 0.08 0.16 0.07 
Labial palps 1week GI 0.20 0.35 0.21 
Labial palps 1week GI 0.17 0.40 0.15 
Labial palps 1week GI 0.23 0.29 0.19 
Labial palps 1week GI 0.19 0.34 0.16 
Labial palps 1week GI 0.20 0.28 0.17 
Labial palps 1week GI 0.20 0.30 0.16 
Labial palps 1week GI 0.16 0.21 0.15 
Labial palps 1week GI 0.18 0.29 0.14 
Labial palps 1week GI 0.19 0.27 0.17 
Labial palps 1week GI 0.39 0.40 0.25 
Labial palps 1week GI 0.24 0.29 0.17 
Labial palps 1week GI 0.22 0.31 0.16 
Labial palps 2weeks GI 0.18 0.52 0.20 
Labial palps 2weeks GI 0.25 0.83 0.36 
Labial palps 2weeks GI 0.16 0.51 0.19 
Labial palps 2weeks GI 0.19 0.72 0.21 
Labial palps 2weeks GI 0.13 0.41 0.15 
Labial palps 2weeks GI 0.17 0.58 0.20 
Labial palps 2weeks GI 0.06 0.27 0.09 
Labial palps 2weeks GI 0.10 0.49 0.12 
Labial palps 2weeks GI 0.08 0.27 0.11 
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Tissue Time Temperature G0/G1 S G2/M 
Labial palps 2weeks GI 0.06 0.35 0.07 
Labial palps 2weeks GI 0.09 0.15 0.12 
Labial palps 2weeks GI 0.09 0.27 0.11 
Labial palps 5weeks GI 0.14 0.48 0.15 
Labial palps 5weeks GI 0.10 0.29 0.14 
Labial palps 5weeks GI 0.07 0.28 0.09 
Labial palps 5weeks GI 0.09 0.24 0.11 
Labial palps 5weeks GI 0.02 0.04 0.02 
Labial palps 5weeks GI 0.13 0.28 0.14 
Labial palps 5weeks GI 0.10 0.32 0.12 
Labial palps 5weeks GI 0.10 0.28 0.11 



















Table B.8.  Immunohistochemical data of labial palp nuclei labeling indices for high percent of PCNA concentrations (Chapter 2). 
Tissue Number Negative-PCNA Positive-PCNA Labeling Index (LI) 
15±10-4-2 998 2 0.20 
15±5-7-2 999 1 0.10 
15±1-8-1 985 15 1.52 
GI-6-1 992 8 0.81 
INT-14 997 3 0.30 
27-9-1 998 2 0.20 
10±1-9-1 996 4 0.40 
15±1-11-1 974 26 2.67 
20±1-8-1 991 9 0.91 
10±1-1-2 1000 0 0.00 
 
Table B.9.  Immunohistochemical data of labial palp nuclei labeling indices for low percent of PCNA concentrations (Chapter 2). 
Tissue Number Negative-PCNA Positive-PCNA Labeling Index (LI) 
GI-11-4 983 17 1.73 
20±1-3-4 998 2 0.20 
15±5-11-4 997 3 0.30 
10±5-7-4 999 1 0.10 
27-6-4 984 16 1.63 
20±5-3-4 999 1 0.10 
15±10-2-3 993 7 0.70 
10±5-3-3 971 29 2.99 
15±1-3-4 1000 0 0.00 
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